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 I 
Thesis abstract  
Recent studies of experimental glaucoma have suggested that retinal ganglion cells 
(RGCs) undergo a period of pre-morbid dysfunction, and there is some evidence that 
this may also occur in humans with glaucoma. A conceptual model by Porciatti & 
Ventura (2012) illustrates that reduced visual function owing to pre-morbid changes in 
RGCs may be recoverable in early disease with timely intraocular pressure-lowering 
treatment. In this thesis, pre-morbid dysfunction is investigated in glaucoma patients 
before, and 6 months after, trabeculectomy treatment with measures of spatial 
summation (specifically, Ricco’s area, previously found to be larger in glaucoma 
patients than in healthy controls in visual field regions with very early damage). 
Controls were a cohort of patients with stable glaucoma, and age-similar healthy 
individuals. The hypothesis was that an already-enlarged Ricco’s area would shrink in 
response to IOP-lowering treatment, while no between-visit change would be 
observable in the stable glaucoma and healthy control groups. A slight overall reduction 
in Ricco’s area was found in those test locations with least baseline damage, but an 
overall enlargement was found in those with more moderate-advanced baseline damage. 
An initial study of Ricco’s area in amblyopia, a condition in which the retinal receptive 
fields are understood to be normal, found that Ricco’s area was larger than normal when 
measured through the amblyopic eye, and smaller than normal when measured through 
the non-amblyopic eye. This finding, together with findings described in published 
literature suggest a cortical origin for Ricco’s area. Thus, it may be that in regions with 
early damage, recovery from dysfunction was observed, while in those with moderate-
advanced damage, a cortical adaptation to cell death was observed. Finally, permutation 
of between-visit differences in Ricco’s area and sensitivity to a Goldmann III stimulus 
indicates that the former has a relatively higher signal-to-noise ratio (SNR) for 
identifying change over time.
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Chapter 1: Glaucoma and Spatial Summation 
 
1.1. Introduction 
Glaucoma is a single term used to describe a group of degenerative eye conditions that 
cause optic nerve damage, with resultant lost of visual function (Quigley 2005). It is the 
second most prevalent cause of irreversible blindness worldwide, with an estimated 60 
million people affected, predicted to increase to 111.8 million people by 2040 (Tham et 
al. 2014). Its prevalence increases with age and is more commonly reported in people 
over 40 years of age (Quigley & Vitale 1997). 
 
There are two subdivisions of glaucoma types, open and close angle. Both can be 
subdivided into primary and secondary diseases. Primary refers to cases of 
glaucomatous optic neuropathy with normal or elevated intraocular pressure (IOP) with 
no other pathological causes present. Secondary refers to cases occurring secondary to 
trauma, as a side effect of medication or ocular pathology such as anterior uveitis, 
neovascularization, pigment dispersion and pseudoexfoliation syndrome. These 
conditions can elevate IOP either by loss of cellular tissue or pigment deposition in the 
trabecular meshwork (Casson et al. 2012; Foster et al. 2002).   
 
Primary open angle glaucoma (OAG) is most commonly bilateral (not necessarily 
symmetrical) asymptomatic optic neuropathy, with or without elevated IOP. Previously, 
Primary OAG with IOP <21mmHg was called ‘Normal Tension Glaucoma (NTG)’, but 
this term has fallen out of favour, as we now know that disease progression can happen 
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at all IOP levels. The loss of visual function in POAG usually progresses slowly, 
beginning in the mid-periphery and expanding both toward the center and periphery 
(Foster et al. 2002; Quigley 2011).  
 
Primary angle closure glaucoma has elevated IOP that caused by obstruction of aqueous 
humor outflow due to narrowing and closure of the anterior chamber angle. The anterior 
chamber angle closure can be caused by age-related enlargement of crystalline lens, 
pushing the peripheral iris to be in contact with posterior cornea, leading to obstruction 
of the trabecular meshwork for more than half of the 360° angle that is observable in 
gonioscopy. Unlike primary OAG in which the patient is usually asymptomatic until the 
moderate or advanced stage of the disease, Primary angle closure patients report pain 
and sudden decrease in vision due to the acute rise in IOP (Foster et al. 2002; Quigley 
2011). Primary OAG is more common in the West African population than in 
Caucasian population, whilst primary angle closure glaucoma is more common in Asian 
populations (Foster et al. 1996; Foster et al. 2000; Racette et al. 2003). 
1.2. Pathophysiology of glaucoma 
In healthy eyes, the flow of aqueous humor against resistance result in a mean IOP of 
approximately 15mmHg, with 21mmHg taken as the threshold for IOP normality 
(Hollows & Graham 1966). For many years, the widely held hypothesis was that 
glaucoma is caused by elevated IOP to a pressure higher than 21mmHg due to 
disruption of the aqueous outflow. This has since been questioned by population studies 
(Buhrmann et al. 2000; Sommer et al. 1991; Quigley et al. 2001) showing individuals 
with IOP higher than ‘normal’ not developing glaucoma and individuals with ‘normal’ 
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IOP diagnosed with glaucoma. Thus there must be other mechanisms involved in the 
pathogenesis of glaucoma. 
 
Elevated IOP, although now not considered as the main cause of glaucoma, is now 
widely recognized as one of the treatable risk factors, with the greatest risk factor being 
age (Chauhan et al. 2008a; Klein et al. 1992; Quigley et al. 2001). It has been 
demonstrated that an IOP reduction of 20% slows down the rate of progression in 
glaucoma by 50% (AGIS-Investigators 2000; Heijl et al. 2002; Kass et al. 2002). IOP is 
balanced by the secretion of aqueous humor by the ciliary body and its drainage through 
the trabecular meshwork and the uveoscleral pathway. Elevated IOP can cause 
mechanical strain on the back surface of the eye, particularly on the lamina cribosa, the 
weakest point in the posterior eye surface. This causes compression and deformation of 
the lamina cribosa, giving rise to axonal damage and disruption of both orthograde and 
retrograde delivery of essential trophic factors. Therefore experimental models of 
glaucoma with elevated IOP should provide useful insights into the pathogenesis and 
pathophysiology of glaucoma. Indeed, experiments to study the nature of glaucoma are 
still done by observation of the histological changes in animal eyes (rodents and 
primates), with glaucoma that is induced by elevating the IOP experimentally or which 
occurs spontaneously in rodent models that have been manipulated genetically (Johnson 
& Tomarev 2010; Morrison et al. 2008) 
 
Loss of retinal ganglion cells (RGCs) is responsible for visual field loss in glaucoma. 
The normal human retina contains approximately 1.07 million RGCs with 0.3-0.6% loss 
per year due to ageing (Harwerth et al. 2008; Mikelberg et al. 1989). This number 
increases to an average of 4.4% per year in glaucoma (Medeiros et al. 2012). The 
Chapter 1 	
 
 4 
primary mechanism of RGCs loss in glaucoma is not clear, but evidence has suggested 
that it occurs via apoptosis, a programmed cell death in the absence of inflammation, 
characterized by DNA fragmentation, chromosome clumping, cell shrinkage and 
membrane blebbing (Nickells 1999; Derick et al. 1994; Pease et al. 2000; Quigley 
1999). Several hypotheses have been proposed to be responsible for RGCs loss and will 
be discussed in details in subsequent sections. 
 
1.2.1. Mechanical changes in the optic nerve head 
Studies in experimental glaucoma have provided extensive evidence for the optic nerve 
head (ONH) /optic disc as the site of initial damage. It has been observed in 
experimental glaucoma, that IOP elevation causes compression of the structural plates 
of the connective tissue of the ONH and outward rotation of the insertion of the laminar 
plates into the sclera (Quigley, Davis & Anderson 1977; Quigley et al. 1983; Quigley 
1995). One of the widely held hypotheses for the trigger of the RGCs death process in 
glaucoma is that these mechanical changes in ONH cause interruption to the axonal 
transport at the level of the lamina cribosa, blocking of anterograde and retrograde 
axoplasmic transport, leading to deficits in brain derived neurotrophic factor and 
neurotrophins 4/5 from the superior colliculus to RGC soma, which is necessary for 
RGC survival (Chen & Weber 2001; Di Polo et al. 1998; Johnson et al. 2000; Quigley 
1999; Weber & Harman 2008). When neurotrophic factors such as nerve growth factor, 
ciliary neurotropic factor and brain derived neurotrophic factor were administered 
exogenously, there was evidence of in vitro and in vivo RGC protection (Johnson et al. 
1986; Rabacchi et al. 1994). Racial and gender differences were observed despite 
similar IOP profiles, suggesting lack of perfect correlation between IOP and visual field 
loss (Foster et al. 1996; Vajaranant et al. 2010). It is possible that there are variations in 
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the biomechanical properties of tissues at ONH and sclera, contributing to variability of 
deformation of ONH (Downs 2015).  
 
1.2.2. Ischaemic theory in glaucoma 
Reduced ocular blood flow had been proposed to cause RGC death either by recurrent 
mild ischaemic injury, that leads to chronic oxidative stress and excitotoxicity, or by 
reducing RGC tolerance to secondary insults from glutamate, nitric oxide and 
phototoxicity causing mitochondrial dysfunction (Chrysostomou et al. 2013; 
Mozaffarieh & Flammer 2013; Osborne 2010). This theory is supported by increased 
prevalence of glaucoma with age, as mitochondrial function decreases with age and is 
more susceptible to insult caused by elevated IOP (Chrysostomou et al. 2010; 
Lascaratos et al. 2012). Positive association has been observed between glaucoma with 
peripheral vascular conditions (Wang et al. 1997) and migraine (Cursiefen et al. 2000).  
 
1.2.3. Neurotoxicity theory in glaucoma 
The toxic effect of glutamate, an excitatory neurotransmitter in the mammalian central 
nervous system in RGCs, was first observed when subcutaneous glutamate injections in 
mice caused severe degeneration of inner retinal layers, including the RGC layer (Lucas 
& Newhouse 1957). It was also observed to cause loss of the RGC layer in neonatal 
mice (Siliprandi et al. 1992) and rats (Dreyer et al. 1994). RGC death in glutamate 
toxicity was hypothesized to occur due to the production of matrix-metalloproteinases 
by astrocytes that leads to apoptosis of RGCs (Zhang et al. 2004). Glutamate toxicity 
has also been observed in other neurodegenerative conditions, such as Parkinson’s and 
Huntington’s disease (Choi 1988). 
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Nitric oxide synthase-2 has been suggested to produce neurotoxic effects upon RGCs, 
since its concentration rose proportionally with increase in IOP. Nitric oxide synthase-2 
has been observed to increase in glaucomatous eyes, when compared to healthy eyes 
(Neufeld et al. 1997; Neufeld et al. 1999) 
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1.3. Tests for diagnosis and assessment of glaucoma 
The progressive loss of RGCs in glaucoma is detected, monitored and evaluated with a 
combination of structural and functional tests. In clinical practice, a triad of tests is 
routinely used to diagnose glaucoma; optic nerve head assessment, IOP measurement 
and perimetry (EGS Guidelines 2017). 
 
1.3.1. Tests of neural structure in glaucoma 
RGCs are post-mitotic neurons, and thus are not replaced once lost. The loss of RGCs is 
usually manifest structurally as progressive thinning of nerve fibers in the retina that is 
observable clinically with direct ophthalmoscopy and indirect slit-lamp biomicroscopy 
as an enlargement of the optic nerve cupping in relation to constant disc size (cup-to-
disc ratio [C/D ratio]) (Quigley 2011).  
 
Traditionally, horizontal measurement of C/D ratio is used to assess the presence and 
monitor the progression of glaucoma (Armaly 1967). However, it was observed that the 
optic cup enlarged more vertically in glaucoma, possibly due to the lack of connective 
tissue support in upper and lower poles of the optic disc that in turn accelerates the 
axonal loss in the areas with resultant enlargement of vertical C/D ratio, contributing to 
greater interruption of axonal transport in the areas (Garway-Heath et al. 1998; Quigley 
& Addicks 1981; Quigley 1999). Thus vertical C/D ratio is thought to provide a better 
insight into progression of glaucoma. Subjective assessment of ONH with 
ophthalmoscopy and slit-lamp biomicroscopy suffers from inter- and intra- subject 
variability that impedes the judgment of the presence and progression of glaucoma 
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(Varma et al. 1992). The major problem with trying to assess glaucoma with this 
technique is that there is a wide range of C/D ratio in the normal population (up to 
0.87), with big optic discs having bigger cup sizes and vice versa, making it a challenge 
to categorize an optic disc as normal or glaucomatous (Jonas et al. 1988a). Foster et al. 
(2002) in a population-based study suggested that a C/D ratio of 0.7 represents 97.5 
percentile for limits of normality in most of the ethnic groups participating in the study. 
But it has to be noted that even though 0.7 is considered the threshold for normality, it is 
not a clear-cut point for all people. Hypermetropes generally have a smaller ONH with 
smaller optic cup and thus need to lose more of the neural tissue before the C/D ratio 
exceeds ‘normal’ range, and vice versa for myopes (Jonas et al. 1988b; 
Papastathopoulos et al. 1995). 
 
There are other signs of glaucomatous optic nerve damage that, when taken into account 
with the C/D ratio, can help improve diagnosis accuracy of glaucoma. Glaucoma 
usually affects the eyes asymmetrically and thus can cause asymmetry in C/D ratio 
between two eyes; C/D ratio differences of more than 0.2 are considered suspicious 
(Sharma & Chaturvedi 1982). Other glaucomatous signs in the optic disc include 
stretching of the pores of lamina cribosa (Susanna 1983), focal notching due to 
localized nerve fiber layer loss, peri-papillary atrophy, optic disc pallor, arterial 
narrowing, overpass vessels, disc hemorrhages and uneven reflections from the nerve 
fibre layer (Hitchings 1978).   
 
Objective techniques for imaging the optic nerve head and for quantifying the retinal 
nerve fibre layer have been developed in an attempt to more accurately identify changes 
in the neural retina in glaucoma. Confocal scanning laser ophthalmoscopy and optical 
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coherence tomography (OCT) have been used as adjuncts to subjective ONH 
assessment.  Confocal scanning laser ophthalmoscopy uses a laser point light source to 
scan the retina, enabling retinal photographic imaging. The confocal pinhole aperture 
acts to minimize scattered and reflected light outside of the image focal-plane, 
increasing the lateral resolution when compared to fundus photography. However 
confocal scanning laser ophthalmoscopy does not work well when patients have small 
pupils or ocular opacities (Alexandrescu et al. 2010). OCT is a non-invasive optical 
imaging system that utilizes low-coherence interferometry to produce a two-
dimensional cross sectional image of the retina. Spectral domain OCT has been used 
clinically to monitor longitudinal retinal nerve fiber layer changes in glaucoma. 
However OCT still cannot visualize RGCs due to their near transparent nature (Bussel 
et al. 2014).  
 
1.3.2. Tests of visual function in glaucoma 
Visual field (VF) measurement with white-on-white standard automatic perimetry 
(SAP) remains the most common measurement of visual function for detection and 
monitoring glaucoma progression in clinical practice. As the ‘gold standard’ functional 
measurement for assessing the effectiveness of glaucoma treatment, SAP is surprisingly 
variable (Artes et al. 2002; Bengtsson, Heijl & Olsson 1998; Heijl, Lindgren & 
Lindgren 1989; Spry et al. 2001). Artes et al. (2002) highlight the problem particularly 
well. They were looking at the variability of SAP thresholds and reported that SAP only 
performed relatively well in areas of visual field with high sensitivity. As can be seen 
from Figure 1.1, the test-retest variability increases with decreasing sensitivity. The 
variability then decreases again at near zero region because of the limited dynamic 
range of SAP, the so called “floor effect” (Artes et al. 2002).  SAP has also been shown 
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to exhibit even larger amounts of variability in patients with glaucoma and in glaucoma 
suspects (Donovan et al. 1978; Flammer, Drance & Zulauf 1984; Werner et al. 1982). 
The variability in SAP causes difficulty in distinguishing whether the changes observed 
in the field are true glaucomatous VF loss, or just the variation in test results (Heijl et al. 
2003; Keltner et al. 2006). Consequently, multiple measurements over a long period of 
time are needed to distinguish true glaucomatous field loss from long-term fluctuations. 
Chauhan et al. (2008b) performed statistical calculation to detect the rates of mean 
deviation change for a given number of presentations and reported that in order to detect 
a typical scenario with moderate glaucoma progression (-0.5dB/year loss), 13 years are 
needed, if one VF examination is performed per year; 6.4 and 4.3 years are required for 
two and three examinations respectively. Quigley, Addicks & Green (1982) compared 
the number of human optic nerve axons with the SAP data from the same eye and 
observed that up to 50% of ganglion cells needed to be lost before SAP would show a 
defect. Similar findings were obtained by Harwerth et al. (1999) study with trained 
monkeys. However, Harwerth and colleagues plotted their data with logarithmic scale, 
thus putting more emphasis on more advanced stages of RGCs loss. Later work by 
Garway-Heath et al. (2002) comparing SAP with structural measurements with the 
Heidelberg retina tomograph reported that, when the data are plotted on a standard 
linear scale, the structure and function relationship is linear, though the data still vary 
greatly.  
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Figure 1.1 Test-retest limits of SAP measured with SITA standard. Thin vertical lines 
indicating 90% of the test-retest intervals between the 5th and 95th percentiles. Vertical 
bars indicate the interquartile ranges and solid lines represent 90% retest limits for 
Full Threshold strategy. Picture taken from Artes et al. (2002). 
 
The inadequacies of SAP drove scientists to develop more accurate functional tests. 
They argued that the white-on-white perimetry stimulated a wide range of RGC types, 
and thus had considerable redundancy that can mask early glaucomatous damage. The 
ideal test should isolate a specific population of RGCs that either is preferentially lost 
early in the disease, or has less redundancy.  
 
In 1988, Quigley and colleagues suggested a preferential loss of large optic nerve fibers 
in glaucoma, which are mostly part of the magnocellular visual processing stream. As 
magnocellular cells are known to be sensitive to motion and high frequency flicker, it 
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was thought that tests that target this response property will detect glaucoma earlier 
(Dandona, Hendrickson & Quigley 1991; Quigley, Dunkelberger & Green 1988). 
Frequency doubling perimetry (FDP) and its successor, FDP – 2 which has a different 
thresholding algorithm and more refined test pattern, compared with the previous 
version, were developed for the purpose of isolating magnocellular cell activity, more 
specifically a subset of magnocellular cells first reported in cat named My cells, by 
employing flickering grating stimuli of fixed spatial frequency (Artes et al. 2005; 
Johnson & Samuels 1997). Frequency doubling is an illusion, in which alternating light 
and dark bars will appear to be twice the actual number of bars when low spatial 
frequency sinusoidal gratings are flickered at high temporal frequency (>10Hz) and the 
illusion is reportedly mediated by the My cell (Maddess and Henry 1992; Kelly 1966). 
However, although FDP is created based on the illusion, the task involved in this 
psychophysical test is detection of the gratings and not the illusion. Cross-sectional 
studies have reported constant test-retest variability over the dynamic range of the 
instrument and lower variability with increasing defect severity in both FDP and FDP2, 
suggesting they may be better tests for earlier detection and monitoring progression of 
glaucoma than SAP. The effects of eccentricity on variability are also less than those 
reported in SAP. These superior performances of FDP have been attributed to the larger 
stimulus size used by FDP, which might be less affected by small eye movements 
compared to SAP (Artes et al. 2005; Chauhan & Johnson 1999; Leeprechanon et al. 
2007; Spry et al. 2001; Wall et al. 2009). FDP1 has been shown to be able to detect 
glaucoma earlier by as much as 4 years in 59% of 105 glaucoma suspects (Medeiros et 
al. 2004). However the result from Medeiros and colleagues should be viewed with 
caution, as the objective was to assess the strength of FDP in predicting future 
development of SAP visual field defect in glaucoma suspects, thus the majority of 
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participants had normal baseline SAP visual fields. This could have omitted populations 
of people that might have abnormal SAP, but normal FDP. 
 
Direct comparison between the threshold estimate of FDP1&2 and SAP are difficult due 
to the different scale of measurement. In both versions of FDP, a 1-dB change in 
threshold equals a 0.05 log unit change in stimulus contrast, whilst with SAP, a 1-dB 
change equates to a contrast change of 0.1 log unit. They also differ in measurement 
ranges, with SAP showing a greater floor effect compared to FDP2 (Artes et al. 2005) 
and thus limiting the usefulness of results of previous studies comparing the techniques 
based solely on the mean and pattern standard deviations. Artes & Chauhan (2009) 
compared SAP and FDP2 using estimation of the ratio between signal and noise; here 
asymmetries in the differences in sensitivity between superior and inferior mirror pairs 
of sectors in the visual field, were taken as signal and the variability of sensitivity 
differences from test to test, as noise. This allows identification of localized VF loss that 
is independent of decibel scale, and thus gives better comparison between techniques. 
The authors found a higher signal to noise ratio in FDP2, supporting the hypothesis that 
FDP2 has superior ability compared to SAP in detection of glaucoma progression over 
time. However Redmond et al. (2013a) in a longitudinal study of 5 year on 100 patients 
using permutation point-wise linear regression, an analysis method that gives a single P 
value that is independent of the scale of original measurement, however, found no 
evidence that FDP2 is more sensitive than SAP in identification of visual field 
progression at fixed specificity.  
 
Recent histological and psychophysical evidence has cast doubt on the preferential loss 
of magnocellular cells hypothesis (Ansari et al. 2002b; Morgan 2002; Sample, 
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Bosworth & Weinreb 1997; Weber et al. 1998). It is now presumed that RGCs are 
affected non-selectively in glaucoma (further explanation available in section 1.5). But 
this does not mean that tests which selectively target the magnocellular pathway have 
no more utility than SAP, as tests that only isolate one particular aspect of visual 
processing will also prevent the sparing in other visual systems from compensating for 
the damage caused by glaucoma and thus could detect glaucoma earlier (Ansari et al. 
2002b). However it is unclear whether FDP actually preferentially stimulates the My 
cells, as studies looking at the presence of this subgroup of highly non-linear cells in 
primates with retrograde labeling and counter-phased modulated sinusoidal gratings 
recording have not been able to confirm their presence (Levitt et al. 2001; White et al. 
2002). White et al. (2002) instead suggest that the illusion originated at the level of 
cortex and not the retina. Furthermore there is a large overlap between the respective 
response characteristics of the magnocellular and parvocellular pathways. The 
parvocellular pathway peak temporal frequency, cut off temporal frequency and peak 
spatial frequency only differ by 15% from those of magnocellular pathway (Merigan & 
Maunsell 1993). Swanson et al. (2011), looking at the response of magnocellular and 
parvocellular cells to SAP and FDP, reported that a Goldmann size III stimulus in SAP 
is better than sinusoidal gratings in FDP at preferentially stimulating magnocellular 
cells. They observed that the abrupt ON and OFF of the Goldmann stimulus provides it 
with high temporal frequency components, whilst the lack of a chromatic component 
causes a weak P cell response. 
 
Short wavelength automated perimetry (SWAP) was developed following the finding of 
short wavelength colour vision defects in patients with early glaucoma (King-Smith, 
Lubow & Benes 1984). SWAP employed a blue Goldmann size V stimulus to 
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preferentially stimulate the blue cones. Yellow background of 100cd/m2 is used to 
simultaneously adapt the green and red cones, and also to saturate the rod activity. 
Longitudinal studies on SWAP have shown it to be able to detect progression of 
glaucoma 6 months to 5 years earlier than SAP and also that the rate of VF progression 
is more rapid for SWAP in early glaucoma patients (Johnson et al. 1993; Sample, 
Boynton & Weinreb 1993; Bayer & Erb 2002). SWAP sensitivity to earlier damage is 
attributed to its ability to detect selective damage to the short wavelength sensitive 
pathway in early glaucoma (Heron et al. 1987; Sample et al. 1988). As it is now 
recognized that all pathways in the retina are affected equally in glaucoma, a more 
convincing alternative hypothesis states that its potential to monitor the small 
population of small bistratified ganglion cells (1-7%), which are responsible for 
mediating the short wavelength sensitive pathway, may be one reason behind the earlier 
detection by SWAP of glaucomatous damage (Dacey 1994; Johnson 1994; Morgan et 
al. 2000). However not all studies agree on the apparently superior performance of 
SWAP in early diagnosis of glaucoma. Conflicting studies have reported that SAP field 
loss can occur prior to or at the same time as SWAP, and some found that SWAP visual 
field loss is not followed by SAP even after 5 years follow up (Havvas et al. 2013; van 
der Schoot et al. 2010). Possible explanations for this discrepancy of findings are: 
different studies utilize different criteria of abnormality; sampling bias in which only 
participants with normal SAP are included, but not those with abnormal SAP and 
normal SWAP fields; failing to take into account the extended learning effect - up to 5 
examinations (Wild et al. 2006); and different criteria of abnormality between studies. 
The major problem with SWAP is its use of blue stimulus that is heavily absorbed by 
the yellowing crystalline lens (Sample & Weinreb 1992), and thus cumbersome to be 
used in clinical routine, as the prevalence of glaucoma increases with age. SWAP has 
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also been reported to have higher variability compared to SAP (Blumenthal et al. 2003), 
possibly owing to the longer testing time. Recently, a faster thresholding algorithm 
called Swedish Interactive Threshold Algorithm (SITA) has been implemented on 
SWAP to reduce testing time, and Bengtsson & Heijl (2006) reported that SITA SWAP 
has comparable diagnostic sensitivity with SAP. 
1.3.3. Measurement of Intraocular Pressure (IOP) 
Goldman applanation tonometry was first introduced in the 1950s and has since enjoyed 
the reputation as the gold standard test for IOP measurement. It converts the force 
necessary to flatten the cornea into a measurement of pressure. Goldman applanation 
tonometry was designed/ calibrated for an estimated corneal thickness of 500 µm and 
thus the instrument tends to overestimate IOP in corneas with above the ‘normal’ 
thickness, and to underestimate IOP in corneas with thickness below normal. This can 
cause many patients to be misclassified as glaucoma suspect and thus the measurement 
of IOP in practice nowadays is accompanied by measurement of central corneal 
thickness, when deemed necessary (Doughty & Zaman 2000). Although glaucoma is 
now recognized as a multifactorial disease, and elevation of IOP over 21mmHg is not 
synonymous with glaucoma, measurement of IOP is still of paramount significance. 
Elevated IOP is the major risk factor for glaucoma and IOP lowering therapy remains 
the only treatment with proven benefit in slowing down progression of glaucoma 
(Chauhan et al. 2010; Leske et al. 2003).  
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1.4. Retinal ganglion cell dysfunction 
Histological studies analyzing the RGC soma distribution in post-mortem humans and 
primates reported a selectively greater reduction in large RGCs in early stages of 
glaucoma (Glovinsky et al. 1991; Glovinsky et al. 1993; Quigley et al. 1987; Quigley, 
Dunkelberger & Green 1988). The RGC and axon sizes correspond roughly with the 
RGC type, midget and parasol cells (Perry et al. 1984). Midget cells represent 80% of 
the RGC population; they have medium sized soma with small to medium sized 
dendritic trees. The axons of the midget cells project to the parvocellular layers of the 
lateral geniculate nucleus (LGN). They respond best to chromatic stimulus with high 
spatial and low temporal frequency. Parasol cells on the other hand only represent 10% 
of the RGC population and have large somas and dendritic trees. They project to 
magnocellular layers of the LGN and respond best to achromatic stimuli of high 
temporal and low spatial frequency (Dacey & Petersen 1992; Dacey 1994; Rodieck et 
al. 1985; Leventhal et al. 1981). 
The selective loss of large RGCs was interpolated as evidence of preferential damage of 
parasol cells in glaucoma. This hypothesis was supported by significant loss of cells in 
magnocellular laminae, but not in parvocellular laminae of the LGN in five post-
mortem patients with glaucoma and thus drove the creation of psychophysical tests that 
target the properties of the parasol cells (Ansari et al. 2002a; Chaturvedi et al. 1993). 
Although psychophysical tests targeting parasol cell dysfunction demonstrated deficits 
in motion perception in patients with early glaucoma and ocular hypertension, defects 
were also reported with tests that target midget cell function (Casson, Johnson & 
Saphiro 1993; Johnson 1994; Sample et al. 1994). Noting the inconsistency between 
histological and psychophysical evidence, Morgan (1994) questioned the selective 
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parasol cell loss hypothesis. He reasoned that the inconsistency could be explained if 
there was cell shrinkage and theorized that if all RGC cells were to undergo the same 
percentage of shrinkage during the early stage of glaucoma, this effect would be greater 
for larger cells, and thus may generate cell size distributions that appear as if larger 
RGCs had been selectively affected. However, even though the hypothesis was 
consistent with the histological data from Quigley et al. (1987) and Quigley, 
Dunkelberger & Green (1988), the RGC shrinkage hypothesis was dismissed. The 
selective RGC damage hypothesis indicates that there is an absolute relationship 
between cell type and cell size, and that RGCs do not undergo shrinkage or any change 
prior to the onset of apoptosis. It means that RGCs go from the state of good structural 
health to death with no degenerative or “sickness” period in between. This is 
inconsistent with other degenerative conditions, such as Alzheimer’s (Hollingworth et 
al. 2011), Parkinson’s (Zaja-Milatovic et al. 2005) and Huntington’s (DiProspero et al. 
2004) diseases, in which neuronal and dendritic shrinkage are two of the hallmarks in 
degenerative change preceding cell death. In 1998, a study looking at the degenerative 
effect of chronic elevation of IOP in primates found that the earliest structural changes 
observable in glaucoma were a reduction in RGC dendritic field size, followed by a 
decrease in axon diameter. The reduction of cell body size occurred at the same time as 
axonal thinning, or shortly after (Weber et al. 2000). Morgan et al. (2006) and Shou et 
al. (2003) in experiments with rodent and cat glaucoma models, respectively, supported 
the Weber et al. (2000) finding.  
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Figure 1.2. Confocal images of RGCs from primate retina. (A) Normal parasol cell. (B) 
Normal midget cell. (C) Parasol cell and (D) Midget cell in primate retina with severe 
ocular hypertension. Picture taken from Weber et al. (1998). 
The pruning of dendrites as the first sign of structural change could be due to RGCs 
trying to conserve their energy initially, by shaving off the distal dendrites. The energy 
shortage in glaucomatous RGCs could be caused by aforementioned deprivation of 
neurotrophic factor (Weber et al. 2000) or could be the direct effect of mitochrondrial 
insult due to elevated IOP (Lee et al. 2011). Retinal ganglion cell activity is dependent 
on the shape and functional integrity of its dendritic tree. It is the dendrites of RGCs that 
generate the characteristic center surround receptive field organization by summing 
input from bipolar cells; the soma then sends an action potential via its axon to the 
higher visual areas (Yang & Masland 1994). The shrinkage of the dendrites is expected 
to compromise signal integration from the outer retina and consequently reduces the 
accuracy of the RGC response to a stimulus (Morgan 2012). In living humans, it is 
impossible to perform a histological study to investigate the presence of a dysfunction 
period and it cannot be assumed that the RGC dysfunction period is also present in 
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humans due to the interspecies differences. Thus, the best way to investigate this is to 
look for changes in RGC signal integration activity. Pattern electroretinogram (PERG) 
employs a stimulus of contrast-reversal gratings or checkerboard to investigate the 
physiologic integrity of RGC objectively. The amplitude in PERG is labeled P50 and 
N95, which refer to a prominent positive peak at 50ms and a slow broad trough with a 
minimum at 95ms, respectively. P50 is reduced in glaucoma and other diseases of the 
optic nerve, coupled with its elimination by tetrodotoxin, which blocks the action 
potential of RGCs, suggesting that P50 is a signal generated by RGC. It is less clear 
where N95 originates from, as it is not affected by tetrodotoxin, but is reduced in 
monkeys and humans with glaucoma. Thus, it is speculated that N95 is generated by 
ganglion cell bodies or other structures distal to it. PERG amplitude and phase measure 
different aspects of RGC function (Holder 1987; Viswanathan et al. 2000). The 
reduction of PERG amplitude could be caused by a loss of RGCs, RGC dysfunction, or 
even a combination of the two. PERG phase reductions mostly suggest that the RGCs 
are still alive, but they respond in slower fashion, as it has been showed that PERG 
phase becomes delayed in aging (Porciatti & Ventura 2004; Porciatti & Ventura 2009). 
 
Porciatti and Ventura (2005) were the first to employ PERG to investigate the presence 
of RGC dysfunction in humans. They compared the PERG amplitude and phase in 49 
eyes of participants with ocular hypertension, chronic OAG, normal tension glaucoma 
and primary ACG that were under oculohypotensive treatment, with 44 eyes that were 
under observation/no treatment. They reported a PERG amplitude and/or phase increase 
beyond the test-retest variability in 40% of the treated group, compared to the non-
treated group. The difference was for ocular hypertension, normal tension glaucoma and 
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chronic OAG. Even though one eye of primary ACG was included, there is no mention 
of its PERG amplitude/phase in the paper.  
The increase in PERG amplitude and/or phase of the treated group suggests the 
presence of a population of RGC with IOP-dependent dysfunction, which was able to 
generate a stronger electrical signal after oculohypotensive treatment (Porciatti & 
Ventura 2005). The recovery of PERG amplitude following treatment has also been 
reported in a group treated with oculohypotensive treatment by North et al. (2010) and 
in an eye that underwent trabeculectomy, in Sehi et al. (2010). 
 
 
 
Figure 1.3. Right eye of a patient that was not responding to ocular hypertensive 
treatment that went on to undergo trabeculectomy in Sehi et al. (2010) study. This 
patient’s mean IOP reduced from 26 to 11mmHg. (A) Normal optic disc in fundus 
photograph. (B) Normal SAP result. (C) The average amplitude of PERG that increases 
from 0.6 to 0.9 after surgery. 
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A very interesting finding by Porciatti and Ventura (2005) was that a greater PERG 
improvement was reported in participants with normal or early altered VF, implying the 
presence of a larger population of viable/sick RGCs in eyes with preserved VF. The 
research group then embarked on a longitudinal study (with a minimum of 6 years), 
investigating the progressive changes of retinal ganglion cell function before and after 
treatment in participants with normal SAP and glaucomatous disc (glaucoma suspect).  
Out of 59 eyes involved in the study, 28 eyes received treatment at some point during 
the follow up and 31 eyes remained untreated. As can be seen from Figure 1.4, PERG 
amplitudes decreased progressively with time in both treated and untreated groups. The 
negative amplitude trend was slowed or even inhibited after treatment in the treated 
group, but the negative trend of PERG amplitude carried on in the untreated group 
(Ventura et al. 2012). It is important to note, however that there is considerable variance 
in the data which will likely contribute to variability around the slope estimate. With 
such a small effect size between groups, it is difficult to have complete confidence in 
the effect of treatment. Another interesting point is that PERG amplitude in the treated 
group did not show a positive trend, suggesting that current glaucoma treatment might 
not be sufficiently effective to recover RGC function, but only to slow down 
progression. 
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Figure 1.4. PERG amplitudes recorded throughout the entire follow up period in (A) 
untreated group and (B) treated group. Thick lines are the linear mixed models that 
fixed the data. Break point is assigned a zero value to normalize the time scale and 
represent the time of the first recording after initiation of treatment in (B) and randomly 
assigned in (A). Picture taken from Ventura et al. (2012) 
 
Sehi et al (2011) conducted a placebo-controlled, double masked clinical trial with 
latanoprost 0.005% on 68 eyes of participants with OAG, ocular hypertension and those 
suspected of having glaucoma due to the elevated IOP. They reported no difference in 
PERG amplitude and phase after 4 weeks in either the participants receiving latanoprost 
therapy or placebo, supporting findings of Nesher et al. (1990) 6 years study, in which 
there were no meaningful differences in mean PERG amplitude between eyes treated 
with timolol 0.5% and those with placebo. Sehi et al. (2011) proposed a number of 
factors that might account for the discrepancy in findings between their two studies 
(Sehi et al. 2010), and those of Porciatti and colleagues even though they used the same 
PERG measurement protocol. One suggestion was that the magnitude of IOP reduction 
of 21% in the study was not significant enough to cause improvement in PERG 
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amplitude. Taking into account the improvement of IOP in all of the studies (Table 1.1), 
this is however questionable. Although there was a reduction in IOP (47%) following 
trabeculectomy in the study by Sehi et al. (2010) study, the other studies only reported 
mild to modest reduction in IOP. All the studies have been unable to find a relationship 
between the extent of IOP reduction and the recovery of PERG amplitude, and thus it is 
unlikely that IOP is the sole factor causing the discrepancy. 
 
Table 1.1. Summary of mean IOP in untreated and treated eyes in different studies 
investigating RGC dysfunction with PERG.*Although baseline IOP and IOP after 
treatment were measured as part of the protocol, they did not include any exact 
quantification of IOP, other than giving information that there were two different 
categories of baseline IOP on the study (<21mmHg, average 15±3 and >21mmHg, 
average 29±12).** The untreated and treated IOP came from two different groups of 
participants (treated and untreated ocular hypertension groups). This is an 
observational study, with no influence on the decision of treatment. 
IOP 
(mmHg) 
Porciatti and 
Ventura(2005)* 
North et al. 
(2010)** 
Sehi et al. 
(2010) 
Sehi et al. 
(2011) 
Ventura et 
al. (2012) 
Untreated NA 24.81 19.7±8.6 18.8±4.7 16.84±3.96 
Treated NA 19.17 10.4±4.6 14.9±3.8 14.8±3.24 
Percentage NA 23% 47% 21% 12% 
 
Other more possible explanations between the discrepancy of PERG findings include; it 
is known that the diminishing of PERG amplitude in early glaucoma gives rise to the 
limited dynamic range of amplitude measurement for moderate or advanced glaucoma. 
It is possible that the participants recruited by Sehi et al. (2011) study were more 
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advanced than the others, and thus any changes that might had taken place went 
unnoticed. It is well documented that PERG measurement has moderate variability 
between participants and is affected by visual acuity (VA) and media opacities (Porciatti 
& Ventura 2004; Ventura et al. 2006; Yang & Swanson 2007). Although care was taken 
by Sehi and colleagues to exclude eyes with moderate cataract and poor vision, it is 
possible that the patients recruited for their study had inferior media clarity and/or VA 
compared to other studies. Lastly, as PERG amplitude is the sum activity of the RGCs 
and the neurons in inner retina, it is possible that there are changes in inner retina that 
masked the changes in PERG amplitude (Porciatti & Ventura 2004). It is also possible 
that they calculated the sample size incorrectly and thus were not able to observe effect.  
 
PERG measurement has provided an invaluable support for the RGC dysfunction 
hypothesis. However, PERG measurement has many shortcomings over and above that 
mentioned in the previous paragraph. It is operator-dependent, has increased test-retest 
variability when the measurement is different from the mean; the amplitude does not 
reduce to noise level even when the participant has no light perception, there are wide 
ranges of normal PERG; and depending on the type of electrode used, the procedure 
might require topical anesthetic. Most importantly the PERG signal is very small with a 
high noise level and thus is difficult to differentiate from noise at times (Porciatti & 
Ventura 2004; Porciatti & Ventura 2009; Ventura et al. 2013; Walsh et al. 2005; Yang 
& Swanson 2007).  
 
Supporting the hypothesis of RGC dysfunction in human is not the sole goal of the 
studies investigating RGC dysfunction in human. Another objective of this research is 
to establish a functional measure that is sensitive enough to detect the subtle changes 
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that take place when the viable RGCs are under stress, with low variability that could be 
easily implemented in clinical practice. Although PERG has potential as a tool to target 
the neuroprotective effects or other oculohypotensive agents under clinical trials, it is 
too cumbersome and non-patient friendly for clinical application. In addition, PERG 
only measures the consequences of damage at the level of the retina; there is no 
information on what might be happening higher in the visual pathway. When we are 
seeing, we are not only using photoreceptors and other retinal cells. We are seeing with 
the whole visual system, from photoreceptors to the cortical cells. Even when there is 
extensive retinal damage, it does not automatically mean that the patient is blind, 
because the brain might be compensating for the changes. Recent evidence from animal 
models of glaucoma has suggested effects on higher visual areas (Davis et al. 2016). 
PERG is useful if one wishes to understand the retinal structure and retinal function in 
the disease, but if detection of visual loss is required then we need to test the visual 
system as a whole. The technique that is able to measure the sum of activity of the 
whole visual system currently is perimetry. But it is highly variable and since it uses 
just a single sized spot of light, it is not likely to provide comprehensive information. 
Instead, we might borrow ideas from studies of early glaucoma in animals, that there is 
shrinkage of RGC dendrites that should in turn affect the way the visual system gathers 
light information over space. Redmond et al. (2010a) studied on changes of area of 
complete spatial summation (Ricco’s area) in humans and found an anomaly of spatial 
summation in early glaucoma. However, before further explanation of the current study, 
and aim of this PhD, are provided, an extensive summary of what constitutes Ricco’s 
area and its potential origin in the visual system will be provided. 
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1.5. Spatial summation and Ricco’s area 
1.5.1. Introduction 
For a visual stimulus to be detected by the visual system, the strength of the stimulus 
signal must be greater than the intrinsic noise. In order to improve detection, the visual 
system increases its sensitivity by integrating or pooling signals over space (spatial 
summation) and time (temporal summation). Spatial summation improves detectability 
but unfortunately, it lowers the eye’s resolution by impeding the discrimination of 
separations between targets and thus visual acuity (Barlow 1958; Richards 1967; 
Wilson 1970). In 1877, Ricco introduced the law of complete spatial summation (Ricco 
1877). According to this law, the threshold needed for detection of a signal is inversely 
proportional to the area of the stimulus.  
 
A x I = k         (Equation 1) 
 
Where A represents stimulus area, I represents intensity and k is a constant. 
 
The largest area for which this law holds true is called Ricco’s area, or the area of 
complete spatial summation. It is also known, in some literature, as the critical area. 
Intensity thresholds for stimuli smaller that Ricco’s area are governed by Ricco’s law, 
while those for stimuli larger than Ricco’s area are governed by incomplete spatial 
summation. There are various laws of incomplete spatial summation, such as Piper’s 
law, where threshold is inversely proportional to the square root of area (Piper 1903); 
Other laws, including Piéron’s law, Goldmann’s approximation, and Weber’s law, 
however only operate under very specific experimental conditions (Brindley, 1970). 
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Glezer (1965) reported an eventual absence of spatial summation when stimulus size 
increased to very large levels. 
It is well established that Ricco’s area varies under different experimental and adaptive 
conditions. It enlarges with increasing retinal eccentricity (Vassilev et al. 2003; 
Volbrecht et al. 2000; Wilson 1970), decreasing background luminance (Barlow 1958; 
Glezer 1965), and decreased duration of the stimulus (Glezer 1965). Even under the 
same experimental conditions, Ricco’s area exhibits considerable inter-subject 
variability (Volbrecht et al. 2000; Schefrin et al. 1998).  
 
The physiological basis of Ricco’s area is still a subject of debate. In an effort to 
understand this, Ricco’s area has been investigated under, and compared between, 
different visual pathways (e.g. the achromatic and S-cone pathways), which involves 
measuring Ricco’s area under conditions that preferentially stimulate or isolate the 
pathway of interest and comparing it to that found in the achromatic pathway, mindful 
of known differences in physiology and cellular morphology between the two pathways. 
The relationship between Ricco’s area and structural features in the retina has also been 
investigated.    
 
The traditional explanation for the basis of Ricco’s area is that it represents the size of 
the RGC receptive field centre (Brown et al. 1989; Barlow 1958; Glezer 1965). Glezer 
(1965) reported a shrinkage of achromatic Ricco’s area with increasing background 
luminance, and attributed this change to increased centre-surround antagonism in the 
receptive field of RGCs. Given the association between the RGC receptive field size 
and dentritic tree size (Wässle & Boycott 1991), it was reasonably assumed that Ricco’s 
area would also be associated with RGC dendritic tree size and/or density. Based on this 
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notion, Volbrecht et al. (2000) assessed the relationship between Ricco’s area and 
retinal field eccentricity, by using stimuli isolating the S-cone and L-cone pathway 
respectively from 0 – 20° retinal eccentricity. They reported a good correlation between 
Ricco’s area size and the parasol dendritic field size with eccentricity. However, the 
pattern of change of Ricco’s area with eccentricity did not correspond with the pattern 
of dendritic field change of the small bistratified RGCs (Volbrecht et al. 2000). Vassilev 
et al. (2000) reported a similar result. These results suggest that the size of Ricco’s area 
is not solely governed by the RGC dendritic or receptive field size. This conclusion is 
further supported by Redmond et al. (2013b), who reported a shrinkage of Ricco’s area 
with increased blue background luminance under experimental conditions preferentially 
stimulating the S-cone pathway; a finding similar to that of Glezer (1965) in the 
achromatic pathway. However, the receptive fields of small bistratified RGCs do not 
have antagonistic spatial (center-surround) organization (Dacey & Lee 1994). Thus, the 
finding of changes in Ricco’s area with blue background luminance in the S-cone 
pathway are not what one would expect, if the hypothesis of Glezer (1965) for the 
physiological basis of Ricco’s area holds true. Redmond et al. (2013) proposed an 
alternative hypothesis. Spatial antagonism is still required for the formation of Ricco’s 
area and the changes observed with background luminance. However, this spatial 
antagonism should involve receptive field components that are reactive to the same 
chromaticity; in the S-cone pathway, this spatial antagonism should be of the 
configuration S+/S-, but receptive fields meeting this criterion are not found at the level 
of the retina. In fact, they are first encountered in double-opponent cells in the visual 
cortex (Conway 2001; Conway & Livingstone 2006; Hubel & Wiesel 1968; Shapley & 
Hawken 2011; Wiesel & Hubel 1966). 
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Volbrecht et al. (2000) suggested that there could be an equal number of RGCs 
underlying Ricco’s area at each visual field location, because it was observed that even 
though Ricco’s area increased with eccentricity, it retained a constant intensity threshold 
for that area. This hypothesis had been proposed earlier by Fischer (1973) and Ransom-
Hogg & Spillmann (1980). To investigate this hypothesis, Schefrin et al. (1998) 
compared Ricco’s area in old and young individuals, to evaluate the effect of age related 
loss of RGCs. Indeed, they reported a slight increase in the size of Ricco’s area with age 
under scotopic conditions. They suggested a possible alternate hypothesis that the RGC 
loss with age resulted in an increase in convergence of the photoreceptors onto the 
residual RGCs, that in turn causes an increase in the size of Ricco’s area. This 
photoreceptor density hypothesis was not supported by the study of Volbrecht et al. 
(2000), in which Ricco’s area was more strongly correlated with  RGC density than 
with photoreceptor density. Furthermore, Zele et al. (2006) measured Ricco’s area in 
participants with early age-related macular degeneration, a disease that is known to 
primarily affect the outer retina, and reported no changes in Ricco’s area despite 
elevated thresholds. 
 
Studies of the effect of age on Ricco’s area, guided by the notion that spatial summation 
should change with age-related neural changes, were unable to identify an association 
(Brown et al. 1989; Redmond et al. 2010b). Redmond and colleagues suggested that it 
is possible that an enlargement of Ricco’s area with age is masked by age-related optical 
changes, whereby an increase in wide angle scatter with age may give rise to an 
enlargement of the point spread function associated with the stimuli used to measure 
Ricco’s area. If the point spread functions of the differently-sized stimuli are enlarged, 
this means that the stimulus area on the retina is larger than what the investigator had 
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intended. With this in mind, the critical area of complete spatial summation would 
appear to be smaller, simply because the stimuli are larger on the retina. Redmond et al. 
(2011, ARVO Abstract), using filters to simulate the wide-angle scatter associated with 
the optics of a given older age, demonstrated shrinkage of the measured Ricco’s area. 
They calculated the expected RGC dropout for the simulated age, and then calculated 
the expected enlargement in Ricco’s area given this level of RGC dropout. They found 
that the shrinkage of Ricco’s area due to wide-angle scatter and the predicted 
enlargement of Ricco’s area due to age-related RGC dropout were equal and opposite, 
suggesting that an age-related increase in intraocular stray light masks the effects of 
increased spatial pooling with age. 
 
A less popular hypothesis for the physiological basis of Ricco’s area is one by Davila & 
Geisler (1991). They performed a predictive calculation of the size of Ricco’s area in 
the fovea in an ‘ideal observer’, including only pre-neural factors (pupil and lens effect) 
and photoreceptors in their calculation, and then compared this to their measurements of 
Ricco’s area in four participants. They concluded that Ricco’s area is the effect of 
photoreceptor summation and the optics of the eye (Davila & Geisler 1991). This 
conclusion has since been challenged by Dalimier & Dainty (2010) who used adaptive 
optics to correct for the effect of optical aberrations on Ricco’s area. They reported that 
even though the optics of the eye account for most of the formation of Ricco’s area in 
the fovea, and that optical factors influence the size of Ricco’s area, in more peripheral 
regions there was still a break point on the spatial summation curve, indicating that 
Ricco’s area is first and foremost a neural phenomenon. 
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Combining the evidence from multiple studies, it is likely that the physiological basis 
for Ricco’s area does not lie in one specific region of the visual pathway. Although 
studies have provided evidence for and against various locations in the visual pathway 
as the basis for the phenomenon, it should be borne in mind that visual processing of 
light is a continuous process from cornea to cortex and that spatial summation can occur 
at multiple levels. Therefore, the size of Ricco’s area is likely the product of spatial 
summation in the visual pathway. Specific spatial mechanisms in the visual cortex can 
be preferentially stimulated with specific experimental conditions. Under the conditions 
of SAP, it is likely that the spatial mechanism preferentially stimulated determines the 
size of Ricco’s area (Pan & Swanson 2006; Redmond et al. 2010a). 
 
1.5.2. Statistical fitting of spatial summation functions 
A wide range of methods for determining the amount of spatial summation, or the size 
of Ricco’s area has been reported in the literature, limiting direct comparisons between 
studies. Variations include different visual field locations measured (Glezer 1965), 
different stimulus sizes (Wilson 1970), different background luminance level (Barlow 
1958), different stimulus chromaticity (Volbrecht et al. 2000), different psychophysical 
task (detection versus resolution) and different statistical methods to fit the data 
(Latham et al. 1994). Using temporal summation data, Mulholland et al. (2015) 
demonstrated the importance of using a statistical procedure that not only minimises 
residuals to the fitted curve, but also one that caters for the laws governing the 
thresholds.  
 
Barlow (1958) and Wilson (1970) fitted their spatial summation data by manually 
approximating the point at which deviation is observed from a reference line with slope 
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of -1 (the manual estimation technique). Another method is called constrained least 
square analysis, which fits two lines to the spatial summation data, constraining the 
slope of the first line to -1, with respect to Ricco’s law, and that of the second line to -
0.5, with respect to Piper’s law (used by Richards 1967) or slope of 0 (used by Brown et 
al. 1989; Davila & Geisler 1991). The point at which the two lines meet is taken as an 
estimate of Ricco’s area. Schefrin et al. (1998) fitted linear regression lines to their data, 
constraining the slope of the first line to -1, and allowing the slope and intercept of the 
second line to vary (two-phase regression analysis); the intersection/ break point gives 
an estimate of Ricco’s area size.  
 
The manual estimation technique can be variable, as the transition between complete to 
incomplete summation is gradual. In addition, the technique suffers from very strong 
operator bias. Mulholland et al. (2015) compared different fitting techniques for 
estimating the critical duration of temporal summation, (the relationship between 
intensity and stimulus duration is the same as that between intensity and area), which 
are the same techniques as those used for the estimation of area of complete spatial 
summation. They reported that the manual technique could give a larger estimation of 
Ricco’s area, when compared to the other two techniques. In the same paper, 
Mulholland and colleagues showed that constraining the slope of the second line to 0 in 
the same data set resulted in a larger breakpoint value than was the ground truth. The 
problem with constraining the second line to -0.5 is that variable degrees of partial 
summation have been observed in the literature (Volbrecht et al. 2000; Schefrin et al. 
1998). As previously mentioned, these laws are only observable under very specific 
experimental conditions (Brindley 1970). Constraining the slope of the second line to 0 
(an assumption that there is no summation) did not account for the presence of 
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incomplete summation. Although a varying degree of incomplete summation has been 
observed across published literature, it is evident in most cases. Iterative two-phase 
regression analysis addresses both the strong operator bias of manual technique and the 
wide range of slope in the second line. Importantly, it allows a close fit to the data, 
while also accounting for both Ricco’s law and the variable nature of incomplete 
summation between locations, individuals, and conditions. However, it is still a semi-
subjective method, in that it requires subjective estimation and input of an initial 
breakpoint value, intercept of the first line, and slope of the second line. 
 
Comparing different fitting techniques available in the literature, the most suitable 
fitting technique should be the one respecting Ricco’s law and not discounting the 
presence of varying levels of partial summation. Of all of the techniques described, 
iterative two-phase regression analysis best meets these criteria. 
 
The following equation is used in the analysis outlined in the current thesis:  
 
Threshold= (intercept1-area)*(area<breakpoint)+(intercept1-breakpoint+slope2*(area-
breakpoint))*(area>breakpoint).      (Equation 2) 
 
c = estimated intercept of the first line  
mb = estimated slope of the second line  
A = stimulus area  
AR = estimated breakpoint 
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1.5.3. Ricco’s area in glaucoma 
 
Fellman et al. (1989) observed that the difference in thresholds to Goldmann III and V 
stimuli was greater in participants with glaucoma than that in healthy controls. They 
also observed that enlarging the stimulus area caused a greater increase in measured 
contrast sensitivity than did increasing the stimulus intensity. They found that the 
opposite was true in healthy controls. They hypothesized that the greater increase in 
measured sensitivity to larger stimuli in glaucoma was due to either the stimulus 
covering more regions of normal retina, or to pathological spatial summation. Redmond 
et al. (2010b) measured achromatic and chromatic (S-cone pathway) Ricco’s area in the 
visual field of 24 participants with early POAG and NTG (average TD at test locations: 
-1.3dB) and 26 age matched healthy participants. They reported an overall larger 
Ricco’s area in patients with glaucoma, relative to that in healthy controls, under both 
chromatic and achromatic conditions. They demonstrated that when changes in Ricco’s 
area are accounted for, thresholds for a range of perimetric stimulus sizes overlap 
between patients in controls, and that disproportionate differences in thresholds between 
large and small stimuli in glaucoma are no longer observable. They hypothesized that 
Ricco’s area might be determined by the receptive field size of a cortical spatial 
mechanism that receives input from a critical number of RGCs (31 cells, in line with the 
report by Swanson et al. (2004) that approximately 31 RGCs underlie Ricco’s area 
across the visual field).  
 
To explain, as RGCs are lost in glaucoma, the mechanism that receives input from 31 
RGCs now receives input from a smaller number of cells (Figure 1.5 cell B). However, 
a mechanism that previously received input from a greater number of RGCs (and hence 
has a larger receptive field), but has now lost input from some RGCs, might now meet 
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the criteria of 31 underlying RGCs (Figure 1.5 cell C). The extent of the receptive field 
associated with that mechanism would now determine the size of Ricco’s area. This 
hypothesis would allow for the maintenance of a constant sensitivity at Ricco’s area that 
has previously been reported in published literature.  
 
Cell A Cell B Cell C
Healthy
Glaucoma
Input: 24 RGCs 
Sensitivity: <31dB
Complete spatial 
summation
Input: 19 RGCs
Sensitivity:<< 31dB
Complete spatial 
summation
Input: 31 RGCs 
Sensitivity: 31dB
Complete spatial 
summation
Input: 28 RGCs 
Sensitivity: <31dB
Complete spatial 
summation
Input: 31 RGCs 
Sensitivity: 31dB
Complete spatial 
summation
Input: 40 RGCs 
Sensitivity: >31dB
Probability spatial 
summation
 
Figure 1.5. Cortical cells A, B and C receiving input from different amount of RGCs on 
the same retinal locations.  
 
An alternative hypothesis is that remaining healthy cells, likely in the visual cortex, 
extend their receptive fields in response to RGC death. Plasticity in the visual cortex has 
previously been observed in the monkey (Gilbert & Wiesel 1992). In that study, the 
investigators performed laser ablation of outer retinal cells, and observed an 
enlargement of receptive fields of cortical cells next to the region that would otherwise 
have received input from the damaged retinal region. Also, an enlargement of receptive 
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fields in the superior colliculus was observed following chronic elevation of IOP in rats 
(King et al. 2006).  
 
It might reasonably be assumed that both RGC death and dysfunction would have an 
effect on how information of light is pooled by the visual system. Both would involve 
an absence, or reduction, respectively, of signal inputs into higher visual areas. A pre-
morbid shrinkage of dendrites, or death of RGCs in early glaucoma could cause an 
anomaly of spatial pooling in the visual system, in an attempt to maintain a constant 
signal-to-noise ratio. If recoverable RGC dysfunction causes Ricco’s area to enlarge, a 
shrinkage of Ricco’s area might be observable after successful administration of 
treatment. Therefore, a comparison of the size of Ricco’s area before and after the 
commencement of rigorous glaucoma treatment would provide a valuable opportunity 
to investigate pre-morbidity in RGCs in human glaucoma, and the visual effects 
associated with it. 
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1.6. Aims and objectives of the PhD 
The main objective of this PhD is to investigate the presence of a period of RGC 
dysfunction in patients with glaucoma, by comparing the size of Ricco’s area before and 
after trabeculectomy surgery. Two control cohorts, one of stable glaucoma patients and 
another of healthy individuals will also undertake identical experiments. A secondary 
objective is to better understand the physiological basis for Ricco’s area, which is 
enlarged in glaucoma patients relative to that in age-similar healthy individuals, and to 
which reduced perimetric sensitivity to a Goldmann III stimulus can be mapped. This 
investigation will be undertaken in a cohort of individuals with amblyopia, a condition 
in which retinal receptive fields have previously been found to be normal, but in which 
deficits in visual function have a cortical origin. A third objective is to provide proof of 
concept that measurements of a change in Ricco’s area have superior utility to 
measurements of a change in sensitivity to a Goldmann III stimulus in the identification 
of glaucomatous visual field damage. 
 
Prior to addressing the aims and objectives, it was necessary to undertake a series of 
preliminary methodological studies, in order to determine the optimum experimental 
parameters for use in the main experiments. These are described in Chapter 2. 
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Chapter 2: Preliminary Studies and Optimisation 
of Experimental Methods 
 
2.1.   Introduction 
This chapter goes into in-depth details on the factors influencing accurate experimental 
methodologies for the estimation of Ricco’s area. As mentioned in Chapter 1, the 
measurement of Ricco’s area involves measuring thresholds for a range of precisely 
circular stimulus sizes. Smaller stimulus sizes will need very high luminance level for 
the thresholds to be measured. Considering the large amount of stimulus presentations 
involved, thresholding algorithms with an acceptable test time and adequate precision 
should be chosen. Number of test locations should also be balanced with reasonable test 
times.  
However, before going into the stimulus parameters, the first thing to be considered is 
experimental apparatus. 
2.1.1. Experimental apparatus  
In order to construct a spatial summation curve and extract Ricco’s area estimate, 
circular stimuli need to be presented on the retina. The stimulus needs to be highly 
precise and the apparatus used needs to be able to present a very high luminance level in 
order to be able to measure thresholds for the smaller stimulus sizes. Currently available 
instruments are cathode ray tubes, liquid crystal displays and bowl projection systems.  
Display monitors have been widely used in studies of visual field because they offer 
advantages such as accurate user control of the stimulus colour and luminance values on 
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a pixel-by-pixel basis. Display monitors also come at lower cost compared to bowl 
projection systems. However, the luminance of the display monitor can be inconsistent 
between the central and peripheral display locations and, depending on the monitor 
used, this can be up to 27% or more, affecting large stimulus size presentation (Bach et 
al. 1997; Ghodrati et al. 2015; Metha et al. 1993). The stimulus presented has also been 
reported to suffer from non-uniformity of pixel area across the range of luminance and 
thus there could be a difference between the intended stimulus area and the one actually 
presented, which was observed on study conducted by Pelli (1997). The projection 
angle of a pixel to the retina changes across the monitor affecting incident luminance. 
Display monitors also have limited dynamic range in display, which approximately 
ranges from 250 to 365 cd/m2 depending on monitors, with OLED monitors having 
even lower luminance display (Ghodrati et al. 2015). 
 
Up until recently, experiments were usually programmed with software and displayed 
on the monitor. Bowl and projection systems were not programmable due to the 
restriction from the manufacturer.  New software has since been developed to allow 
vision scientists to use the open-source programming language, R to control 
commercially available perimeters: the Open perimetry interface (OPI). Currently the 
OPI can be accessed on three instruments: The Octopus 900, KOWA AP7000 and the 
Heidelberg Edge Perimeter (Turpin et al. 2012). Commercial perimeters tend to have a 
large usable dynamic range (e.g. up to 3185cd/m2 on the Octopus 900 perimeter) and 
this factor is of particular advantage for this project as it involves threshold 
measurement of stimulus sizes as small as Goldmann size I where more light energy is 
needed for the stimulus detection. The Octopus 900 and KOWA AP7000 have a 
hemispheric projection bowl of radius 33 cm ensuring a consistent projection angle of 
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stimulus to retina. The light reflected back from the bowl is polydirectional (i.e. not 
concentrated in a narrow angle as is the case with LCDs). Therefore, background 
luminance is more uniform across the surface of the bowl than it is with LCDs. The 
other advantages are uniform luminance over the area of a stimulus without the stimuli 
having a dot pitch, which is common in display monitors (i.e. spacing between two 
adjacent pixels in which no light energy is emitted). The surface of bowl projection 
systems means that the stimulus projected will be more circular than a stimulus 
projected on a flat screen (i.e. presentation of a circular stimulus on the periphery of a 
flat screen will be projected as a vertical oval to the retina because of perspective). An 
additional advantage of using a commercial perimeter machine, and indeed the OPI, is 
that if particular hypotheses are accepted following experiments on this platform, then 
the path to translation becomes much clearer and other groups could also replicate this 
work freely, if the stimuli was programmed on a monitor in matlab. Even though the 
problem with circular stimuli and screen background uniformity in the display monitor 
can be corrected, the problem with limited dynamic range remains a fundamental 
disadvantage. Given the requirements for the experiments outlined in this thesis, the 
decision was made to conduct experiments on the Octopus 900 perimeter (Haag Streit 
Ltd., Koeniz, Switzerland). The study by Redmond et al. (2010a) in which achromatic 
Ricco’s area was measured showed that Ricco’s area in glaucoma participants was 
between Goldmann III and IV, approximately, whilst for healthy participants it was 
between Goldmann II and III. Therefore, the use of Goldmann I – V stimulus sizes in 
our study enables measurements of Ricco’s area size for both groups. 
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2.1.2. Choosing a thresholding algorithm 
There are numerous thresholding strategies available for the psychophysical 
measurement of visual threshold. They have various methods to reach threshold, 
different testing speed, different repeatability, and adaptive or non-adaptive strategies. 
Non-adaptive strategy has the trials distribution that is specified in advance and can be 
called the method of constant stimuli. This method employs pre-determined stimuli with 
different intensities and presents them in a randomised order (Spearman 1908; 
Treutwein 1995). Due to the large number of stimulus presentations needed, this 
technique can be time consuming and inefficient if the pre-determined stimulus testing 
intervals do not include the true threshold. The fewer the trials needed to reach a 
particular standard deviation of the estimate, the more efficient that strategy is. Adaptive 
strategy involves the distribution of trials that are dependent upon the outcome of the 
previous trials and is considered to be more efficient, as it does not present a stimulus 
that is remote from thresholds that provide little information. One of the adaptive 
methods is the staircase method, whereby the stimulus intensity is changed by a pre-
determined amount, depending upon the subject’s previous response to the stimulus. If 
the subject perceived the stimulus, the intensity is decreased and vice versa. The change 
from seeing to non-seeing and from non-seeing to seeing is called a reversal. The 
staircase method stops after a certain number of reversals. There are different types of 
adaptive staircase methods available. One of the adaptive staircase methods is the X up 
and Y down procedure or more commonly known as a transformed staircase (Levitt 
1971). The staircase could begin supra-thresholdly and each time the observer make Y 
number of correct responses consecutively, the contrast will be reduced. And when the 
observer cannot detect the stimulus by X amount of responses, then the contrast will be 
increased. The inflection point is named the reversal point. The procedure stops after a 
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certain number of reversals. The threshold can be taken as an average of whatever 
number of reversals is selected. Depending upon the starting threshold level, the steps of 
staircase and the reversals points, the staircase method can be more or less efficient than 
MOCS (Cornsweet 1962). 
 
Another adaptive method is PEST or Parameter Estimation by Sequential Testing, 
which started by presenting a block trial at a fixed intensity. The next section of block 
trial is then presented at higher and lower intensities depending on the sequential 
likelihood test. It terminates when the amount of correct responses differ significantly 
from that expected from the threshold-criterion probability. (Taylor 1967). 
 
Common adaptive methods with higher efficiency are the maximum likelihood methods 
of QUEST (Watson & Pelli 1983) and a modified version of QUEST, called ZEST 
(Zippy Estimation by Sequential Testing) (King-Smith et al. 1994). Both methods have 
been shown to exhibit narrower distribution of errors compared to the staircase method 
and PEST (King-Smith et al. 1994). Both strategies employ prior knowledge about the 
expected distribution of thresholds (the initial probability density function [pdf]) and the 
response that is made by the patient (seen or not seen) to alter the intensity on 
subsequent trials. The maximum likelihood technique reduces testing time and test-
retest when compared to adaptive methods such as staircase method and PEST, 
especially when the initial threshold estimates used by the procedures are dissimilar to 
the true threshold of the location (King-Smith et al. 1994; Turpin et al. 2003). Although 
computer simulations have shown QUEST to exhibit less precision compared to ZEST 
(King-Smith et al. 1994), many of these same modifications that have been applied to 
ZEST have also been applied to QUEST, resulting in QUEST+ (Watson 2017). 
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QUEST+ was not available at the time of commencement of the experiment and 
therefore it was decided that ZEST would be the best option and only ZEST will be 
explained in great details. 
 
The initial pdf used in ZEST contains information for each possible threshold (0-50dB): 
the probability of the subject’s threshold at a particular location. Figure 2.1 illustrates 
how ZEST utilizes the pdf. The top panel of Figure 2.1a shows that the initial pdf 
assumes that 14dB is the most likely threshold for the subject (P= 0.13) and that it is 
very unlikely that the threshold will be 2, 3, 4, 19 or 20dB (P= 0.001). The first stimulus 
that is presented will have a contrast equal to the mean of the initial pdf, which is 12dB 
in this case denoted by the vertical dashed line in Figure 2.1. If the subject responds no, 
then the initial pdf is modified by multiplying it with a likelihood function, which is the 
frequency of seeing curve, to give greater probability to the lower values (decibels) 
(Figure 2.1a bottom panel). In other words, after each response, the [posterior] pdf is 
modified by multiplying each value in the pdf by the likelihood of observing that 
particular response, given that particular parameter value. The next stimulus presented 
will have intensity equal to the mean of the new pdf, which is 9dB. If the subject had 
responded yes to the initial 12dB, the pdf would have been modified to give greater 
probability to the higher values (decibels) (Figure 2.1b). The process continues until it is 
stopped by either one of two termination criteria: after a specified number of trials or 
when the estimated threshold has the confidence interval that is smaller than a criterion 
level, which is <1.5 dB of the pdf standard deviation (dynamic termination criterion). 
The subject threshold is the mean of the final pdf (Turpin et al. 2003; Turpin et al. 
2007) 
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Figure 2.1. The first step of ZEST thresholding procedure. Top panel: initial pdf; 
middle: likelihood functions with the 50% seeing point aligned with the mean of initial 
pdf; bottom panel: the posterior/new pdf. Dashed vertical lines: mean of pdf. Picture 
taken from Turpin et al. (2002). 
Anderson (2003) performed a computer simulation comparing the two different 
termination criteria, fixed number of trials and dynamic termination. Dynamic 
termination ends the thresholding procedure when the confidence interval for the 
estimated threshold is smaller than a criterion level. Anderson recommended the used of 
fixed number of trials criterion due to its reduced testing time and comparable 
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distribution of errors with dynamic criterion. However, he was using a starting pdf that 
only consisted of normal threshold data and therefore his observation might not be 
applicable for ZEST method in this study, as the pdf used will consist of threshold data 
from both healthy and glaucoma participants (bimodal pdf), derived by Turpin et al. 
(2002). Dynamic criterion tends to last longer in cases when the threshold estimate does 
not match the initial pdf value (Turpin et al. 2002), which could explain the observation 
of Anderson (2003). As the participants in this PhD study consist of both healthy and 
glaucoma individuals, the danger of using a fixed number of trials on all participants is 
that in some cases the thresholding procedure would stop before it reaches a patients’ 
‘true’ threshold level. Therefore, it was decided that the ZEST algorithm used in this 
study would use the bimodal pdf derived by Turpin and colleagues, which was derived 
for Goldmann size III. How appropriate the bimodal pdf is for other Goldmann sizes 
remains to be seen. The dynamic termination criteria met when the standard deviation of 
the pdf is <1.5 dB.  
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2.2. Optimisation of thresholding algorithm and test time 
The ZEST codes used in this project were adapted from code written by Andrew Turpin 
and Luke Chong (University of Melbourne, accessed on 19th January 2014). The 
original code can be found at 
http://people.eng.unimelb.edu.au/aturpin/opi/interface.html. The modifications to the 
code are listed below: 
• Measuring threshold for Goldmann size I-V as opposed to just GIII 
• Stimulus presentation time was increased to 200ms  
• Dynamic range of the thresholding method was increased from 30dB to 40dB, as 
the average dB value observed during the pilot study of this project for 
Goldmann V of healthy participants is 33dB 
• Amendment to the test location patterns, as it was observed that the code 
miscalculated the presentation location and the test location is shifted 3° superior 
and 3° temporal away from the intended location. 
 
Two-phase regression analysis in this study involved fitting two lines onto a set of 
threshold data. This interative analysis is based on using two simple linear regressions 
(y=mx+b), where, within the estimated breakpoint, the data are best described by the 
first part of Equation 1, which incorporates a constraint on the slope (m = -1). For data 
beyond the estimated breakpoint, the data are best described by the second part of 
Equation 1. The two equations are fitted to the data in order to minimize residual sum of 
square. The equation for the two-phase regression analysis in the study can be found in 
Chapter 1. In our study, the slope of the first line will be constrained to -1 to respect 
Ricco’s law whilst the intercept of the first line, and slope of the second line is allowed 
to vary. The break point between first and second lines denotes Ricco’s area estimation. 
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The more variable the thresholds measured in the study, the harder it is to fit two-phase 
regression analysis. The fitting procedure is semi-objective with an initial breakpoint 
needed to be estimated subjectively and put into the formula to obtain a final breakpoint 
estimate. When the threshold data is variable, the initial breakpoint estimate could be 
off and the two-phase regression analysis can fail to run. Also, to ensure the accuracy of 
the Ricco’s area estimate obtained, coefficient of determination (R2) output from the 
linear regression on the data that is less than 0.9 will be excluded from further analysis. 
The lower the R2 is, the worse the linear regression is able to fit the data and thus could 
give inaccurate Ricco’s area estimates. 
 
A pilot study investigating a good compromise of test precision and test duration was 
conducted on 3 participants. This exploratory study was conducted with two 
thresholding methods, ZEST (experiment 1) and the adaptive staircase method 
(experiment 2) to measure threshold of GI-V on different number of test locations to 
assess the parameters that produce more spatial summation curves with R2>0.9. 
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2.2.1. Method for experiment 1 
2.2.1.1. Subjects 
Three participants (age: 23, 27 and 31 years) were recruited from students and staff of 
Cardiff University. One of the participants (P003) withdrew from the study after one 
session due to the length of time needed to complete the experiment. Two participants 
completed the study. All participants underwent ocular health investigation with slit 
lamp biomicroscopy and Topcon 3D OCT 1000. All participants had best corrected 
visual acuity of at least -0.2 LogMAR and IOP < 21mmHg with a Topcon CT-80 non-
contact tonometer. All participants underwent visual field investigation with SAP 
(Humphrey visual field analyser [HFA] II, 24-2 SITA-Standard, Carl Zeiss Meditec, 
Dublin, CA) and all had full fields. Only the right eye of each participant was tested. All 
participants were recruited in accordance with declaration of Helsinki. 
 
2.2.1.2. Apparatus and Stimuli 
Stimuli were Goldmann sizes I-V (0.11°, 0.22°, 0.43°, 0.87° and 1.7°), presented on an 
Octopus 900 perimeter (Haag Streit, Koeniz, Switzerland) with background luminance 
of 10 cd/m2 for 200ms, driven by the Open perimetry interface (Turpin et al. 2012).  
 
2.2.1.3. Procedure 
The study commenced using ZEST algorithm to measure thresholds for 5 Goldmann 
sizes with Yes/No criterion on the standard 24-2 pattern, (50 locations within 24° and 
two extra locations in nasal field, at 30° eccentricity) of the visual field. Based on the R2 
from the fitting of two-phase regression analysis at the 50 locations and the number of 
Ricco’s area estimates that can be processed successfully with two-phase regression 
analysis, the number of test locations was reduced. When the R2 and number of 
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successfully run two-phase regression analysis were low, the numbers of test locations 
were reduced to 44 and two-phase linear regression analysis was performed on the data 
again. This process was repeated with test locations cut down to 30 and 16 (Figures 
demonstrating the test patterns can be found in section 1.1.2). Threshold measurement 
procedure was conducted twice for 16 test locations, first with only one set of 
Goldmann I-V sensitivity measurements and then repeated with two sets of Goldmann 
I-V sensitivity measurements to assess improvement in R2. The time needed to finish 
the tests was recorded. ZEST gets the information of the starting value of a test location 
from the other locations adjacent to it. Therefore, when the test locations were excluded, 
the residual locations needed to be connected to neighbouring points. No initial starting 
values from each intensity was inputted manually as ZEST got its starting value from 
pdf that was collected by Turpin et al. (2002). All procedures were carried out with 
natural pupil sizes and full refractive correction (with full aperture trial lenses) in place 
for the relevant working distance. Fixation was monitored visually and patient position 
adjusted when the eye pupil drifted on the fixation camera on the instrument. 
 
Data processing and statistical analysis. 
Sensitivity values (dB) were converted into increment threshold (ΔI) and plotted against 
area. Two-phase regression analysis was performed in the freely available open-source 
statistical environment, R (version 3.1.0) to obtain Ricco’s area estimates at each 
eccentricity. The slope of the first line was constrained to a value of -1, following 
Ricco’s law, whilst the intercept of first line, slope of the second line and break point 
were allowed to vary. The breakpoint estimated was taken to be the Ricco’s area 
estimate. 
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2.2.2. Results for experiment 1 
Table 2.1 shows average test durations for GI-V for 52 test locations. 
 
Table 2.1. Average test times for 4 different locations on 2 participants with ZEST 
Goldmann 
Sizes 
  
Number of test points 
  
52 30 16 16 (2x) 
I 11 mins 48 secs 7 mins 43 secs 5 mins 12 secs 10 mins 2 secs 
II 10 mins 27 secs 7 mins 2 secs 4 mins 55 secs 10 mins 14 secs 
III 7 mins 2 secs 3 mins 18 secs 2 mins 3 secs 3 mins 57 secs 
IV 7 mins 50 secs 4 mins 10 secs 2 mins 46 secs 5 mins 17 secs 
V 8 mins 30 secs 5 mins 6 secs 3 mins 3 secs 6 mins 9 secs 
Total test 
durations 
45 mins 37 secs 27 mins 19 secs 17 mins 59 secs 35 mins 39 secs 
 
With the ZEST algorithm, the test time is longer for Goldmann sizes that are not 
Goldmann III. ZEST was initially run on 52 locations. The time listed on Table 2.1 is 
the test time without breaks. Participants needed at least 5 minutes rest after the 
threshold measurement of each Goldmann size, which added another 25 minutes to the 
test times in addition to the test time mentioned in the Table 2.1. This is in addition to 
regular breaks given to the participants. A total of 520 thresholds were measured, 
representing 104 test locations across two participants, and thus 104 data sets with 
which to plot 104 spatial summation functions. When data were arranged in order to 
plot spatial summation curves at each location, it was found that curves could not be 
fitted in 47 locations, which means only 54.81% of data could be processed to produce 
Ricco’s area estimates (Figure 2.2). The mean R2 of spatial summation curves that could 
be successfully fitted was 0.89, which does not reach the criteria of successful fitting of 
0.9. The number of test locations was reduced further to 30 (Figure 2.3) and then to 16 
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(Figure 2.4) and the analysis was repeated each time. The proportion of locations for 
which spatial summation curves could be fitted successfully was 66.67% (40 out of 60) 
for the 30-location test grid (with mean R2 of 0.91, Figure 2.3) and 75% (24 out of 32) 
for the 16-location test grid (mean R2 of 0.94, Figure 2.4). Goldmann I-V thresholds 
were then measured twice with the 16-location test grid to assess any improvement in 
mean R2 when thresholds for individual Goldmann sizes at individual locations were 
averaged. The success rate of curve fitting procedure increased from 75% to 87.5% (42 
out of 48) with mean R2 of 0.97. 
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Figure 2.2. Top and bottom left images show 54 test locations visual field pattern with 
Ricco's area estimates for subjects P001 (top left) and P002 (bottom left). Top right 
image shows an example of one of the worst spatial summation curves and bottom right 
image shows an example of one of the best spatial summation curves with the 54- 
location test grid from both participants. The locations with numbers were those where 
the curve successfully fitted, whilst those without numbers were not successfully fitted. 
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Figure 2.3. Top and bottom left images show the 30-locations visual field test pattern 
with Ricco's area estimates for subject P001 (top left) and P002 (bottom left). Top right 
image shows an example of one of the worst spatial summation curves and bottom right 
image shows an example of one of the best spatial summation curves with the 30-
location test grid from both participants. The locations with numbers were those with 
curve successfully fitted, whilst those without numbers were not successfully fitted.
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Figure 2.4. Top and bottom left images show 16 test locations visual field pattern with 
Ricco's area estimates for subject P001 (top left) and P002 (bottom left). Top right 
image shows an example of one of the worst spatial summation curve and bottom right 
image shows an example of one of the best spatial summation curves for the 16-
locations test grid with two repeats from both participants. 
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2.2.3. Discussion for experiment 1 
The goodness-of-fit of spatial summation functions, as denoted by mean R2, improved 
as the number of test locations was reduced. It increased to a satisfactory level of 0.97 
and good successful fit on spatial summation curve of 87.5%, with two repeat threshold 
measurements at 16 test locations. 
 
The increase of test time for Goldmann sizes other than Goldmann III agrees with the 
report of Turpin et al. (2002), that the testing time increases when the participant’s 
threshold does not match the initial threshold estimate of the pdf, as more presentations 
are required (correct estimate = 2-3 presentations; incorrect = 4-6 presentations). The 
pdf used in this study is based only on a threshold of Goldmann III stimuli of 856 
individuals and it was outside the scope of this project to create new pdf for the other 
Goldmann sizes. This defeated the purpose of using the ZEST algorithm, as one of the 
primary advantages of this procedure is reduced test time.  
 
Another drawback became apparent when the number of test locations was reduced in 
that, a problem with randomisation of thresholding procedure arose. The majority of 
tests at 16 test locations involved spots of light appearing systematically at one test 
location at a time, changing in intensity until the threshold was reached, before it moved 
to the next location, i.e. disruption of the randomisation procedure. Phu et al. (2016) 
observed that when participants can anticipate where the stimulus is going to appear 
next, contrast sensitivity measurement increases for Goldmann I and III, but not V. This 
has the potential to affect the size of Ricco’s area obtained. 
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Due to the randomisation problem, a staircase method was adapted from Andrew Turpin 
and Luke Chongs’ codes (University of Melbourne) and tested in experiment 2 to assess 
the goodness-of-fit of spatial summation function, the number of successfully fitted 
curves, time taken to perform the test and any potential problems with the 
randomisation procedure. 
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2.2.4.     Methods for experiment 2 
Leading on from the findings of experiment 1, a staircase method (Figure 2.5) was used 
to repeat the threshold measurements. It was conducted on 8 test locations because 
during the preparation for the pilot study, the duration of a test-run on 1 participant with 
16 test locations, was more than double that of ZEST with the same number of 
locations, with mean R2 reducing to 0.93.  
 
 
Figure 2.5. Staircase method thresholding procedure 
 
2.2.4.1. Procedure 
Participants and apparatus were the same as those described in section 2.3.1. The 
difference was that the staircase thresholding algorithm method was used to measure 
threshold in Goldmann I-V. The staircase method employed in this experiment 
terminated after 8 reversals at each location with the final threshold taken as an average 
of the last 4 reversals. Three factors were assessed in this experiment to determine the 
optimum parameters for testing in the main experiments. Using the improvement in the 
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mean R2 of spatial summation function as an indicator of success, the following steps 
were taken:  
 
1) Repeated threshold measurements for Goldmann I-V. Threshold measurements 
were repeated twice and then three times for the same 8 test locations. These 
were then averaged by location and stimulus size. Time needed to finish the tests 
was recorded. 
 
2) Staircase step sizes were altered. The effect of a 4-1dB and 4-0.5dB strategy was 
assessed. A 4-1dB strategy means that before the first reversal, the step size was 
4dB. For subsequent reversals, the step size was 1dB. 
 
The first stimulus intensity was based on a range of threshold values for Goldmann I-V 
obtained in experiment 1. In order for the staircase method to run efficiently, the first 
stimulus intensity needed to be close to the threshold.  
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2.2.5.   Results for experiment 2 
Test durations increased as Goldmann sizes were reduced for the staircase thresholding 
algorithm, unlike for the ZEST algorithm, where the testing time increased for all 
Goldmann sizes except for Goldmann III (Table 2.2). Total test duration for the 
staircase method was reasonably short. The percentage of Ricco’s area estimates 
obtained with the staircase method with twice repeated measure was 93.75% (15 out of 
16) and mean R2 was 0.98. Percentage stayed the same for the staircase method with 
triple repeated threshold measurement, however mean R2 improved to 0.99. 
 
Table 2.2. Test durations for staircase thresholding procedure 
Goldmann Sizes 
 
Number of test points 
8 (2x) 8 (3x) 
I 7 mins 30 secs 9 mins 36 secs 
II 6 mins 44 secs 10 mins 9 secs 
III 5 mins 20 secs 8 mins 15 secs 
IV 5 mins 6 secs 7 mins 7 secs 
V 5 mins 2 secs 7 mins 11 secs 
Total test durations 29 mins 42 secs 42 mins 18 secs 
 
Staircase method was then run with two different step sizes 4-1dB step and 4-0.5dB. 
There was no difference between the mean R2 of 4-1dB step and 4-0.5dB step sizes of 
0.99. However test duration increased by half an hour with 4-0.5dB. 
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Figure 2.6. Top and bottom left images show 8 test locations visual field pattern with 
Ricco's area number for subject P001 (top left) and P002 (bottom left). Top right image 
shows an example of one of the worst spatial summation curves and bottom right image 
shows an example of one of the best spatial summation curves with the 54-location test 
grid from both participants.  
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2.2.6. Discussion for experiment 2 
The staircase method exhibited no randomisation problem, had reasonable test time and 
allowed the determination of spatial summation data that could be fitted successfully. It 
is therefore a better thresholding algorithm compared to ZEST for this experiment. 
Mean R2 improved by 12% with three repeats measured, indicating that increasing 
repeat threshold measurements improved the fit of spatial summation function 
substantially. Time needed to perform the triple repeated test measurement was also 
acceptable with 8 visual field test locations. 
 
The 4 - 0.5dB strategy exhibited a similar mean R2 with the 4 - 1dB strategy but with a 
substantially longer test time. Both participants reported that the test was very taxing 
and required additional rest times. One important consideration is that participants in 
this study were young researchers with relatively good concentration levels, so if the 
test was too difficult for these participants then we can assume that participants with 
glaucoma, who are more senior, would find the test even more challenging. Therefore a 
4-1dB step staircase was considered a better option. 
 
In conclusion, the optimum protocol for the main experiments was chosen as follows: 8 
test locations in which three repeated threshold measurements are conducted with a 
staircase procedure, a 4 -1dB strategy, 8 reversal termination criterion and final 
threshold taken as the average of last 4 reversals. This protocol enabled a reasonable 
balance between test duration, number of satisfactory fitted spatial summation curves 
and the goodness-of-fit of these curves (as denoted by mean R2 of more than 0.9). 
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2.3. Learning effect and variability 
2.3.1. Introduction 
SAP has been reported to exhibit a learning effect, whereby inexperienced participants 
present with artificial VF defects that disappear in subsequent tests as participants 
acquire more experience in performing the test (Kulze et al. 1990; Wild et al. 1989). 
The learning effect is characterized by an increase in absolute mean sensitivity with 
subsequent examinations, that is especially significant between the first and second 
examinations in SAP (Kulze et al. 1990; Wild et al. 1989). It has also been shown in 
FDP (Fujimoto et al. 2002; Iester et al. 2000) and SWAP (Wild et al. 2006; Rossetti et 
al. 2006). It is unclear whether Ricco’s area measurement suffers from a learning effect. 
This needs to be investigated in order to establish which testing session measurement 
should be used as the baseline data, as any learning effect could minimise the possibility 
of detecting small changes in Ricco’s area. It is expected that there will only be a 
learning effect for the thresholds for different sizes/ contrast detection (vertical arrows 
in Figure 2.7), but not for Ricco’s area size (horizontal arrow), as intuitively we do not 
expect a participant to be able to learn to move the inflection point on spatial summation 
curves. To shift the inflection point, the mean sensitivity will have to be systematically 
greater (or smaller) with increasing stimulus size. Unlike the perception of being near 
threshold on a contrast detection task, participants have no way of perceiving the size of 
Ricco’s area in relation to the stimuli being presented. Also, as outlined in the previous 
experimental chapter, the different stimulus sizes will be presented randomly, and thus 
making it difficult for participants to learn to shift the inflection point.  
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Figure 2.7. Illustration of possible improvement in Goldmann size thresholds (black 
vertical arrows) and Ricco’s area size estimates (red horizontal arrows). 
 
Nevertheless, it is prudent to conduct the study to eliminate such an effect. To the 
author’s knowledge, no literature assessing a learning effect of different stimulus sizes 
is currently available. If a learning effect is indeed present, it is expected to appear in 
the form of systematic enlargement or reduction of size of Ricco’s area between visits. 
 
It is clear from the literature that Ricco’s area size varies between individuals, but it is 
unclear what is the intra-individual variability in Ricco’s area size (Redmond et al. 
2010a; Volbrecht et al. 2000). Measurement of the variability of Ricco’s area can better 
help inform true changes from physiological fluctuations between two visits (see 
Chapter 4). 
 
The aims of this study are twofold: firstly, to explore the presence of a learning effect 
on Ricco’s area measurements and, secondly to investigate the variability of Ricco’s 
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area estimates between visits in observers with previous experience of visual field 
testing, compared to inexperienced observers.  
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2.3.2.  Methods 
2.3.2.1. Subjects 
Four healthy participants (two aged 21 and two aged 22 years old) that were naïve to 
psychophysical testing, and 3 participants (aged 23, 28 and 51 years old) with prior 
experienced of performing psychophysical testing, were recruited from students and 
staff of Cardiff University. All participants underwent ocular health investigation with 
slit lamp biomicroscopy and Topcon 3D OCT 1000. All participants had best corrected 
visual acuity of at least -0.2 LogMAR and IOP<21mmHg with Topcon CT-80 non-
contact tonometer. All participants underwent visual field investigation with Humphrey 
SITA-Standard, which was measured after completion of Goldmann I-V threshold 
measurements to confirm visual field normality. Only right eyes of all participants were 
tested.  
 
2.3.2.2. Apparatus and Stimuli 
Experiments were performed on an Octopus 900 perimeter (Haag Streit, Koeniz, 
Switzerland) controlled with OPI, presenting Goldmann sizes I-V (0.11°, 0.22°, 0.43°, 
0.87° and 1.7° diameter) on a white background (10 cd/m2) for 200ms. Eight visual field 
locations were measured at eccentricities of 12.7° and 21.2° (Figure 2.8) based on 
previous experiments, where the success rate of spatial summation curve fitting was 
observed to be higher at these eccentricities.  
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Figure 2.8. 8 visual field test locations 
 
2.3.2.3. Procedure 
Sensitivity (in dB) was measured for each of the Goldmann sizes (I-V) at each visual 
field location in an interleaved manner. In each test, a different Goldmann size was 
used, chosen at random. A 4:1 staircase procedure was used, which was adapted from 
that produced by Andrew Turpin and Luke Chong (University of Melbourne, 
http://people.eng.unimelb.edu.au/aturpin/opi/interface.html, accessed on 15th March 
2014). Step size was 4 dB before the first reversal and 1dB thereafter. A yes/no 
response criterion was used. At each location, the procedure stopped after 8 reversals 
and the final threshold returned was an average of the last 4 reversals. The entire 
procedure was repeated twice more. So at each test location, 3 values for sensitivity 
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were obtained for each Goldmann size. Therefore a total of 15 sets of sensitivity 
measurements were obtained per location, and 120 measurements per participant for 
each appointment visit. Sensitivity measurements of Goldmann I-V were conducted for 
4 appointment visits over the period 3 weeks for experienced participants and 5 
appointment visits for naïve participants. All procedures were carried out with natural 
pupil sizes and central refractive error corrected fully with full aperture trial lenses. 
Fixation was monitored visually and patient position adjusted when fixation began to 
drift from central. Breaks were given approximately every 10 minutes (roughly two 
threshold measurements) and whenever a patient asked for a break.  
 
2.3.2.4. Data analysis 
Sensitivity values (dB) for Goldmann I-V were converted into increment threshold (ΔI) 
and plotted against area. Two-phase regression analysis was performed in the freely 
available open-source statistical environment, R (version 3.1.0) to obtain Ricco’s area 
estimates at each location. The slope of the first line was constrained to a value of -1, 
following Ricco’s law, whilst the intercept of first line, slope of the second line and 
break point were allowed to vary. The breakpoint estimated was taken to be the Ricco’s 
area estimate. For each appointment visit, eight Ricco’s area estimates were obtained 
from each participant. Ricco’s area estimates were compared between visits to explore 
any learning effect and variability between visits. Kolmogorov-Smirnov test was 
conducted and showed the data to be non-normally distributed and therefore a two-way 
Friedman test was used to investigate significant differences between sessions. Research 
was conducted in accordance with the tenets of the Declaration of Helsinki. 
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2.3.3.   Results 
When the Ricco’s area data from all locations were pooled together, averaged for each 
participant and plotted by each visit, all 3 experienced participants exhibited different 
patterns of Ricco’s area changes between visits (Figure 2.9). P006 Ricco’s area seemed 
to exhibit a pattern of enlargement from visit 1 to 3 that was not observed for the other 
participants. P004 Ricco’s area got smaller from visit 1 to 2, but then enlarged. P005 
Ricco’s area appeared to stay relatively stable from visit 1 to 2 and then got smaller, 
before it stayed somewhat stable again. The same was observed with naïve participants, 
where different participants exhibited different patterns of Ricco’s area changes 
between visits, with P009 showing the largest change in Ricco’s area estimates between 
visits. 
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Figure 2.9. Ricco's area estimates of all 3 experienced (top) and naïve (bottom) 
averaged across all locations. 
The Friedman test showed no statistically significant difference in Ricco’s area 
estimates between visits in experienced (p=0.96) and naïve (p=0.48) participants. Mean 
and standard deviation between visits for P004, P005, and P006 are -1.18 ± 0.03, -1.03 
± 0.05, and -0.78 ± 0.08 respectively. Slightly larger standard deviation is observed with 
naïve participants, mean and standard deviation for P007, P008, P009, and P010 are  
-0.75 ± 0.07, -0.73 ± 0.10, -0.62 ± 0.14 and -0.64 ± 0.04 respectively. 
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2.3. Threshold values of Goldmann I, III and V for 4 visits in experienced participants. 
Standard deviation depicting range of threshold values found in 8 test locations. 
Goldmann 
size 
Visit 1 (dB) Visit 2 (dB) Visit 3 (dB) Visit 4 (dB) 
I 18.91 ± 1.95 18.39 ± 2.45 18.88 ± 1.72 18.88 ± 1.71 
III 30.41 ± 0.75 30.48 ± 0.86 30.68 ± 0.67 30.19 ± 0.82 
V 34.41 ± 0.38 34.59 ± 0.56 34.58 ± 0.31 34.23 ± 0.5 
 
There was no improvement in sensitivity values with visits in experienced participants 
for any Goldmann I, III and V (Table 2.3). Mean and standard deviations of sensitivity 
(dB) between visits for Goldmann I, III and V are 18.77 ± 0.25, 30.44 ± 0.20 and 34.45 
± 0.17 respectively.  
Table 2.4. Threshold values of Goldmann I, III and V for 5 visits in naive participants. 
Standard deviation depicting range of threshold values found in 8 test locations. 
Goldmann 
size 
Visit 1 
(dB) 
Visit 2 
(dB) 
Visit 3 
(dB) 
Visit 4 
(dB) 
Visit 5 
(dB) 
I 
15.44 ± 
1.46 
16.02 ± 
1.37 
15.80 ± 
1.22 
15.82 ± 
1.34 
16.00 ± 
1.52 
III 
28.30 ± 
1.21 
28.82 ± 
0.91 
28.58 ± 
1.02 
28.63 ± 
1.04 
28.67 ± 
0.89 
V 
33.56 ± 
0.42 
33.78 ± 
0.62 
34.04 ± 
0.48 
33.77 ± 
0.42 
33.91 ± 
0.42 
 
There was a slight improvement of sensitivity values from first to second visit in naïve 
participants, more so for smaller Goldmann sizes. Mean and standard deviations of 
sensitivity values (dB) between visits for Goldmann I, III and V are 15.81 ± 0.23, 28.6 ± 
0.19 and 33.81 ± 0.18 respectively. 
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2.3.4.   Discussion 
The learning effect is reportedly present with SAP, FDP and SWAP in the form of an 
increase in absolute mean sensitivity that is most notable between the first and second 
examinations (Fujimoto et al. 2002; Iester et al. 2000; Kulze et al. 1990; Rossetti et al. 
2006;  Wild et al. 1989; Wild et al. 2006). However, such an effect does not appear to 
be present in Ricco’s area measurements. The lack of systematic changes of Ricco’s 
area estimates and the random pattern of changes of Ricco’s area estimates between 
visits in both experienced and naive participants suggest an absence of a learning effect 
in Ricco’s area measurement.  
 
A slight improvement in sensitivity values of Goldmann III in the range of 0.20 - 
0.58dB was observed in naïve participants, which is smaller than reported in the 
published literature (Kulze et al. 1990; Wild et al. 1989). One possible explanation is 
that repeated threshold measurements of different Goldmann sizes in one session 
allowed participants to learn the visual field task better than in SAP. In this study, as 
thresholds of Goldmann I-V were repeatedly measured, if Goldmann size II was taken 
as an example, by the time the observer takes the second Goldmann II threshold 
measurement, he/she would have undertaken the threshold measurement for all the other 
Goldmann sizes and will be on at least the 6th test at this point. The observer would have 
learned how brief the stimulus duration was, the test locations, and how far into the 
periphery, etc. Because even though the Goldmann sizes were different, the task was the 
same, consisting of detecting achromatic contrast.  
 
There was no obvious learning effect for different stimulus sizes in experienced 
participants. Neither the experienced nor the naïve participant data exhibited an increase 
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in variability with decreasing stimulus sizes, disagreeing with Wall et al. (2009) study, 
where they observed reduced variability with Goldmann V when compared to 
Goldmann I and III. 
 
The good repeatability of Ricco’s area measurement in the current study is encouraging, 
with the largest standard deviation being 0.14. The participants recruited in this study 
were students and research associates with a high level of concentration and motivation. 
When the test is conducted on participants from elderly populations (as glaucoma 
prevalence increases with age), although it is expected that the concentration will affect 
threshold measurements, the variability of Ricco’s area is expected to remain 
unchanged. 
 
In conclusion, a learning effect was not observed in the participants that had performed 
SAP and those with no visual field task experience. Therefore, in the main PhD study 
there is no need to exclude Ricco’s area measurement from the first session. The good 
repeatability exhibited by the current study, together with the trials of different 
parameters in previous sections suggested that the psychophysical protocol for the main 
experiment is optimised. 
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2.4.   Corneal wavefront aberrations. 
2.4.1.Introduction 
One of the main aims of the PhD was to test the hypothesis that Ricco’s area shrinks 
following more rigorous IOP-lowering treatment. The treatment form chosen in the 
study was trabeculectomy surgery. Trabeculectomy surgery is a procedure that allows 
the lowering of IOP by creating a corneoscleral fistula that causes subconjunctival bleb 
formation (Cairns 1968). A more detailed explanation of the surgery can be found in 
Chapter 4. This procedure had been documented to cause changes in corneal curvature 
(Egrilmez et al. 2004; Hong et al. 1998) and it was felt that this could affect the 
projected size, on the retina, of stimuli used in the measurement of Ricco’s area. Thus, it 
was felt to be important to investigate between-visit changes in corneal aberrations and 
their effect on between-visit measurements of Ricco’s area. More details about that 
experiment can be found in Chapter 4. Here, the principles of corneal aberrations will be 
described, and a preliminary study of the repeatability of measurements will be 
reported. 
 
Wavefront aberrations illustrate the distortion of wavefronts as they go through a non-
optimal optical system.  Wavefront aberrations can be described mathematically by a 
polynomial series, with Zernike polynomial expansion chosen to become the standard 
for describing ocular wave aberrations (Thibos et al. 2002). The Zernike polynomial is a 
set of basic functions, with each having a coefficient. Coefficients depict how much 
contribution that aberration has to the overall wavefront aberration. The Zernike terms 
are construed by radial order n and frequency m over a unit circle with orthogonal polar 
co-ordinates ρ and θ.  
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Figure 2.10. Pyramids of Zernike term up to 5th order. Image reproduced from 
http://www.telescope-optics.net/monochromatic_eye_aberrations.htm.  
 
The Zernike pyramid organizes aberrations into a hierarchy with an increasing radial 
order (Figure 2.10). Lower order aberrations are zero (piston), first (tilt), and second 
order (astigmatism and defocus), and can be corrected with spectacle lenses. Higher 
order aberrations consist of third order aberrations and above; these imperfections 
cannot be corrected with spectacle lenses.  
 
The cornea, as the contributor of approximately two-thirds of the power of the relaxed 
eye, has great influence on ocular aberration. Trabeculectomy causes a change in 
corneal curvature, and has previously been observed to cause a change in corneal higher 
order aberrations, which return to pre-operation values 3 months after surgery (Fukuoka 
Chapter 2 	
 
 76 
et al. 2011). Corneal aberrations are estimated based on corneal elevation data, where 
the Zernike polynomial is fitted as close as possible to the measured height data. Given 
the possibility of misinterpreting normal variability in wavefront aberration 
measurements as true surgery-related changes, it was considered important to gain an 
understanding of normal measurement variability in otherwise healthy individuals. 
 
Here, an exploratory study is described in which corneal wavefront aberrations are 
measured over multiple visits in a cohort of healthy participants, to gain an 
understanding of normal between-visit variability. The Optical Society of America 
(OSA) recommendations were followed throughout the study (Thibos et al. 2002).  
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2.4.2. Methods 
In this experiment, corneal aberrations were measured in 4 healthy participants, on 5 
visits, over a period of 3 weeks. 
2.4.2.1. Participants 
Four healthy participants (two aged 21 and two aged 22 years old) were recruited from 
students of Cardiff University. All participants underwent an ocular health investigation 
with slit lamp biomicroscopy and optical coherence tomography (OCT) with a Topcon 
3D OCT 1000 (Topcon Corp., Tokyo, Japan). All participants had a best corrected visual 
acuity of at least -0.2 LogMAR and IOP < 21mmHg, as measured with a Topcon CT-80 
non-contact tonometer (Topcon Corp., Tokyo, Japan). All participants had a normal 
visual field, as determined with Standard Automated Perimetry (SAP; 24-2 SITA-
Standard, Humphrey Field Analyser, Carl Zeiss Meditec, Dublin, CA, USA). The right 
eye of each patient was tested.  
2.4.2.2. Apparatus and Stimuli 
An Oculus Pentacam (Oculus, Wetzlar, Germany) was used to obtain measurements of 
corneal wavefront aberrations. The instrument uses a 475nm UV-free LED and two 
cameras, and a method based on based on the Scheimpflug principle to capture the size 
and orientation of the pupil and capture images from the cornea. An attempt to calibrate 
the instrument with a steel ball of known radius was unsuccessful because, in order to 
take the measurement, the Pentacam relies on the backward light scattering properties of 
the front and back surface of the transparent cornea. The instrument was instead 
calibrated with a 3D-printed model eye. 
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2.4.2.3. Procedure 
Three repeated measurements of corneal aberrations were acquired each visit. Each 
acquisition lasted approximately two seconds. On occasions when data were missing 
from the Pentacam report, (e.g. due to ptotic eyelids or long eyelashes), an attempt was 
made to hold the eyelid. Care was taken to ensure that the eyelids were held against the 
brow, avoiding any manual compression of the globe, or moving the eyelid to an 
abnormal position. Room lights were switched off during the measurement to ensure a 
reflection-free image. The automatic release mode was used, in order to reduce operator 
dependency for all tests, wherein the Pentacam automatically captured the scan when it 
decided that correct alignment with the corneal apex had been achieved.  
2.4.2.4. Data analysis  
Due to raw data export restrictions with the Pentacam, Zernike numbers had to be hand-
typed from a screenshot of the report from each acquisition. Forty-five Zernike 
coefficients were obtained from each acquisition from the front surface of the cornea, 
and 45 from the back surface of the cornea. As three acquisitions were made per visit, 
the total number of Zernike coefficients obtained per participant, per visit, was 270. 
Therefore, 1,350 Zernike coefficients were recorded in total, across the 5 visits for each 
participant. As a quality control, Zernike coefficients were hand-typed three times, in 
order to check for transcription errors. To do this, every third Zernike number was 
transcribed again on two separate occasions. Coefficients, transcribed on the 2nd 
occasion were subtracted from their corresponding data, transcribed on the first 
occasion, to ensure that a value of zero was obtained (i.e. no transcription error). This 
was repeated for the 1st and 3rd data sets, and the 2nd and 3rd data sets. For each 
participant, on average 24 minutes were needed to type out the Zernike numbers per 
visit. As recommended by Atchison (2004), Zernike polynomials up to the 6th order 
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were included in the analysis so that the error of the fit that comes with a coefficient 
does not become as significant as the coefficient itself. 
 
Data from all participants, at all five visits, were pooled by polynomial. The median 
coefficient was calculated for each front surface polynomial in each participant. These 
were plotted by polynomial number. Then, the median coefficient for all participants 
was calculated for each polynomial. The coefficient range (i.e. difference between the 
maximum and minimum measurement for each polynomial) was calculated per 
participant and plotted by polynomial. The mean coefficient range was then calculated 
for each polynomial and plotted together on the same graph. All analysis was then 
repeated for the back surface data. 
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2.4.3.   Results 
Front surface data 
In the front surface data, the polynomial with the highest mean aberration coefficient is 
polynomial 0 (median = 0.13, Figure 2.11), followed by polynomial 4 (median = 0.08). 
The polynomial with the lowest median between-visit difference in coefficients was 
polynomial 20 (median = -9.45 × 10-5, Figure 2.12). The polynomial with the highest 
mean coefficient range (i.e. mean(maximum – minimum) across all four participants) 
was polynomial 2 (0.0013; Figure 2.13), and that with the lowest variance was 
polynomial 23 (8.05 × 10-5). 
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Figure 2.11. Aberration coefficients for polynomials 0 – 28 for all four participants 
(front surface). 
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Figure 2.12. Aberration coefficients for polynomials 0 -28 for all participants. Data are 
the same as those in Figure 2.11 above, except that polynomials 0 and 4 are removed 
for ease of visualisation of the remaining data. 
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Figure 2.13. Coefficient range (maximum – minimum) for each front surface polynomial 
pooled across all participants (+ symbols). Mean coefficient range for each polynomial 
is denoted by the red symbols. 
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Back surface data 
In the back surface data, the polynomial with the highest mean aberration coefficient is 
polynomial 0 (median = 0.17, Figure 2.14), followed by polynomial 1 (median = -
0.003). The polynomial with the lowest median between-visit difference in coefficients 
was polynomial 1 (median = -0.003, Figure 2.15). The polynomial with the highest 
mean coefficient range (i.e. mean(maximum – minimum) across all four participants) 
was polynomial 0 (0.0003; Figure 2.16), and that with the lowest variance was 
polynomial 24 (0.00028). 
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Figure 2.14. Aberration coefficients for polynomials 0 – 28 for all four participants 
(back surface). 
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Figure 2.15. Aberration coefficients for polynomials 0 -28 for all participants (back 
surface). Data are the same as those in Figure 2.14 above, except that polynomials 0, 1, 
and 4 are removed for ease of visualisation of the remaining data. 
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Figure 2.16. Coefficient range (maximum – minimum) for each back surface polynomial 
pooled across all participants (+ symbols). Mean coefficient range for each polynomial 
is denoted by the red symbols. 
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2.4.3.  Discussion 
This exploratory study enabled an understanding of normal between-visit and between-
participant differences. It can be seen that the largest variation is found in lower order 
aberrations, with this variation becoming considerably less with increasing order. 
 
It is difficult to comment, at this stage, on whether or not the variation observed is 
clinically meaningful, but these data serve to provide a context for any between-visit 
differences in polynomial coefficients observed in patients undergoing trabeculectomy 
in the study described in Chapter 4. 
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2.5.    Effect of localised defocus on measurements of Ricco’s 
area 
Trabeculectomy surgery has been observed to cause a shallowing of the anterior 
chamber up to 5 years post-surgery (Husain et al. 2013; Man et al. 2015), shortening of 
axial length up to 5 years following surgery (Husain et al. 2013; Pakravan et al. 2015) 
and changes in corneal curvature in the form of flattening of anterior curvature, 
resulting in increase in with-the-rule astigmatism in some cohorts by up to 2.00D at 12 
months post-surgery (Hong et al. 1998; Kook et al. 2001). The resultant dioptric blur 
could mask subtle changes in Ricco’s area after trabeculectomy surgery and thus need 
to be investigated. 
Low spatial frequency stimuli have been observed to be more robust to the effect of 
defocus, compared to high spatial frequency stimuli (Campbell & Green 1965). It is 
well documented that refractive error increased with visual field eccentricity, with the 
astigmatic component going up to 2.00D at 30° eccentricity (Calver et al. 2007; 
Millodot 1981; Rempt et al. 1971; Tabernero & Schaeffel 2009). Anderson et al. (2001) 
reported that a higher detection threshold with small stimulus sizes at more peripheral 
locations and thus their finding is in agreement with the robust effect of bigger stimulus 
sizes. This suggests that with increased dioptric blur, small stimulus sizes lead to point 
spread function enlargement with increasing defocus, whilst at larger stimulus sizes the 
point spread function remained unaffected. Considering that the assessment of Ricco’s 
area involved measurement of Goldmann I-V threshold, if the smaller stimulus size 
threshold is affected whilst the larger stimulus size is not, it is expected that the Ricco’s 
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area estimate will be affected as well. Therefore qualification and quantification of the 
effect of dioptric blur on Ricco’s area is needed. 
The aim of this study is to investigate the effect of optical defocus on the measurement 
of Ricco’s area at three different retinal eccentricities.  
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2.5.2.  Methods 
2.5.2.1. Subjects 
Five healthy participants (mean age: 23, range 21 – 25 years) were recruited from 
students of Cardiff University. All participants underwent an ocular health investigation 
with slit lamp biomicroscopy and indirect ophthalmoscopy to ensure no retinal 
pathology or abnormalities were present. All participants had a best corrected visual 
acuity of -0.2 logMAR, IOP <21mmHg (Topcon CT-80 non-contact tonometer) and 
demonstrated full visual fields with a Humphrey field analyser with SITA-Standard. 
Only right eyes of all participants were tested. All participants were recruited in 
accordance to Declaration of Helsinki. 
 
2.5.2.2. Apparatus and stimulus 
Goldmann I-V stimuli were presented on a white background (10 cd/m2) for 200 ms. 
Five different stimulus areas were used, GI-V (0.11°, 0.22°, 0.43°, 0.87° and 1.7°). The 
Octopus 900 perimeter (Haag Streit, Koeniz, Switzerland) controlled with OPI was used 
to present the stimuli at all measured visual field locations. Stimuli was presented on 6 
visual field locations at eccentricities of 12.7°, 21.2°, and 29.7° (Figure 2.17). Three test 
stimuli were located at 12.7°, 21.2°, and 29.7° inferotemporally, with three control 
locations at the same eccentricities superonasally to aid central fixation. The 
inferotemporal test location was chosen to avoid possible influence of shadow cast by 
nose bridge and eyelid. A Keeler retinoscope was used to assess refractive error at 
central locations and three inferotemporal test locations (more details in section 2.5.2.3).  
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Figure 2.17. 6 test locations in visual field of right eye 
2.5.2.3. Procedure 
1.  Ricco’s area measurement 
Sensitivity (in dB) was measured for each of the Goldmann sizes (I-V) at each visual 
field location in an interleaved manner. In each test, a different Goldmann size was 
used, chosen at random. A 4:1 staircase procedure was used, which was adapted from 
that produced by Andrew Turpin and Luke Chong (University of Melbourne, 
http://people.eng.unimelb.edu.au/aturpin/opi/interface.html, accessed on 15th March 
2014). Step size was 4 dB before the first reversal and 1dB thereafter. A yes/no 
response criterion was used. At each location, the procedure was terminated after 8 
reversals and the final threshold returned was an average of the last 4 reversals. The 
entire procedure was repeated twice more. So at each test location, 3 values for 
sensitivity were obtained for each Goldmann size. Therefore, a total of 15 sets of 
sensitivity measurements were obtained per location, and 45 measurements per 
participant. Thresholds for five Goldmann sizes were measured three times each, first 
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with central refractive correction in place and a +3.00D lens to control accommodation, 
then with addition of induced optical blur in the form of full aperture trial lenses of 
+1.00D and +2.00. Only plus lenses are used in this study, as the effect of refractive 
blur is the same for plus and minus lenses. Participants included in the study were 
young with healthy accommodation; adding a minus lens will prevent accurate 
assessment of an influence of refractive blur on Ricco’s area estimates by triggering 
their accommodation. All procedures were carried out with natural pupil sizes. Fixation 
was monitored visually and participants’ head position adjusted whenever needed.  
 
Sensitivity values (dB) for Goldmann I-V were converted into increment threshold (ΔI) 
and plotted against area. Two-phase regression analysis was performed in the freely 
available open-source statistical environment, R (version 3.1.0) to obtain Ricco’s area 
estimates at each location. The slope of the first line was constrained to a value of -1, 
following Ricco’s law, whilst the intercept of the first line, slope of the second line and 
break point were allowed to vary. The breakpoint estimated was taken to be the Ricco’s 
area estimate. Three Ricco’s area estimates were obtained from each participant, one for 
each eccentricity inferotemporally. Superonasal location data was not analysed as only 
the spot of light used to maintain fixation was used here. The average test time 
including breaks for each participant was 4 hours 30 minutes. 
 
2. Peripheral refractive error 
For peripheral refractive error measurements, a central black fixation target and six 
peripheral targets corresponding to test locations (12.7°, 21.2°, and 29.7° at superonasal 
and inferotemporal visual field locations) were attached to a white wall. The required 
locations of the targets were calculated for a working distance of 3 metres: 
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Figure 2.18. (A) X and Y coordinates of Octopus 900 testing locations; (B) schematic 
representations for target distance calculation. 
 
Based on Figure 2.18 (B) the viewing angle for test location (9, -9) coordinate (Figure 
2.18(A)) or 12.7° inferotemporally is 9°.  In order to establish the peripheral target 
(A) 
(B) 
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distance, a and b in Figure 2.18(B) calculation with trigonometry was required. So for a 
working distance of 3m: 
 
 
Figure 2.19. Right angle triangles for calculations of peripheral target distance. 
 
Tan9 =a/3; a=0.4752m (47.5cm) 
 
The same method of calculation was applied to inferotemporal peripheral targets at 
21.2° and 29.7°, with resultant target set up that was shown in Figure 2.19. 
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Figure 2.20. Target set up for peripheral refractive error measurement.  
 
Participants were seated 3m away and instructed to look at a central fixation target for 
measurement of central refractive error. Retinoscopy was used with sphero-cylindrical 
lenses to estimate the amount of refractive error. All measurements were performed 
with the participants’ head held straight in primary position (0°) and the investigator 
seated straight in line with the participant’s visual axis. To get the peripheral refractive 
error at 12.7° inferotemporal visual field location, participants were instructed to look to 
the target located at 12.7° superonasal visual field location whilst the practitioner 
continued to be positioned on the former central axis.  
 
Total defocus 
Peripheral refractive error measurements were used to estimate the amount of total 
peripheral defocus. Estimates of peripheral ocular blur were obtained by subtracting the 
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central refractive error value from the peripheral refractive error value at each location. 
When a central refractive correction was worn the amount of ocular blur at the primary 
position was always zero. The amount of optical blur at the peripheral location was 
taken to be the difference between the peripheral refractive error, at that location, and 
the central refractive error. For example, if a participant had a central refractive error of 
-2.00 and peripheral refractive error of -2.50, after the correction of central refractive 
error, the amount of ocular blur left at 12.7° eccentricity would be 0.50 D. The total 
amount of defocus induced was a combination of ocular blur at the test location and the 
induced optical blur (blur resulting from introduction of positive spherical lenses, 
Figure 2.21).  
 
Figure 2.21. Illustration of estimation of total defocus (the sum of optical and ocular 
blur) at 12° eccentricity (adapted from Charman & Radhakrishnan (2010)). 
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Data of Ricco’s area estimates was observed to be normal based on Kolmogorov-
Smirnov test. Ricco’s area estimates with added blur were separated into 3 groups with 
increasing amount of dioptric blur (0-1.00D, 1.10-2.00D and 2.10-3.00D). Data from 
each dioptric blur group was plotted against visual field eccentricity and repeated 
measures ANOVA performed to check whether there were significant differences of 
Ricco’s area changes at different level of blur with increasing visual field eccentricity. 
 
Another investigation involved looking at changes of dioptric blur at each measured 
eccentricity and performing repeated measured ANOVA comparing Ricco’s area 
estimates at each measured eccentricity with increasing dioptric blur. A Holm-
Bonferroni correction was used when the same hypothesis was tested multiple times, 
and only when p ≤ 0.05 was achieved, to reduce the likelihood of a type I error. 
Chapter 2 	
 
 96 
2.5.3.   Results 
Forty-five spatial summation curves were generated in total. There was a general 
increase in astigmatism in 4 out of 5 participants. All but one participant exhibited 
peripheral myopic shift with increasing eccentricity (Table 2.5). 
 
Table 2.5. Peripheral refractive errors in all participants 
Eccentricity P007 P008 P009 P010 P011 
Sph Cyl Sph Cyl Sph Cyl Sph Cyl Sph Cyl 
0 +2.00 -1.50 -0.25 0.00 +0.75 0.00 +1.00 -0.50 +0.50 -0.25 
12.7 +1.25 -0.75 -0.50 0.00 +0.75 0.00 +2.00 -0.25 +0.25 -0.25 
21.2 +1.00 -0.25 -0.75 0.00 +0.50 -0.25 +2.50 -0.50 0.00 -0.50 
29.7 +0.25 -0.25 -1.00 0.00 +0.50 -1.00 +3.00 -1.50 -0.50 0.00 
 
Mean refractive errors of all participants, at different eccentricities is represented in 
Table 2.6.  
 
Table 2.6. Values of the mean refractive errors at all test locations in all participants 
Eccentricity Peripheral refractive errors (D) 
0 0.70/-0.05 x 90 
12 0.75/-0.25 x 90 
21 0.65/-0.30 x 90 
29 0.45/-0.55 x 180 
 
The averages of ocular blur after central correction at 12.7°, 21.2°, and 29.7° 
inferotemporally were 0.53D, 0.81D, 1.14D respectively. The maximum of total 
defocus at 12.7°, 21.2°, and 29.7° inferotemporally were 2.53D, 2.81D and 3.14D 
respectively. 
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Figure 2.22. Ricco's area estimates obtained at three eccentricities under 3 different 
levels of optical blurs 
There was a general trend towards enlargement of Ricco’s area with eccentricity at all 3 
levels of total defocus (Figure 2.22), however the magnitude of Ricco’s area size change 
with eccentricity seemed to reduce with increasing amount of total defocus. The trend to 
enlargement with eccentricity did not reach statistical significance at any level of blur 
(repeated measures ANOVA, all p>0.12).  
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Figure 2.23. Ricco's area estimates at individual test eccentricities (12.7°, 21.2° and 
29.7°) and averaged. 
There was no clear pattern of change in Ricco’s area size, nor was there a statistically 
significant change of Ricco’s area size with increasing amount of optical blur at 12.7° 
(p=0.54), 21.2° (p=0.18), or 29.7° (p=0.07). When the data from all eccentricities were 
averaged, there was still no statistically significant change in Ricco’s area size with 
increasing defocus (p=0.72). 
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There is a large difference between sensitivity measured in between total defocus of 0 
and 3D of total defocus for Goldmann I of 4.43dB. The differences of sensitivities 
measured between total defocus of 0 to 3D lessen to 3.28dB for Goldmann III and 
1.11dB for GV respectively. 
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2.5.4.  Discussion 
The peripheral myopic shift observed in four out of five emmetropic and myopic 
participants in this study is in agreement with the finding of Calver et al. (2007) and 
Gustafsson et al. (2001). Other studies observed hyperopic shift in myopes and myopic 
shift in hyperopes (Millodot 1981; Mutti et al. 2000).  
 
In agreement with previous studies investigating peripheral refractive error changes 
with eccentricity, there is an increase in the astigmatic components of the refractive 
error. The increase in astigmatism with eccentricity is smaller than that found in other 
studies.  Here we demonstrate an average increase of 0.50D compared to an average of 
2.00D in Gustafsson et al. (2001), Millodot (1981), Rempt et al. (1971), and Seidemann 
et al. (2002). This could be attributed to the different measurement techniques, as other 
studies had used different methods, such as a double pass method and auto-refractor, as 
they were concerned that peripheral refractive error measurement with retinoscopy 
could be too variable and subjective. Retinoscopy was chosen as the measurement 
method for the study because the only available autorefractor was unable to measure 
peripheral refractive error and the person undertaking the retinoscopy was skilled in the 
technique. On the other hand, it is also clear from the literature that there is large inter-
subject variability in patterns of peripheral refractive error changes (Millodot 1981; 
Rempt et al. 1971; Seidemann et al. 2002). This is a more likely reason for the 
discrepancy of current study astigmatism in the literature. 
 
Although there is a general trend for enlargement, the increase in Ricco’s area size with 
eccentricity under normal conditions in this study did not reach statistical significance. 
Comparing the extent of Ricco’s area enlargement in the current study with the findings 
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of Khuu & Kalloniatis (2015), where they showed that the average enlargement of 
Ricco’s area from 10° to 20° in 28 participants was 0.35 log unit in the temporal 
meridian, there were lesser changes of Ricco’s area size with eccentricity in current 
study; here the change from 12.7-21.2° was 0.17 log unit. Ricco’s area had also been 
shown to exhibit large inter-subject variability (Redmond et al. 2010a; Volbrecht et al. 
2000) and therefore could have different level of change of Ricco’s area with 
eccentricities even between normal subjects causing different of changes of Ricco’s area 
estimates with eccentricity between results from Khuu & Kalloniatis (2015) with our 
study.  
 
The lack of significant changes of Ricco’s area size with increasing defocus up to 
3.14D, was unexpected because of two factors. Firstly, the enlargement of point spread 
function (PSF) with defocus. Figure 2.24 shows the point-spread function of a projected 
stimulus without a blurring lens, on the left and with additional blur, on the right. When 
a blurring lens is added, the image of the stimulus on the retina will be larger than the 
image of a stimulus without a blurring lens. Ricco’s area would be expected to be 
‘filled’ sooner and as a consequence, Ricco’s area should appear to reduce in size. This 
hypothesis was also proposed by Redmond et al. (2010b) who observed no change in 
Ricco’s area with age. They hypothesized that changes in the crystalline lens with age 
causes an increase in PSF, which causes Ricco’s area to be filled sooner. No effect on 
Ricco’s area was observed in Redmond et al. (2010b) study and they further 
hypothesized that the increase in PSF was cancelled out by loss of RGC with age. 
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Figure 2.24. Top left image shows a projected stimulus without any optical filtering 
falling onto one Ricco's area, and its point-spread function is shown bottom left. Top 
right image is of a projected stimulus with added blurring lens, causing widening of its 
point spread function (bottom right). 
 
This study observed no reduction in Ricco’s area either. The lack of changes could be 
due to the conventional fitting method used to obtain Ricco’s area estimates in both 
studies. Perhaps the greater effect to thresholds of small Goldmann sizes causes 
steepening of the left limb of the spatial summation functions. Two-phase regression 
analysis, that is used to obtain Ricco’s area estimates in this study, constrained the slope 
of the first line to -1 would have the effect of dragging the inflection point from the true 
point to a larger value along the x axis, and thus causing an apparent enlargement in 
Ricco’s area size, negating the smaller Ricco’s area caused by an increase in defocus 
(Figure 2.25).  
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Figure 2.25. Two spatial summation curves. Pink dots are the thresholds for Goldmann 
I-V without any blurring lens, whilst brown dots are thresholds after addition of 
blurring lens. 
According to the hypothesis above, the effect of optical blur on threshold data for a 
Goldmann I should be greater than that for a Goldmann III, which in turn should be 
greater than that for the Goldmann V. This is supported by the data here where the 
difference in sensitivity for Goldmann I, III and V is 4.43dB, 3.28dB and 1.11dB 
respectively when 3D of optical blur is added. 
 
It should be noted that this study by no means supports the idea of no changes in 
Ricco’s area with defocus, as it is clear from published literature that optical factors 
influence the measurement of Ricco’s area (Dalimier & Dainty 2010; Davila & Geisler 
1991). Nevertheless, the absence of obvious changes in Ricco’s area observed in this 
study is in support of the notion that the effect of small refractive changes (at least up to 
3.14D) on Ricco’s area, and induced astigmatism with trabeculectomy, will likely not 
be a major cofounder in the determination changes in Ricco’s area, owing to neural 
change following trabeculectomy surgery. Considering that changes of refractive error 
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up to 6 months after trabeculectomy surgery was reported to be a maximum of 3.00D, 
the measurement obtained for Chapter 4 is unlikely to be influenced by optical blur.
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Chapter 3: On the Physiological Basis for Ricco’s 
Area: A Study of Amblyopia 
 
3.1. Introduction 
For a visual stimulus to be detected, the strength of the stimulus signal must overcome 
intrinsic noise that is inherent in the visual pathway. Pooling of signals over space 
(spatial summation), increases detectability, but at the expense of reduced visual 
resolution. Ricco’s law of spatial summation (Ricco 1877) states that for a range (Piper 
1903) of small stimulus areas, stimulus area and intensity are inversely proportional at 
threshold (A x I = k), i.e. spatial summation is complete. However, Ricco’s law applies 
only within a critical area, known as Ricco’s area. Beyond Ricco’s area, spatial 
summation is incomplete and, depending on the precise conditions under which it is 
measured, threshold is governed by laws of incomplete summation, such as Piper’s law 
(Piper 1903), or Pieron’s law (Kleitman & H 1929)  
The physiological basis for Ricco’s area is not entirely understood. The traditional 
explanation has been that it is the psychophysical correlate of the area of the RGCs 
receptive field centre (Glezer 1965; Lie 1980). Initially, this may seem reasonable, 
given that it has been found to vary with retinal eccentricity (Vassilev et al. 2003; 
Wilson 1970) and background adaptation level (Glezer 1965; Lelkens & Zuidema 1983) 
in healthy observers. However, despite the close association between Ricco’s area and 
RGC size (Vassilev et al. 2005) as well as eccentricity-related changes in RGC density 
(Volbrecht et al. 2000), it was demonstrated by Pan & Swanson that spatial summation 
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of circular incremental stimuli, as used in clinical visual field testing, cannot be 
accounted for by probability summation across retinal ganglion cells, but rather spatial 
pooling by multiple cortical mechanisms (Pan & Swanson 2006). Further support for 
the physiological basis of Ricco’s area lying at a cortical level comes from Redmond et 
al., who found changes in Ricco’s area in the S-cone pathway, as a function of the blue 
background adaptation level (Redmond et al. 2013b). The traditional explanation of 
changes in Ricco’s area with background luminance, that it is a manifestation of 
increased spatial antagonism in RGC receptive fields (Glezer 1965), cannot account for 
these changes, as centre-surround spatial antagonism is not found in receptive fields of 
the small bistratified cells that mediate the S-cone signal response. Rather, the 
blue/yellow ON and OFF receptive field regions are spatially coextensive (Dacey & Lee 
1994). Receptive fields of the arrangement S+/S- are required to observe such changes, 
and these are not found at the level of the retina. Ricco’s area was also found to be 
larger in patients with glaucoma, a disease characterized by the death of RGCs, with 
respect to age-similar healthy controls. Following reports that RGCs may shrink in early 
glaucoma (Morgan 2002; Morgan et al. 2006), it is difficult to reconcile these changes 
in structure and function using the traditional explanation of Ricco’s area as a retinal 
phenomenon. However, if cortical pooling contributes a sizeable component to Ricco’s 
area, it may partly explain this difficulty. 
Given the observation of an enlarged Ricco’s area in glaucoma, that can account for 
disproportionate deficits in contrast sensitivity to perimetric stimuli of different area, it 
is of great importance to better understand the underlying mechanisms responsible for 
Ricco’s area and anomalies thereof, not just for an improved understanding of a 
fundamental attribute of visual processing, but also for a more scientifically sound 
design of diagnostic functional tests of the visual field that can be used clinically. To 
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achieve a better understanding of the role of spatial summation in glaucoma and more 
broadly in reconciling visual function with retinal structure, one must also investigate 
the possible role of non-retinal sites, and therefore must look to a neurological condition 
affecting vision that is not characterised by anomalies at the retinal level. One such 
condition is amblyopia, a developmental disorder in which there is a reduction of vision 
in one eye, or more infrequently, both eyes, even with optimum optical correction and 
in the absence of detectable ocular abnormality. 
Approximately 3.6% of the UK population has amblyopia (Williams et al. 2008). 
Histological studies of experimentally induced amblyopia have suggested that the 
primary site of neural deficit in amblyopia is V1 (Hendrickson et al. 1987; Kiorpes et 
al. 1998). RGCs have been observed to be anatomically and functionally normal in 
experimental models of amblyopia (Kratz et al. 1979; Sherman & Stone 1973; Spear & 
Hou 1990). LGN cells have been observed to change in size, their spatial resolution has 
been found to be unaffected (Derrington & Hawken 1981; Jones, Kalil & Spear 1984; 
Movshon et al. 1987; von Noorden 1970), suggesting the possibility of subtle binocular 
interactions. Amblyopia is therefore a suitable eye condition to investigate post-retinal 
involvement in the formation of Ricco’s area. Previous studies of spatial summation in 
amblyopia reported an accelerated rise in sensitivity with greater of stimulus width in 
amblyopic eyes, reaching maximum sensitivity at much greater stimulus widths than in 
non-amblyopic eyes (Hagemans & van der Wildt 1979; Katz, Levi & Bedell. 1984); a 
finding that is suggestive of an enlargement of Ricco’s area in amblyopia.  
The aim of this study was to form a better understanding of the physiological basis of 
Ricco’s area, by investigating differences in spatial summation of perimetric stimuli 
between amblyopic observers and normally-sighted controls with binocular vision. 
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Amblyopia is an eye condition that has been widely documented to be of cortical origin 
with no retinal and LGN involvement. Investigating spatial summation in amblyopia 
and comparing it to normally-sighted controls with binocular vision can help ascertain 
the cortical involvement in formation of Ricco’s area. 
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3.2.  Methods 
Spatial summation functions were measured in both eyes of adults with strabismic or 
anisometropic amblyopia, as well as normally-sighted controls with binocular single 
vision. Ricco’s area was estimated at each test location and analysed as a function of 
visual field eccentricity. 
3.2.1. Participants 
Fourteen adults (median [IQR] age: 20.5 [19.25, 22.00] years) with amblyopia and 15 
normally-sighted participants with normal binocular vision (median [IQR] age: 24 [22, 
25] years) were recruited from staff and students of Cardiff University, as well as a 
participant database at the Cardiff University Eye Clinic. All participants underwent an 
ophthalmic and orthoptic assessment, including a visual acuity test (Bailey-Lovie chart, 
logMAR notation), optical coherence tomography (Topcon 3D OCT 1000, Topcon 
Corp, Tokyo, Japan), and slit-lamp biomicroscopy with anterior eye assessment, to 
screen for any other ocular or visual abnormalities that may affect visual performance. 
Binocular status was confirmed using tests for simultaneous perception (Bagolini 
lenses), suppression (Worth’s 4 dot test), stereopsis (TNO, Oculus, Wetzlar, Germany), 
eccentric fixation (ophthalmoscope grid), and the prism cover test. Binocular vision was 
confirmed if the participant demonstrated simultaneous perception, no suppression, and 
measurable stereopsis. Participants were included in the amblyopic group if they had an 
inter-ocular difference in visual acuity of ≥0.2 logMAR (≥ two lines on the Bailey-
Lovie chart). Anisometropic amblyopia was classified on the basis of an inter-ocular 
difference in refractive error of ≥ 1.00DS, or a history of anisometropia in the absence 
of strabismus or strabismus surgery. Strabismic amblyopia was classified on the basis of 
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a manifest strabismus, history of childhood strabismus, or previous strabismus surgery. 
Patients’ current distance refractive error was recorded or, if his/her refractive 
correction had been >2 years old, a refraction was undertaken as part of the research 
visit. Refractive correction, appropriate for the test distance of 33cm, was worn during 
experiments. Appropriate refractive correction was also used for the relevant orthoptic 
assessments. Both eyes were included in the study. 
3.2.2. Apparatus and stimuli 
Experiments were conducted on an Octopus 900 perimeter (Haag Streit Ltd, Koeniz, 
Switzerland), driven by the Open Perimetry Interface. Stimuli were achromatic circular 
increments of different area (Goldmann I – V; 0.01, 0.04, 0.15, 0.58, and 2.27 deg2), 
modulating in contrast on an achromatic background of 10cd/m2. Presentation duration 
was 200ms, with a square temporal profile. Stimuli were presented to 12 visual field 
locations (4 locations at each of 12.7o, 21.2o, and 29.7o eccentricity, Figure 3.1).  
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Figure 3.1. Visual field locations tested in the current study. A conventional 24-2 visual 
field pattern (right visual field), used in clinical visual field tests, is displayed for 
clinical reference 
3.2.3. Procedure 
Thresholds were measured at each visual field location with one of the five Goldmann 
stimuli at twelve visual field locations in an interleaved fashion. This was then repeated 
with the other four Goldmann stimuli, in a randomised order. Thresholds were 
measured a second time for each of the five Goldmann sizes, in a randomised order, and 
averaged with the first set of measurements by stimulus size and location. Experiments 
were carried out on both eyes separately, with the order in which eyes were tested 
randomised between subjects.  In all experiments, a 1:1 staircase and yes/no response 
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criterion were used to determine threshold. Fixation was monitored visually, on the 
Octopus 900 fixation monitor. 
3.2.4. Statistical analysis 
Thresholds were averaged by eccentricity in each eye, giving one spatial summation 
function for each of the three visual field eccentricities. In order to estimate Ricco’s area 
at each eccentricity, an iterative two-phase regression analysis was performed on the 
eccentricity-averaged data. The fitting procedure is described in depth in our previous 
work; briefly, a two-phase regression function was fitted to the threshold data for the 
five stimulus areas, constraining the slope of the first line to -1 (respecting Ricco’s law), 
and allowing the intercept of the first line, the slope of the second line, and the 
breakpoint value to vary. The breakpoint, estimated by the model, was taken to 
represent Ricco’s area. Each eye had three Ricco’s area estimates, one for each 
eccentricity.  
In the amblyopic participants, Ricco’s area estimates were compared between 
amblyopic and non-amblyopic eyes at each eccentricity. Similarly, Ricco’s area 
estimates were compared between the right and left eyes of normal participants. Inter-
ocular differences were tested for at each eccentricity with a paired t-test. A Holm-
Bonferroni correction was applied to p-values obtained for each of the three 
eccentricities.  
To investigate the effect of a) type of amblyopia, b) binocularity, and c) inter-ocular 
difference in central visual acuity on the difference in Ricco’s area between amblyopic 
and fellow non-amblyopic eyes, linear mixed effects model analysis was performed, 
with the inter-ocular difference in Ricco’s area as the dependent variable, and type of 
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amblyopia, binocularity, and inter-ocular difference in VA as fixed effects. Subject and 
eccentricity were included as random effects, with random intercepts added to the by-
subject and by-eccentricity effects. For this analysis, data from each eccentricity and 
from each subject were pooled into a single dataset. The magnitude of each of the 
effects was determined from the analysis. A likelihood ratio test of the model (including 
all effects), and the same model with the effect in question removed, was performed in 
order to determine the statistical significance of that effect. 
Statistical analysis was performed with the open source statistical environment R and 
the lme4 package where applicable. 
The datasets generated and analysed during the current study are available from the 
corresponding author on reasonable request. 
Ethical approval was granted by the Wales Research Ethics Committee 1. Informed 
consent was obtained before participants were included. The research was conducted in 
accordance with the tenets of the Declaration of Helsinki. 
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3.3. Results 
Table 3.1. Clinical characteristics of amblyopic participants in the current study 
 
Subjects 
Refractive 
error 
Acuity 
(LogMAR) 
Stereoacuity History 
RB (18) 
R +4.50/ -
1.50 x 50 -0.1 Absent 
RE 2pd Esotropia; 3pd 
Hypertropia 
Strab R +4.50/ -
1.50 x 15 
-0.3   Patched and glasses @3, 
No surgery 
TN (23) 
R -4.25/ -
0.75 x 100 
-0.08 Absent LE 8pd Esotropia 
Strab L -3.75/ -0.50 
x 82 
0.32   Patched and glasses @ 5, 
No surgery 
IH (19) R +1.00/ -
0.50 x 100 
-0.1 200 seconds LE Esotropia noticed at age 
5 
Strab L +1.50/ -
0.50 x 65 
0.12   Patched and glasses @ 5, 
Surgery @ 5 
AG (21) R +7.25 0.36 Absent RE 6pd Esotopia 
Strab L +6.75/ -
0.25 x 170 
-0.16   Patched and glasses @2 
RT (27) 
R +1.25/ -
1.50 x 155 
-0.1 Absent LE 6pd Esotropia 
Strab L +1.25/ -
0.75 x 55 
0.2   Patched and glasses @ 2 
AR (22) R +1.25/ -
0.50 x 90 
0.16 400 
Seconds 
Microtropia 
Strab 
L +1.00/ -
0.25 x 130 -0.22   Not patched, No surgery 
BE (22) R +0.75/ -
0.50 x 180 
0.3 400 
Seconds 
LE 16pd Hypotropia 
Strab 
L +1.00/ -
0.75 x 173 -0.12   Not patched, No surgery 
EE (35) 
R +6.00/ -
1.50 x 180 0.86 Absent Patched and glasses @7 
Aniso L +0.50 -0.26   No surgery 
SJ (21) R +5.00/ -
0.50 x 30 
0.2 Absent Patched and glasses @4 
Aniso 
L +0.75/ -
0.25 x 120 -0.2     
KF (20) 
R +2.25/ -
2.75 x 3 -0.14 
400 
Seconds Patched and glasses @3 
Aniso 
L_5.00/ -3.75 
x 171 0.36   No Surgery 
DE (20) 
R+2.50/ -0.25 
x 180 0.62 Absent Patched and glasses @6 
Aniso L Plano -0.1   No surgery 
KO (18) R +3.50/ -
1.50 x 180 
0.1 240 seconds Patched and glasses @6 
Aniso 
L +1.35/ -
0.25 x 180 -0.1   No surgery 
JS (20) 
R +1.50/ -
4.50 x 28 -0.1 200 seconds Optical penalization @4 
Aniso 
L -0.75/ -1.25 
x 142 
0.16   No surgery 
FK (19) 
R +0.50/ -
0.25 x 90 -0.2 400 seconds Not patched, glasses @8 
Aniso L +2.75/ -
0.25 x 10 
0   No surgery 
 	
.2  
- 
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Table 3.2. Clinical characteristics of control participants in the current study. 
 
Subjects Refractive error 
Acuity 
(LogM
AR) 
Stereoacuity History 
SR (29) R plano -0.1 40 seconds 
No binocular vision 
anomalies 
Control L plano -0.1     
SJ (25) R -5.50 -0.2 40 seconds 
No binocular vision 
anomalies 
Control L -4.50 -0.2     
LT (24) R -2.50/ -1.00 x 175 -0.2 40 seconds No binocular vision 
anomalies 
Control L -3.00/-0.75 x 180 -0.2     
TR (32) R -1.50/ -2.50 x 82 -0.1 40 seconds No binocular vision 
anomalies 
Control L -2.50/ -2.00 x 81 -0.1     
VS (21) R  -5.00/ -0.50 x 
120 
-0.2 40 seconds No binocular vision 
anomalies 
Control L -5.00/ -0.25 x 45 -0.2     
SL (25) R plano -0.2 40 seconds No binocular vision 
anomalies 
Control L plano -0.2     
KB (25) R Plano -0.1 40 seconds 
No binocular vision 
anomalies 
Control L Plano -0.1     
AN (48) R plano -0.2 40 seconds 
No binocular vision 
anomalies 
Control L plano -0.2     
KB (24) R +0.50 -0.2 40 seconds 
No binocular vision 
anomalies 
Control L +0.50 -0.2     
SM (22) 
R +0.50/ -0.25 x 
160 -0.22 60 seconds 
No binocular vision 
anomalies 
Control L +0.50/ -0.25 x 180 -0.22     
KB (23) R -0.75/ -0.25 x 180 -0.16 40 seconds 
No binocular vision 
anomalies 
Control L -0.50/ -0.25 x 180 -0.22     
JR (25) R -0.25 -0.3 40 seconds 
No binocular vision 
anomalies 
Control L Plano -0.3     
HJ (22) R -0.25/ -0.75 x 80 -0.2 40 seconds 
No binocular vision 
anomalies 
Control L -0.25/ -0.50 x 55 -0.2     
KE (19) R +0.25/ -0.25 x 
180 
-0.24 40 seconds No binocular vision 
anomalies 
Control L +0.25/ -0.25 x 180 -0.28     
ZD (21) R +0.25 -0.24 
40 seconds 
No binocular vision 
anomalies 
Control L Plano -0.22     
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Clinical characteristics of amblyopic and control participants are outlined in Tables 3.1 
and 3.2 respectively. Seven of the amblyopic participants had strabismic amblyopia (of 
which three had binocular vision), while the remaining seven had anisometropic 
amblyopia (of which four had binocular vision). Visual acuity was, on average, 0.42 
logMAR (approx. 4 lines), lower in the amblyopic eye than in the fellow non-amblyopic 
eye (paired t-test, p < 0.001). Acuity in the non-amblyopic eye was, on average, 0.04 (2 
letters) better than the average visual acuity for the right and left eyes in the control 
cohort, but this was not statistically significant (Student’s t-test, p = 0.12).   
A total of 174 spatial summation functions (3 eccentricities in 58 eyes) were determined 
across both groups and included in the analysis. Figure 3.2 shows average Ricco’s area 
as a function of visual field eccentricity for amblyopic eyes, non-amblyopic eyes of the 
same participants, as well as left and right eyes of control participants. Ricco’s area is 
shown to be larger at more peripheral test locations, as reported in previous literature 
(Vassilev et al. 2003; Volbrecht et al. 2000; Wilson 1970).  
Chapter 3 	
 
 117 
 
Figure 3.2. Ricco’s area as a function of visual field eccentricity in amblyopic and 
fellow non-amblyopic eyes (blue, black discs respectively), as well as the left and right 
eye of a normal control cohort (red, green triangles respectively). Error bars: SEM 
At all eccentricities, mean Ricco’s area was larger in amblyopic eyes, compared with 
that in fellow non-amblyopic eyes (all p < 0.01). Inter-ocular differences in Ricco’s area 
in the normal control group were negligible (Figure 3.2), and thus values for the right 
and left eyes were averaged at each eccentricity for further analysis. Compared to the 
average normal at each eccentricity, mean Ricco’s area was larger in amblyopic eyes, 
and smaller in fellow non-amblyopic eyes (Figure 3.2 and Table 3.3).  
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Table 3.3. Difference in mean Ricco’s area between amblyopic participants and normal 
controls (normal Ricco’s area averaged by eye). *Statistically significant at 0.05 level 
(Student’s t-test, Holm-Bonferroni-corrected p-values) 
Eccentricity 
(deg) 
Amblyopic 
eyes (deg2) 
p-value Fellow p-value 
( Student’s t-
test) 
non-
amblyopic 
eyes (deg2) 
(Student’s t-
test) 
12.7 0.35 0.047* -0.12 0.166 
21.2 0.11 0.125 -0.13 0.255 
29.7 0.13 0.125 -0.18 0.255 
 
The difference in mean Ricco’s area between amblyopic eyes and those of normal 
controls was statistically significant at 12.7o eccentricity (p = 0.047, following a Holm-
Bonferroni correction). In subsequent analyses involving linear mixed effects models, 
inspection of the residuals confirmed normality and no heteroscedasticity. 
 
Binocular vs non-binocular vision in amblyopes 
Data were separated according to binocular and non-binocular vision status. 
Distributions of Ricco’s area values for the amblyopic and non-amblyopic eyes of each 
group can be seen in Figure 3.3.  
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Figure 3.3. Ricco’s area in amblyopic (blue boxes) and non-amblyopic (grey boxes) 
eyes at each eccentricity when amblyopes are separated into strabismic (top left) and 
anisometropic (top right) groups, as well as binocular (bottom left) and non-binocular 
(bottom right) groups Error bars: SEM 
Linear mixed effects model analysis reported that the inter-ocular difference in Ricco’s 
area was 0.33 log deg2 (± 0.1 SE) larger overall in the binocular group than in the non-
binocular group (p = 0.005). Separate linear mixed effects analyses, with Ricco’s area in 
the amblyopic and non-amblyopic eyes as dependent variables (with the same fixed and 
random effects), revealed that most of this effect can be attributed to a smaller Ricco’s 
Chapter 3 	
 
 120 
area overall in the non-amblyopic eyes of binocular amblyopes, compared with that in 
non-binocular amblyopes (by -0.327 log deg2, ± 0.1 SE, p = 0.004). This difference can 
be seen in Figure 3.4 (left panel; solid lines: binocular group, dotted lines: non-
binocular group).  
 
Figure 3.4. Mean Ricco’s area as a function of eccentricity in amblyopic participants, 
separated by binocular and non-binocular status (solid and dotted lines respectively, 
left panel). Mean Ricco's area as a function of eccentricity in normal controls are 
shown in the right panel. For ease of comparison, Ricco’s area data from the fellow 
non-amblyopic eyes of non-binocular amblyopes are superimposed on data from 
normal controls (right panel, black symbols). Error bars: SEM 
In fact, mean Ricco’s area in the non-amblyopic eye of non-binocular amblyopes is 
comparable to that in normal controls at each eccentricity. The overall difference in 
Ricco’s area in the amblyopic eye between binocular and non-binocular groups was 
negligible (-0.003 log deg2, ± 0.1 SE, p = 0.96). 
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Strabismic vs anisometropic amblyopia 
None of the strabismic participants in the study had anisometropia (Table 3.1). 
The distributions of Ricco’s area values for the amblyopic and non-amblyopic eyes of 
strabismic and anisometropic amblyopes are shown in Figure 3. Linear mixed effects 
model analysis showed that type of amblyopia was significantly associated with the 
inter-ocular difference in Ricco’s area (p = 0.01) with this difference being 0.28 log 
deg2 larger (± 0.1 SE) overall in strabismic amblyopes. A smaller Ricco’s area in the 
non-amblyopic eyes of strabismic amblyopes relative to that in anisometropic 
amblyopes (by -0.20 log deg2, ± 0.1 SE, p = 0.06) contributed most to this effect. A 
slightly larger Ricco’s area in amblyopic eyes of strabismic amblyopes relative to that in 
anisometropic amblyopes contributed to the effect by a negligible amount (+0.08 log 
deg2, ± 0.1 SE, p = 0.40).  
Severity of amblyopia 
The inter-ocular difference in central visual acuity to standard optotypes was taken as a 
clinical measure of severity of amblyopia. The linear mixed effects model showed that 
inter-ocular difference in VA was significantly associated with the inter-ocular 
difference in Ricco’s area (p = 0.04). 
Monocular vs binocular measurements of Ricco’s area 
A subset of amblyopic participants (n = 12) and all controls (n = 15) underwent 
binocular measurements of Ricco’s area with an identical test protocol to that described 
in the Methods. In controls, Ricco’s area estimates measured binocularly are smaller, on 
average, than those measured monocularly at all eccentricities, with the largest 
difference in mean Ricco’s area observed at 29.7° (Figure 3.5).  
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Figure 3.5. Mean Ricco’s area, measured binocularly, in amblyopic participants 
(purple discs) and normal controls (gold triangles) in left and right panels respectively. 
Mean Ricco’s area estimates in amblyopes and normal controls are also shown, for 
reference. Error bars: SEM 
In amblyopes, binocularly measured Ricco’s area was, on average, smaller than that 
measured monocularly in amblyopic eyes but larger than those measured monocularly 
in fellow non-amblyopic eyes, at 12.7° and 21.2° (Figure 3.5). At 29.7° eccentricity, 
binocularly-measured Ricco’s area was, on average, smaller than that in both amblyopic 
and non-amblyopic eyes. Mean Ricco’s area, measured binocularly was, on average, 
larger at 12.7° and smaller at 29.7° eccentricity in amblyopic eyes than in control eyes, 
with a negligible difference at 21.2° eccentricity. When data were separated by 
binocular vision status, mean binocularly measured Ricco’s area was comparable 
between groups at 21.2° eccentricity. On average, binocularly measured Ricco’s area 
was slightly smaller in the non-binocular than in binocular amblyopes at 12.7°, while 
the opposite was found at 29.7° (Figure 3.4, purple symbols). 
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3.4. Discussion 
This study is the first to formally report on measurements of Ricco’s area in amblyopic 
participants. The finding of a larger mean Ricco’s area, and thus greater spatial 
summation, in amblyopic eyes supports previous findings of disproportionately higher 
thresholds for small stimuli than for larger stimuli in amblyopic cohorts (Hagemans & 
van der Wildt 1979; Flynn 1967). Intriguingly, not only is mean Ricco’s area larger in 
amblyopic eyes compared with that in eyes of control participants, but unexpectedly, it 
is smaller in fellow non-amblyopic eyes (particularly in non-binocular amblyopes) 
compared with that in controls. 
These findings offer some clues as to the loci along the visual pathway that contribute to 
the basis for Ricco’s area. RGCs and the LGN were previously reported to be normal in 
amblyopia (Derrington & Hawken 1981; Jones et al. 1984; Movshon et al. 1987; 
Sherman & Stone 1973; von Noorden 1970), even in stimulus deprivation amblyopia, 
the most severe form. Also, the general consensus is that retinal nerve fibre layer 
thickness is unaffected in the condition (Chen et al. 2013; Ersan et al. 2012; Walker et 
al. 2011; Xu et al. 2013). Therefore, the findings of the current study support 
predictions that Ricco’s area is not solely a retinal phenomenon, and that it likely 
represents summation by multiple mechanisms along the visual pathway (Pan & 
Swanson 2006), i.e. a ‘net’ receptive field, or ‘perceptive field’ (Anderson 2006; 
Vassilev et al. 2005) for a given location in visual space. Indeed, differences in spatial 
summation in pathological conditions affecting the visual pathway from the retina to 
visual cortex (Redmond et al. 2010a; Wilson 1967), as well as under changing S-cone 
adaptation conditions (Redmond et al. 2013b), also support this. 
Chapter 3 	
 
 124 
The findings of the current study are suggestive of either a shift in signal processing to 
the most responsive spatial frequency channels (as has been hypothesized to occur in 
glaucoma (Redmond et al. 2010a)), or a difference between the pathways from each eye 
to the brain, in terms of convergence of signals from a group of lower level neurons on 
to a group of higher level neurons. While both are plausible explanations, it is worth 
considering the finding of a smaller Ricco’s area in fellow non-amblyopic eyes. It is 
difficult to understand how the visual system may gain from a shift to a channel tuned 
to lower spatial frequencies in the amblyopic eye and a shift to a channel tuned to 
higher spatial frequencies in the fellow non-amblyopic eye. Such an adaptation would 
be suggestive of the amblyopic eye being optimized for contrast sensitivity, with the 
fellow eye optimized for visual resolution. Here we put forward an alternative 
hypothesis. If receptive fields of retinal cells and the LGN are unaffected in amblyopia, 
and the number of RGCs is similar between amblyopic eyes and fellow non-amblyopic 
eyes (as denoted by a lack of any notable difference in retinal nerve fibre layer thickness 
in published literature), the first site at which disrupted circuitry, and thus an anomaly 
of spatial summation, might occur is layer 4 of V1, where an asymmetry of ocular 
dominance (OD) columns has been noted in primates (Hubel et al. 1977) and humans 
with early-onset amblyopia (Goodyear et al. 2002), as well as an asymmetry in 
population receptive field size (Clavagnier et al. 2015). In normal observers, ocular 
dominance columns relating to the right and left eyes in a given hypercolumn are equal 
in width, and contain comparable numbers of cells sampling the visual field. Therefore, 
1 minute of visual angle is represented by the same cortical space when viewing with 
the right or left eye. Likewise, the number of geniculocortical axons relaying right eye 
signals from the LGN to layer 4 is equal to the number of geniculocortical axons 
relaying left eye signals. In amblyopia, the region of the hypercolumn sampling the 
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visual field of the non-amblyopic eye is larger (wider OD columns), and that devoted to 
sampling the visual field of the amblyopic eye is smaller (narrower OD columns). 
Therefore, 1 minute of visual angle, viewed through the fellow non-amblyopic eye is 
represented by a larger area of cortex than the same visual angle viewed with the 
amblyopic eye, despite no perceptual difference in object size. Importantly, the 
proportions of geniculocortical axons relaying eye-specific signals from the LGN 
remain unaffected. Increased axonal arbor complexity in the geniculocortical cells 
mediating the signal response of the non-amblyopic eye would mean that those axons 
are available to synapse with a greater number of cells in the hypercolumn, while 
reduced axonal arbor complexity in geniculocortical cells mediating the signal response 
from the amblyopic eye would mean that fewer cells in V1 will synapse with them 
(Antonini & Stryker 1993). Assuming that the density of cells in OD columns is 
unaffected in amblyopia, greater spatial summation might therefore be observed as 
signals from the amblyopic eye converge on to a smaller region of the cortex (smaller 
number of cells), and vice versa. A third, alternative explanation for an enlarged Ricco’s 
area in amblyopic eyes may be increased topographical disarray in receptive fields of 
V1 to at least V3, as reported in a recent fMRI study of amblyopia (Clavagnier et al. 
2015). However, the finding of a smaller-than-normal Ricco’s area in the non-
amblyopic eye raises challenges for this hypothesis.  
The finding of a smaller Ricco’s area in fellow non-amblyopic eyes was unexpected, 
and so peripheral resolution acuity was not measured prospectively. Given the inverse 
association between spatial summation and resolution acuity, however, this finding 
suggests that resolution acuity should be higher in the non-amblyopic eye than in 
normal controls, albeit at the expense of spatial pooling. Conventionally, the non-
amblyopic eye has been referred to as ‘the normal eye’ by clinicians, due to its largely 
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unaffected performance in visual acuity tasks on a high contrast letter chart. However, 
published evidence of the visual performance of fellow non-amblyopic eyes is, as yet, 
inconclusive (Chatzistefanou et al. 2005; Freeman & Bradley 1980; McKee et al. 2003; 
Thompson et al. 2011; Leguire et al. 1990). McKee et al. (2003) reported superior 
contrast sensitivity in the non-amblyopic eyes in participants with visual acuity of 6/30 
or better, but this superiority is only observed in participants without residual binocular 
function. Numerous studies comparing the visual function of the fellow non-amblyopic 
eye have, however, reported impairment in other attributes of visual function, such as 
contrast sensitivity (Chatzistefanou et al. 2005; Reed et al. 1996), Vernier acuity (Cox 
et al. 1996; Levi & Klein 1985), global motion processing (Simmers et al. 2003), dark 
adaptation (Bedell & Kandel 1976), and rarebit sensitivity (Agervi et al. 2010), as well 
as an increase in neural noise (McKee et al. 2003). Standard optotype visual acuity, 
measured in the fovea in the current study, was not significantly different between 
fellow non-amblyopic eyes and those of normal controls. However, although these 
measurements were not performed at the same test locations as measurements of 
Ricco’s area, the findings in the current study indicate that non-amblyopic eyes would 
otherwise be inappropriately considered ‘normal’ in the clinical setting, despite a 
possible anomaly of Ricco’s area. A formal investigation of peripheral grating 
resolution acuity at the same test locations in those eyes is warranted. 
In this study, the finding of a larger-than-normal Ricco’s area in amblyopia, and 
smaller-than-normal area in the fellow eye, was in a cohort containing an equal 
proportion of anisometropic and strabismic amblyopes. Binocular and non-binocular 
participants were also represented in equal proportions, with strabismic and 
anisometropic amblyopes represented in both groups. Statistical analysis indicated that 
binocularity had the largest effect on inter-ocular differences in Ricco’s area in 
Chapter 3 	
 
 127 
amblyopic participants. While the difference in mean Ricco’s area between the two 
groups for amblyopic eyes was negligible, most of the effect of binocularity could be 
explained by a smaller Ricco’s area in the non-amblyopic eyes of binocular amblyopes, 
compared to those of non-binocular amblyopes and normal controls. On inspection of 
Figure 3.4, it can be seen that when Ricco’s area estimates were divided into binocular 
and non-binocular groups, mean values in the non-amblyopic eyes of the non-binocular 
group closely resemble those of normal controls, and that it is, in fact, those estimates in 
the non-amblyopic eyes of the binocular group that are smaller than normal. This 
finding could be explained by a simple cortical model similar to that proposed by 
McKee et al. (2003) (their Appendix A). Suppose that in a given region of the visual 
cortex of a binocular amblyope, 60% of neurons are binocularly-driven (i.e. they receive 
input from both eyes), and the remaining 40% of neurons are monocularly-driven (20% 
from each eye). If one supposes that in non-binocular amblyopes, the same region of the 
visual cortex contains only monocularly-driven neurons; 50% receiving in input from 
one eye, and the other 50% receiving input from the fellow eye. Full-field monocular 
stimulation in binocular amblyopes would result in stimulation of up to 80% of cortical 
cells in that region, whereas in non-binocular amblyopes, the same degree of monocular 
stimulation would elicit a response of up to 50% of cortical cells in that region. If a 
stimulus of a fixed area is projected on to the retina of one eye, the number of 
responding RGCs should be equal in both groups. However, if the number of cortical 
cells responding to the stimulus is smaller in the non-binocular group, this may manifest 
as a larger Ricco’s area, because of greater convergence of signals from the same 
number of geniculocortical axons on to a smaller cortical region. Conversely, in the 
binocular group, the same level of convergence would not be required, which may 
manifest as a smaller Ricco’s area. Swanson et al. (2004) determined that Ricco’s area 
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is sampled by a critical number of RGCs (n = 31) across the visual field of a normal 
observer under perimetric conditions equivalent to those employed in the current study 
(Swanson et al. 2004). If one assumes that Ricco’s area is also sampled by a critical 
number of cortical cells across the visual field, a monocularly-presented stimulus of a 
fixed area would be sampled by approximately 16% more cortical cells in a given 
cortical region in binocular amblyopes than in non-binocular amblyopes. In this case, 
the critical number of cortical cells, and thus the criterion for the extent of Ricco’s area, 
would be met with a smaller stimulus, resulting in a smaller Ricco’s area in those eyes. 
The findings of the current study also have important implications for our understanding 
of visual field sensitivity deficits in glaucoma. Attempts to understand the nature of 
sensitivity loss in glaucoma have typically involved investigations of the relationship 
between RGC number (or a surrogate) and visual field sensitivity to achromatic circular 
luminance increments on a uniform achromatic background. Guided by the fact that 
glaucoma is characterised by death of RGCs, many investigations do not consider 
changes that may occur at extra-retinal levels, but instead make decisions on the utility 
of one functional test over another based on the strength of association between the test 
output and measurements of retinal structure. Given that an enlarged Ricco’s area is also 
observed in glaucoma (Redmond et al. 2010a), the findings of the current study provide 
further support for the case that changes in cortical mechanisms should be taken into 
account when attempting to understand the nature of visual loss in glaucoma, as 
measured with conventional circular incremental stimuli. 
In conclusion, an enlarged Ricco’s area has been found in amblyopic eyes, and a 
smaller-than-normal area has been found in fellow non-amblyopic eyes. This finding is 
suggestive of Ricco’s area being the psychophysical consequence of multiple pooling 
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mechanisms in the visual cortex, rather than in retinal receptive fields alone. Greater 
attention should therefore be given to alterations in cortical processing in glaucoma, 
given that a loss of sensitivity to conventional stimuli can be mapped to an enlarged 
Ricco’s area. The findings in the current study also highlight differences in fundamental 
attributes of visual function between binocular and non-binocular amblyopes as well as 
strabismic and anisometropic amblyopes that warrant further investigation. 
Chapter 4 	
 
 130 
Chapter 4: Changes in Ricco’s area in Glaucoma, 
in Response to IOP-lowering Treatment 
 
4.1. Introduction 
Subtle structural changes in RGC before the onset of apoptosis have been well 
documented in experimental model of glaucoma, with the earliest sign being the 
pruning of RGC dendrites, followed by shrinkage of the RGC soma (Morgan 2002; 
Shou et al. 2003; Weber et al. 2000). This has raised the suggestion that perhaps RGCs 
undergo a period of dysfunction before death in animal models of glaucoma (Morgan 
2002; Shou et al. 2003; Weber et al. 1998) and that the same process could occur in 
human glaucoma (Porciatti & Ventura 2012). However this cannot be ascertained 
currently in human glaucoma, as an in-vivo study of the relationship between the 
structure and function of isolated RGCs is not yet possible in the living human. 
Although early structural changes were observed in experimental glaucoma, it is not an 
absolute indication that RGC function is compromised or absent; it is unclear whether 
RGC function would be lost before the pruning of dendrites occurred or it reduces 
proportionally with structural change. RGC dysfunction in humans was first suggested 
following PERG measurements by Ventura & Porciatti (2005). They observed an 
increase in PERG amplitude and phase in participants with OAG and NTG undergoing 
IOP-lowering treatment, compared with those who were not treated. This result has 
since been supported by other PERG studies where PERG amplitude and/or phase have 
been observed to stabilise or increase following treatment in glaucoma participants 
(North et al. 2010; Sehi et al. 2010). For a more extensive review please refer to 
Chapter 1. 
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4.2. Measuring RGC dysfunction 
True dysfunction could only be determined in one of two ways: a) evidence of 
functional loss prior to, or proportional with the loss of structural integrity of the 
damaged cells, or b) evidence of functional improvement in response to treatment. The 
former method is difficult, because precise measurements of RGC structural integrity in 
vivo are not yet possible. Surrogate measures, such as RGC layer thickness with OCT, 
would be much less imprecise. Furthermore, a precise comparison of structure and 
function, as is needed to provide such subtle evidence, is hampered by the fact that these 
measures have incomparable scales and normative databases. The latter method is 
arguably less difficult.  
 
The ability to measure reduced visual function in glaucoma with PERG is well 
documented, however PERG is not a technique that is widely used or available in 
clinical practice. Currently, there is no other clinical test that has been definitively 
shown to measure RGC dysfunction. In fact, the presence of dysfunction is difficult to 
conclude in vivo. Although it is possible to measure a reduction in contrast sensitivity 
with conventional perimetry, it is not clear how much of this reduction in sensitivity is 
due to cell death and how much is due to dysfunction; this would require precise 
knowledge of the integrity of individual ganglion cells in isolation. Furthermore, 
clinical measures of visual field sensitivity are a result of not only retinal processing, 
but also cortical pooling by multiple spatial mechanisms (Pan & Swanson 2006). 
Therefore, even if a ganglion cell does become dysfunctional prior to death, knowledge 
of the extent of dysfunction of that cell is not enough to adequately assess the effect on 
perimetric sensitivity at that location. It is perhaps more important, clinically, to attempt 
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to identify dysfunction by measuring alterations in spatial pooling that may occur in 
response to RGC damage.  
 
4.3. Changes in spatial summation as a measure of RGC 
dysfunction? 
A study investigating changes in spatial summation over time in glaucoma may provide 
some clues as to whether or not dysfunction occurs, while at the same time offering 
some insight into the impact of such damage on the resulting functional deficit in visual 
field sensitivity. Redmond et al. (2010a) reported a statistically significantly larger 
Ricco’s area in participants with early glaucoma (MD better than -8dB), when 
compared to that in healthy controls, in visual field locations that had, on average, 
minimal visual field damage, with conventional perimetry (average TD -1.3dB; 24-2 
SITA-Standard, HFA II, Carl Zeiss Meditec, Dublin, CA). They suggested that changes 
in Ricco’s area may be due to cortical remodelling, or a result of a greater capacity for 
complete spatial summation in otherwise larger cortical receptive fields due to ganglion 
cell damage. Due to the cross-sectional nature of the study, it could be argued that the 
difference in Ricco’s area found by Redmond et al. (2010a) was due to RGC death only. 
It is impossible to deduce from their data how Ricco’s area changed over time. One 
method of ascertaining this is by measuring Ricco’s area before and after the 
commencement of intra-ocular pressure-lowering treatment (or more rigorous treatment, 
if treatment has already been initiated) and observe whether Ricco’s area a) continues to 
enlarge, b) remains at a constant size, or c) becomes smaller, after treatment. The 
possible options are illustrated in the schematic in Figure 4.1.  
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Figure 4.1. Possible changes in Ricco's area in response to treatment (or more rigorous 
treatment). A further increase would indicate further deterioration, a reduction would 
indicate recovery and thus that any previous enlargement of Ricco’s are was due to 
RGC dysfunction, and no change would indicate stability and that any previous 
enlargement of Ricco’s area may have been due to RGC death.  
 
Pruning of RGC dendrites might be expected to cause impairment in the ability of the 
cell to gather light signals over space. With cell death, there would be a complete 
inability to gather light signals over space. Ricco’s area might be expected to enlarge 
accordingly in order to maintain the signal/noise ratio, as is observed with visual field 
eccentricity in the healthy eye (Wilson 1970). If the enlargement of Ricco’s area 
represents RGC dysfunction, one might expect to observe a shrinkage of Ricco’s area 
after administration of treatment, as the cell recovers. If the enlargement represents 
RGC death, one might expect to observe no change in Ricco’s area after treatment. If 
Ricco’s area enlarges further after treatment, it might be concluded that either death 
and/or dysfunction continue to occur and that treatment had little or no effect. If Ricco’s 
area shrinks to normal (or near normal) levels following treatment, this might be an 
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indication that dysfunction does initially occur, but that recovery occurs in response to 
treatment. 
 
An investigation into changes in Ricco’s area after intraocular pressure-lowering 
treatment is problematic in that compliance to a treatment regime involving topical 
medicine by patients cannot be easily ascertained. Research has shown that nearly half 
of glaucoma patients who know they are being monitored electronically do not use their 
medication as prescribed, 75% of the time (Okeke et al. 2009). The only way to ensure 
maximal compliance is to carry out the investigation on patients in which there is no 
reliance upon adherence to the prescribed use of medication. Patients undergoing 
trabeculectomy surgery to lower intraocular pressure are therefore an ideal cohort in 
which to carry out such an investigation, as they are not required to take regular medical 
treatment at home. Thus, concerns about compliance are greatly reduced. 
 
Trabeculectomy surgery was first introduced by Cairns (1968) and has since undergone 
numerous modifications. It is a procedure that allows the lowering of IOP by creating a 
corneoscleral fistula that causes subconjunctival bleb formation. The use of 
antimetabolites such as mitomycin C increases post-operative success and thus is 
commonly added to the procedure (Chen 1983). Generally patients who undergo 
trabeculectomy surgery tend to be those for whom topical IOP-lowering treatment has 
not been successful, and those in which compliance is a concern. 
 
Given that measurements of Ricco’s area involve projection of spot stimuli on the 
retina, it is important, when determining the neural component to any changes in 
Ricco’s area in response to treatment, that any surgically-induced changes to pre-neural 
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structures that might alter the stimulus configuration between pre- and post-surgery 
experiments are accounted for, or at least considered. Trabeculectomy surgery has been 
observed to cause a shallowing of the anterior chamber up to 5 years post-surgery 
(Husain et al. 2013; Man et al. 2015), shortening of axial length up to 5 years following 
surgery (Husain et al. 2013; Pakravan et al. 2015) and changes in corneal curvature in 
the form of flattening of anterior curvature, resulting in increase in with-the-rule 
astigmatism in some cohorts by up to 2.00D at 12 months post-surgery (Hong et al. 
1998; Kook et al. 2001). As previously discussed in Chapter 2, there do not appear to be 
any notable systematic changes in Ricco’s area, even with a substantial increase in 
optical blur. Therefore it is expected that any small refractive changes that might occur 
in participants undergoing trabeculectomy will not contribute a great deal to any 
observed change in Ricco’s area following surgery. However, refractive blur is not the 
only optical factor that can cause degradation in retinal image quality. In this chapter, 
changes in wavefront aberrations and how these will affect the measurement of Ricco’s 
area will also be taken into account. 
 
4.4. Measurement of corneal wavefront aberrations 
Wavefront aberrations illustrate the distortion of wavefronts as they go through a non-
optimal optical system. Wavefront aberrations can be described mathematically by a 
polynomial series, with Zernike polynomial expansion chosen to become the standard 
for describing ocular wave aberrations (Thibos et al. 2002). The Zernike polynomial is a 
set of basic functions, each having a coefficient. Coefficients depict how much 
contribution that aberration has to the overall wavefront aberration. The Zernike terms 
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are construed by radial order n and frequency m over a unit circle with orthogonal polar 
co-ordinates ρ and θ.  
 
Figure 4.2. Pyramids of Zernike term up to 5th order. Image reproduced from 
http://www.telescope-optics.net/monochromatic_eye_aberrations.htm. 
 
The Zernike polynomial organizes aberrations into a hierarchy with an increasing radial 
order (Figure 4.2). Lower order aberrations are zero (piston), first (tilt) and second order 
(astigmatism and defocus) and can be corrected with spectacle lenses. Higher order 
aberrations consist of third order aberrations and above; these imperfections cannot be 
corrected with spectacle lenses.  
 
The cornea, as the contributor of two-thirds of the power of the relaxed eye, has great 
influence on ocular aberration. Trabeculectomy causes a change in corneal curvature, 
and has previously been observed to cause a change in corneal higher order aberrations 
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post-surgery, returning to pre-operation values 3 months after surgery (Fukuoka et al. 
2011). Corneal aberrations are estimated based on corneal elevation data, where the 
Zernike polynomial is fitted as close as possible to the measured height data. 
 
In any study of spatial summation following a procedure involving anterior eye insult, it 
is imperative that changes in corneal aberrations be investigated before and after the 
procedure has taken place. This will help determine the likelihood that any change (or 
absence of change) in Ricco’s area post-surgery is due to surgically-induced changes in 
aberrations.  
 
The aim of this study is to compare measurements of Ricco’s area before and after 
trabeculectomy surgery, in order to test the hypothesis that an enlarged Ricco’s area in 
glaucoma returns to normal (or near normal) levels following IOP-lowering surgery. 
Secondary aims are to investigate whether or not Ricco’s area is enlarged in patients 
requiring trabeculectomy surgery, relative to that in stable glaucoma participants for 
whom surgery is not required, and to investigate any changes in Ricco’s area that may 
have occurred during this timescale in stable glaucoma participants, relative to that in 
normals, in the absence of any change in sensitivity to a conventional perimetric 
stimulus. As verification of the quality of the data, an additional aim is to confirm the 
finding of Redmond et al. (2010a), of an enlarged Ricco’s area in glaucoma participants 
relative to that in healthy controls. Patients in the trabeculectomy group were recruited 
on the basis of having already been listed for trabeculectomy surgery. All clinical 
decisions regarding treatment were made prior to, and independently of, patients’ 
involvement in the study and were not based on any findings from the current thesis). 
All participants will undergo the same experimental procedures twice, using the same 
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experimental protocol, spaced at least six months apart. Patients undergoing surgery 
will undergo experiments within the 2 weeks prior to their surgery and again, 
approximately 6 months after the surgery. The outcome of this study will enable a 
firmer hypothesis to be made regarding the presence, or otherwise of neural dysfunction 
in humans, as well as enable a determination to be made about whether or not Ricco’s 
area can enlarge with glaucoma severity, given that the results of Redmond et al. 
(2010a) were cross-sectional. 
 
 
Chapter 4 	
 
 139 
4.5. Methods 
Spatial summation curves were measured and Ricco’s area compared between multiple 
visual field locations in one eye of patients with stable glaucoma, patients with 
glaucoma requiring trabeculectomy surgery as part of their normal clinical care, and 
healthy control participants on two separate visits, spaced approximately 6 months apart 
(Experiment 1). In the case of patients requiring trabeculectomy, experiments were 
conducted within a matter of days before their surgery, and again, approximately 6 
months after their surgery. Spatial summation curves were determined from contrast 
thresholds measured with Goldmann size 1-V stimuli. Given that corneal changes might 
be expected as a result of trabeculectomy surgery, it was considered that these changes 
might have an effect on the area of the stimulus being projected on the retina, and thus 
the measurement of threshold. Therefore, corneal aberrations were also measured on the 
same visits in each participant group. In all cases, differences in aberrations between 
visits were determined and the effect of this difference on any changes in Ricco’s area 
was investigated (Experiment 2). 
 
4.5.1. Experiment 1  
4.5.1.1.Participants 
Patients with Primary OAG or NTG (herein referred to as the ‘stable glaucoma 
participants (S)’ and ‘trabeculectomy participants (T)) were recruited from glaucoma 
clinics at the University Hospital of Wales, Cardiff. Age-similar healthy controls (herein 
referred to as ‘healthy participants (H)’ or normal controls) were recruited from staff 
and students of Cardiff University and a research volunteer database at the Cardiff 
University Eye Clinic. Any decisions regarding treatment or otherwise were made by 
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the patients’ care team, and were made on the basis of clinical findings during the 
patients’ visits to the hospital clinic. No decisions on treatment were made on the basis 
of the findings of the current study, nor were they influenced by patients’ inclusion in 
the study. Participants were advised to continue following the advice of the glaucoma 
clinic regarding any topical medication or planned procedures, and not to alter their 
regime because of their inclusion in the study.  
 
Inclusion criteria for all participants were a) spherical refractive error <±6.00DS, b) 
astigmatism <1.50DC, and c) best corrected visual acuity better than or equal to 0.3 
logMAR. Specific inclusion criteria for glaucoma patients were a) diagnosis of POAG 
or NTG by the hospital eye service and b) a visual field defect consistent with 
glaucomatous optic nerve appearance. Specific inclusion criteria for stable glaucoma 
were: a) a diagnosis of stable glaucoma by the glaucoma consultant on the basis of 
stable IOP <21mmHg, b) no identifiable visual field progression, c) stable optic disc 
appearance, and d) no previous trabeculectomy in the eye to be tested. The specific 
inclusion criterion for the trabeculectomy group was a decision by the consultant 
ophthalmologist to list the patient for trabeculectomy surgery, based on a clinical 
determination of progression, or high risk of progression, that could not be controlled 
with medication. Specific inclusion criteria for healthy participants were a) full visual 
field b) healthy optic discs, and c) IOP <21mmHg. Exclusion criteria were a) media 
opacities greater than those expected for the participant’s age (e.g. in older participants, 
no more than mild cataract, graded with LOCS III; grade of ≤2), b) ocular or systemic 
conditions or medication that might be expected to affect visual performance, except for 
glaucoma, where appropriate (e.g. diabetes, thyroid disease), c) corneal opacities, d) 
ocular surgery which might affect visual performance (apart from trabeculectomy, 
Chapter 4 	
 
 141 
where appropriate), e) inability to steadily fixate during the test (e.g. individuals who 
have nystagmus or macular degeneration), f) a family history of glaucoma (first degree 
relative; healthy participants only), and g) brimonidine treatment (e.g. Alphagan) for 
high IOP (glaucoma participants only).  
 
All participants underwent an ocular health investigation with slit lamp biomicroscopy, 
binocular indirect ophthalmoscopy, perimetry (24-2 SITA-Standard; Humphrey Field 
Analyzer II; HFA II, Carl Zeiss Meditec, Dublin, CA), and optical coherence 
tomography (OCT; Topcon 3D OCT-1000, Tokyo, Japan) to confirm that each group 
met the relevant inclusion criteria. Corneal aberrations were measured with an Oculus 
Pentacam (Oculus, Wetzlar, Germany). Only one eye, the eye that best met the 
inclusion criteria, was tested in all participants. In stable and healthy participants, the 
test eye was chosen at random when both eyes met the inclusion criteria.  
 
4.5.1.2. Apparatus and Stimuli 
In all experiments, stimuli were achromatic circular spots of light, presented on a grey 
background (luminance: 10 cd/m2) for 200 ms. Sensitivity was measured at 8 different 
visual field locations across two different eccentricities (12.7° and 21.2°; Figure 4.3) 
with five different stimulus areas (Goldmann sizes I-V; 0.11°, 0.22°, 0.43°, 0.87° and 
1.7° diameter). Stimuli were presented on an Octopus 900 perimeter (Haag Streit, 
Koeniz, Switzerland), controlled with the Open Perimetry Interface (Turpin et al. 2012).  
 
Chapter 4 	
 
 142 
Figure 4.3. Visual field test locations (red), superimposed on a 24-2 HFA II visual field 
test grid, for reference. Visual field eccentricities are given inside each symbol. 
 
4.5.1.3. Procedure 
1)  History and symptoms 
2)  Best corrected visual 
acuity 
3)  Objective refraction 
4)  Visual field measurement  
5)  Ocular health assessment 
6)  Measurement of 
Goldman I-V sensitivity 
7)  Intraocular pressure 
      measurement 
8)  Corneal aberration 
measurement 
(9)  Eye length 
      measurement 
Average time:  
3 hours 
 
Figure 4.4. Schematic timeline of tests for both visits. 
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A summary of the preliminary tests and experiments, and the order in which they were 
performed, is shown in the schematic in Figure 4.4. For the Ricco’s area measurement, 
sensitivity (in dB) was measured with each of the Goldmann sizes (I-V) at each visual 
field location in an interleaved manner. In each test, a different Goldmann size was 
used, chosen at random. A 4:1 staircase procedure was used, which was adapted from 
that produced by Andrew Turpin and Luke Chong (University of Melbourne, 
http://people.eng.unimelb.edu.au/aturpin/opi/interface.html, accessed on 15th March 
2014). Step size was 4 dB before the first reversal and 1dB thereafter. A yes/no 
response criterion was used.  At each location, the procedure stopped after 8 reversals. 
The final sensitivity returned was an average of the last 4 reversals. The entire 
procedure was repeated twice more. So, at each test location, 3 values for sensitivity 
were obtained for each Goldmann size. Therefore a total of 15 sets of sensitivity 
measurements were obtained per location, and 120 measurements per participant. All 
procedures were carried out with natural pupil sizes and central refractive error, 
corrected fully with full aperture trial lenses. A near addition was given for the 
appropriate working distance (33 cm). Fixation was monitored visually and eye position 
was adjusted when the pupil moved from the optimum position in the eye monitor. 
Breaks were given approximately after every 10 minutes and whenever requested by the 
patient. 
 
4.5.1.4. Data analysis 
Severity of glaucoma is classified based on Hodapp-Parrish-Anderson criteria. 
Sensitivity values (dB) for Goldmann I-V were averaged by stimulus size for each 
location (by unlogging, averaging, and then re-logging), converted to increment 
threshold (ΔI), and plotted against area. Two-phase regression analysis was performed 
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in the freely available open-source statistical environment, R (version 3.1.0) to obtain 
Ricco’s area estimates at each location. The slope of the first line was constrained to a 
value of -1, following Ricco’s law, whilst the intercept of first line, slope of the second 
line and break point were allowed to vary. The breakpoint estimated was taken to be an 
estimate of Ricco’s area. Pooling all Ricco’s area data together in participants with 
glaucoma can lead to masking of any subtle changes, as different glaucomatous visual 
fields (and locations within each field) have a different level of severity, and it is 
possible that some will have progressive loss while others will not. To address this 
potential problem, data from each participant group were divided into 3 equally sized 
strata based on total deviation (TD) values ascertained from conventional perimetry (24-
2 SITA-Standard, HFAII). Stratum 1 contained data with more positive / less negative 
TD values (less visual field loss) and level 3 contained data with most negative TD 
values (most severe visual field loss). A paired t-test was performed on data from each 
group to test for overall changes in Ricco’s area between visit 1 and 2. A Holm-
Bonferroni correction was performed on all p values to reduce possibility of a type 1 
error (increased likelihood of statistical significance due to multiple tests of the same 
hypothesis). Given that it was favourable to investigate whether Ricco’s area changes 
between visits in the trabeculectomy group, relative to the other groups, it was 
necessary to account for the multiple factors that might otherwise influence the size of 
Ricco’s area in this study. Linear mixed model analysis was therefore used to assess the 
relationship between participant type and the difference in Ricco’s area between visits. 
The difference in Ricco’s area between visits (ΔRA) was the dependent variable. 
Participant type (without an interaction term) was entered as a fixed effect, while 
intercepts for subjects and test locations, as well as by-subject random slopes were 
entered as random effects. There were no obvious deviations from normality, nor 
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heteroscedasticity. A likelihood ratio test of the model (including all effects) and the 
same model with the effect of interest removed was conducted in order to establish the 
statistical significance of that effect. Individual Ricco’s area values were then plotted 
for both visits to assess changes of Ricco’s area across all locations. Binomial test 
conducted on trabeculectomy group data to assess possibility of the result happening by 
chance. Ricco’s area was also plotted as a function of age and linear regression 
performed to assess age-related enlargement with Ricco’s area size. Slopes of the 
second lines were plotted against total deviation from SITA-Standard 24-2 and 
independent samples t-test run to assess relationship between two variables. Difference 
in RA between visits was plotted against difference in IOP between visits to assess their 
relationship. Sensitivity to a single stimulus area (each of Goldmann I-V stimuli) was 
compared between visits to test for possible changes between visits in each of the 
participant groups. 
 
RGC density 
RGC density was calculated from measures of sensitivity to a Goldmann III stimulus 
from the preliminary perimetry test using the ‘hockey-stick’ method of Swanson et al. 
(2004), at each experimental test location, in all participants, on both visits, to give 
some context, (in terms of the number of functional RGCS lost, or gained), to the 
findings of functional change between visits for the trabeculectomy, stable glaucoma, 
and healthy groups. The ‘hockey-stick’ structure/function model of Swanson et al. 
(2004) predicts that beyond 15° eccentricity, where Ricco’s area in normal eyes is, on 
average, larger than the Goldmann III stimulus, log RGC number (<1.5 log RGCs) is 
linearly related to perimetric sensitivity (dB) and well described with a line that has a 
slope of +1. Within 15° visual field eccentricity, Ricco’s area is smaller than the 
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Goldmann III stimulus, and the relationship between sensitivity and log RGC number is 
well described with a line that has a slope of  +0.25 (2.5dB per 1 log unit difference in 
RGC number). When Ricco’s area is equal to the size of the Goldmann III stimulus, the 
sensitivity is predicted to be 31.25dB. The following calculations can be used to 
estimate RGC density. 
 
When sensitivity to a Goldmann III stimulus is less than 31.25dB: 
 
!"# !"#!""" =  !"#$%&%'%&( !" − 1610  
 
(Equation 3) 
 
When sensitivity to a Goldmann III stimulus is greater than 31.25dB: 
 
!"# !"#!""" = !"#$%&%'%&( !" − 27.44 ×410  
 
(Equation 4) 
 
RGC/mm2 is then calculated by converting the log RGC/GIII to linear units and 
dividing by 0.0119, the area (in mm2) of a Goldmann III on the retina, calculated using 
the conversion of Drasdo & Fowler (1974).  
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4.5.2. Experiment 2 
Given the effect of optical factors on the size of Ricco’s area (Davila & Geisler 1991; 
Dalimier & Dainty 2010), it was considered prudent to determine the effect of changes 
in optical quality, owing to trabeculectomy surgery, on any changes in Ricco’s area 
between visits. If a change in Ricco’s area is found between visits in the trabeculectomy 
group, it is important to ascertain whether this change is due to surgically-induced 
alterations of the cornea, or true neural changes. In this experiment, corneal aberrations 
were measured on both visits in the trabeculectomy group, as well as the stable 
glaucoma and healthy groups (control groups). 
 
Corneal wavefront aberrations were measured before surgery in trabeculectomy 
participants and at least 6 months after surgery. Corneal wavefront aberrations were 
observed to vary greatly even among healthy individuals (Wang et al. 2003). An 
additional advantage in the current longitudinal study is that aberrations (and Ricco’s 
area values) can be compared before and after trabeculectomy in the same participants, 
thus each participant acts as his/her own control. The Optical Society of America 
recommendations were followed throughout the study (Thibos et al. 2002). 
 
4.5.2.1. Participants 
Participants were the same as those who took part in Experiment 1. Full participant 
details can be found in Chapter 4.  
 
4.5.2.2. Apparatus and Stimuli 
An Oculus Pentacam (Oculus, Wetzlar, Germany) was used to obtain measurements of 
corneal wavefront aberrations. The instrument uses a 475nm UV-free LED and two 
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cameras and a method based on based on Scheimpflug principle to capture sixe and 
orientation of the pupil and capture images from the cornea. An attempt to calibrate the 
instrument with a steel ball of known radius was unsuccessful because, in order to take 
the measurement, the Pentacam relies on the backward light scattering properties of the 
front and back surface of the transparent cornea. The instrument was instead calibrated 
with a 3D-printed model eye. 
 
4.5.2.3. Procedure 
Three repeated measurements of corneal aberrations were taken each visit. Each 
acquisition lasted approximately two seconds. When the Pentacam gave reports with 
missing data, (e.g. due to droopy eyelids or long lashes), attempt were made to hold the 
eyelid up. Care was taken to ensure that the eyelids were held against the brow, 
avoiding any manual compression of the globe. Room lights were switched off during 
the measurement to ensure a reflection-free image. The automatic release mode was 
used, in order to reduce operator dependency for all tests, wherein the Pentacam 
automatically captured the scan when it decided that correct alignment with the corneal 
apex had been achieved.  
 
4.5.2.4. Data analysis  
Due to raw data export restrictions with the Pentacam, the Zernike coefficients had to be 
hand-typed from a screenshot of the report from each acquisition. Forty-five Zernike 
coefficients were obtained from each acquisition from the front surface of the cornea, 
and 45 from the back surface of the cornea. As three acquisitions were made per visit, 
for each visit the total number of Zernike coefficients obtained per participant were 270. 
The total numbers of Zernike coefficients collected was 15,360 at the first visit and 
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12,000 at second visit, owing to participant dropout. In order to minimize chances of 
subjective error, for every third Zernike coefficient typed out, that coefficient was typed 
out three times on separate occasions. To conclude the quality control check, the 
numbers were subtracted from each other to see whether a value of zero was obtained. 
An error of zero indicated no transcription error.  For each participant, on average 24 
minutes were needed to type out the Zernike coefficients per visit. 
 
To correct for mirror asymmetry between right and left eyes, following suggestion of 
OSA (Thibos et al. 2002), signs of Zernike coefficients from left eyes with Zernike 
polynomials with negative, even meridonial and positive, odd meridonial indices were 
changed for example: , . As suggested by Atchison (2004), Zernike polynomials 
up to the 6th order are included in the analysis so that the error of the fit that comes with 
a coefficient does not become as significant as the coefficient itself. 
 
The difference in Zernike coefficients between visits for the front and back surfaces for 
each participant group was plotted. The median for both cornea surfaces was calculated 
for all groups. They are compared qualitatively with the healthy subjects’ Zernike 
coefficients results obtained from Chapter 3. Linear mixed model analysis was used to 
assess the relationship between between-visit differences in aberrations (ΔA) and ΔRA 
in the superior hemifield. Only ΔRA from the superior visual field were included in this 
analysis, as a) it is most likely that if any disruption to the corneal surface occurs in 
trabeculectomy, it is most likely that this will be in the superior cornea, and b) inclusion 
of the inferior locations could contaminate the identification of any small effects of 
surgical changes on the measurement of Ricco’s area. ΔRA, pooled across all superior 
visual field locations, participants, and participant groups, was the dependent variable. 
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ΔA, corneal surface, and participant group were entered as fixed effects. Intercepts for 
polynomial number, test location, and subjects were entered as random effects. There 
were no obvious deviations from normality, nor heteroscedasticity. A likelihood ratio 
test of the model (including all effects) and the same model with the effect in question 
removed, was conducted in order to establish the statistical significance of the removed 
effect on the dependent variable. 
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4.6. Results 
4.6.1. Experiment 1 
The average testing time for each participant was 3-hours/visit. 
 
Participants 
Trabeculectomy participants 
Twelve trabeculectomy participants with open-angle or normal tension glaucoma met 
the inclusion criteria out of 36 participants listed for trabeculectomy surgery within the 
period of study recruitment from June 2015 to August 2016. All participants underwent 
trabeculectomy with adjunctive Mitomycin C. Three out of 12 participants were lost to 
follow-up after the first visit, and their data were removed from subsequent analysis. 
The trabeculectomy group had a range of VF loss from early to advanced. 
 
Stable glaucoma participants 
Twenty-six glaucoma participants with OAG or NTG were classified as stable by the 
consultant ophthalmologist in the hospital eye service, on the basis of no identifiable 
visual field progression, stable optic disc appearance, and stable IOP < 21mmHg. All 
participants continued to use any topical treatment prescribed to them by the hospital 
eye service throughout the period of the study. None of the participants had any change 
in their prescribed eye drops between the first and second visit. Following the first visit, 
six out of 26 participants in this group were lost to follow up, and their data were 
removed from subsequent analysis.  
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Healthy participants 
Twenty-six participants with no family history of glaucoma or any other eye disease 
were recruited. All participants had IOP < 21mmHg, normal optic disc appearance C/D 
ratio < 0.5 in the test eye, with < 0.2 inter-ocular difference). All had full, normal visual 
fields. Six participants out of 26 were lost to follow-up and their data were removed 
from subsequent analysis. 
 
Table 4.1. Data from preliminary tests in each participant group. *Data from those 
participants lost to follow-up after the first visit have been excluded. 
 Trabeculectomy Stable glaucoma Healthy 
n (first visit) 12 26 26 
n (second visit) 9 20 20 
Median [IQR] age 67  [58 to 77.50] 
69 
[62.50 to 76.50] 
67  
[63.25 to 71.75] 
Median [IQR] 
refractive error (DS) 
-3.25  
[+1.50 to -4.75] 
-2  
[+3.75 to -4.50] 
-0.75  
[+2.75 to -2.25] 
Median [IQR] VA 
(logMAR) 
0.02  
[-0.14 to +0.1] 
0.04  
[-0.12 to +0.16] 
0.06  
[-0.08 to +0.2] 
Median [IQR] MD 
(dB) 1st visit* 
-5.3  
[-8.7 to -3.5] 
-1.9  
[+1.1 to -8.1] 
+0.5 
[-0.6 to +1.4] 
Median [IQR] MD 
(dB) 2st visit 
-5.1 
[-11.6 to -1.4] 
-1.2 
[+3.8 to -8.2] 
+0.9  
[+0.1 to +1.6] 
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Figure 4.5. Graphical representation of MD from first visit of all participant groups. 
 
Overall, changes in refractive error between visits were less than 0.50 D for all 
participant groups, and this was not statistically significant (p=0.76). Median logMAR 
visual acuity between visits was unchanged between visits in the stable glaucoma and 
healthy groups. The overall difference between visits was not statistically significant 
(p=0.69). Eleven participants in the trabeculectomy group had the same logMAR visual 
acuity between visits, but one participant had a small reduction of 0.04 logMAR on the 
second visit. Median (IQR) IOP up to 2 weeks pre-operation and at approximately 6 
months post-operation for trabeculectomy groups were 25 (17-30) mmHg and 14 (9-
18.75) mmHg respectively. Median (IQR) IOP for the stable glaucoma group’s first and 
second visits were 14mmHg (10-19) and 12mmHg (10-16.5), respectively. Median 
(IQR) IOP for the healthy glaucoma group’s first and second visits were 13mmHg (9-
15) and 14.5mmHg (10-16), respectively. 
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Table 4.2. Time difference, in days, between first and second visits of participants in the 
healthy group. LTF = Lost To Follow-up. 
Participant ID Date of Visit 1 Date of Visit 2 Time between visits (days) 
N001 12/05/16 20/11/16 192 
N002 21/10/15 28/04/16 190 
N003 26/08/15 24/02/16 182 
N004 20/09/15 18/03/16 180 
N005 03/09/15 02/03/16 181 
N006 20/08/15 01/03/16 194 
N007 30/08/15 29/02/16 183 
N008 19/08/15 22/02/16 187 
N009 09/09/15 21/03/16 194 
N010 04/09/15 03/03/16 181 
N011 07/10/15 15/04/16 191 
N012 11/09/15 10/03/16 181 
N013 18/03/16 20/09/16 186 
N014 07/04/16 10/10/16 186 
N015 24/04/16 01/11/16 191 
N016 08/08/15 10/02/16 186 
N017 17/03/16 21/09/16 188 
N018 25/11/15 26/05/16 183 
N019 26/11/15 24/05/16 180 
N020 11/03/16 LTF NA 
N021 31/03/16 LTF NA 
N022 09/05/16 LTF NA 
N023 06/05/16 LTF NA 
N024 11/05/16 LTF NA 
N025 06/10/15 LTF NA 
N026 27/04/16 25/10/16 181 
 
Tables 4.2, 4.3 and 4.4 show the time (in days) between visits in healthy, stable and 
trabeculectomy groups respectively. These data are graphically represented in Figure 
4.6. At least 174 days (5.8 months) had passed between the first and second visit for all 
participant groups. The maximum time difference between first and second visits was 
198 days (6.6 months). At least 172 days (5.7 months) had passed between the date of 
surgery and the second visit for the trabeculectomy group.  
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Table 4.3. Time difference in days between first and second visits of participants in 
stable glaucoma group. LTF = Lost To Follow-up. 
Participant ID Date of Visit 1 Date of Visit 2 Time between visits (days) 
S001 02/09/15 11/03/16 191 
S002 15/10/15 25/04/16 193 
S003 30/09/15 08/04/16 190 
S004 08/10/15 06/04/16 181 
S005 15/10/15 LTF NA 
S006 14/10/15 25/04/16 194 
S007 21/10/15 18/04/16 180 
S008 10/11/15 09/05/16 181 
S009 22/10/15 LTF NA 
S010 11/11/15 16/05/16 187 
S011 19/10/15 21/04/16 185 
S012 11/11/15 18/05/16 189 
S013 23/11/15 27/05/16 186 
S014 04/02/16 16/08/16 194 
S015 05/11/15 17/05/16 194 
S016 14/01/16 LTF NA 
S017 17/02/16 LTF NA 
S018 02/02/16 11/08/16 191 
S019 05/01/16 16/07/16 193 
S020 15/02/16 19/08/16 186 
S021 17/02/16 23/08/16 188 
S022 24/02/16 01/09/16 190 
S023 29/03/16 LTF NA 
S024 10/04/16 20/10/16 193 
S025 20/06/16 LTF NA 
S026 14/04/16 19/10/16 188 
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Table 4.4. Time difference, in days, between the first and second visits of participants in 
the trabeculectomy group. The time difference between the date of the operation and the 
second visit is also shown. LTF = Lost To Follow-up 
Participant 
ID 
Date of  
Visit 1 
Date of 
Visit 2 
Date of 
Surgery  
Time 
between 
visits 
(days) 
Time 
between 
surgery and 
Visit 2 
(days) 
T001 06/10/15 08/04/16 10/10/15 185 182 
T002 25/11/15 25/05/16 27/11/15 182 181 
T003 22/03/16 20/09/16 29/03/16 182 182 
T004 05/11/15 10/05/16 09/11/15 187 183 
T005 12/10/15 27/04/16 16/10/15 198 190 
T006 21/10/15 28/04/16 25/10/15 190 186 
T007 15/09/15 20/03/16 20/09/15 187 182 
T008 30/03/16 20/09/16 01/04/16 174 172 
T009 18/02/16 30/08/16 27/02/16 194 185 
T010 31/03/16 LTF 04/04/16 NA NA 
T011 15/09/15 LTF 19/09/15 NA NA 
T012 30/03/16 LTF 02/04/16 NA NA 
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Figure 4.6. Time differences between visits for all participant groups in months. Also 
time between surgery and visit 2 for trabeculectomy group. 
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Figure 4.7. Examples of spatial summation curves determined in this study. Left: an 
example of typical data obtained in the study (two-phase regression line fit R2 >0.9). 
Right: an example of variable data from the study that still met the inclusion criterion of 
R2 >0.9. 
 
Data were excluded from further analysis if a) a two-phase regression line could not be 
fitted to the data, or b) r2 was < 0.9 from the regression.  
 
On this basis, 8 out of 160 spatial summation functions from the first visit, and 15 out of 
160 functions from the second visit were excluded from further analysis in the healthy 
control group. Fifteen out of 160, and 10 out of 160 spatial summation functions were 
excluded from first and second visit data, respectively, in the stable glaucoma group. 
Five out of 72, and 3 out of 72 spatial summation functions were excluded from first 
and second visit, respectively, in the trabeculectomy group.  
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It can be seen in Table 4.5 and Figure 4.8 that median Ricco’s area was larger in the 
stable group than in the healthy participant group. In addition, median Ricco’s area was 
larger in the trabeculectomy group than that in the healthy participant group at visit 2, 
but not at visit 1. In all groups, median log Ricco’s area enlarged from visit 1 to visit 2. 
 
Table 4.5. Median [IQR] log Ricco’s area in each participant group for both visits. 
Data were pooled from all locations in all participants with in each group. 
 Median [IQR] Ricco’s area (deg2)  
P values 
 Visit 1 Visit 2 
Healthy -0.79 [-0.97, -0.61] -0.73 [-0.93, -0.58] 0.36 
Stable glaucoma -0.67 [-0.84, -0.47] -0.63 [-0.84, -0.43] 0.34 
Trabeculectomy  -0.84 [-1.02, -0.53] -0.57 [-0.78, -0.41] 0.21 
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Figure 4.8. Comparison of Ricco’s area data pooled for all locations between visits in 
each participant group (H= healthy group, HV1= visit 1, HV2= visit 2; S= stable 
glaucoma group, SV1= visit 1, SV2= visit 2; T= trabeculectomy group, TV1=visit 1, 
TV2= visit 2.) 
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Table 4.6. Median [IQR] Ricco’s area for each participant group, divided into 3 
different strata according to TD. The higher the stratum the more negative the TD 
values are. Note: strata are not continuous across all groups, but are based on TD 
values in each of the groups, separately. 
 Median [IQR] Ricco’s area (deg2) 
 Stratum 1 Stratum 2 Stratum 3 
 Visit 1 Visit 2 Visit 1 Visit 2 Visit 1 Visit 2 
Healthy 
-0.84  
[-0.99 to 
-0.63] 
0.72  
[-0.94 to 
-0.57] 
-0.76  
[-0.92 to 
-0.61] 
-0.75  
[-0.94 to 
-0.56] 
-0.77  
[-0.98 to 
-0.62] 
-0.71  
[-0.91 to 
-0.60] 
Stable glaucoma 
-0.65  
[-0.84 to 
-0.48] 
-0.66  
[-0.94 to 
-0.54] 
-0.67  
[-0.91 to 
-0.47] 
-0.66  
[-0.84 to 
-0.41] 
-0.66  
[-0.84 to 
-0.46] 
-0.56  
[-0.84 to 
-0.33] 
Trabeculectomy  
-0.60 
[-0.85 to 
-0.52] 
-0.68 
[-0.84 to 
-0.49] 
-0.84 
[-0.97 to 
-0.50] 
-0.56 
[-0.68 to 
-0.40] 
-0.85 [ 
-1.08 to 
-0.51] 
-0.55 
[-0.80 to 
-0.39] 
 
On initial observation of the pooled data, divided by stratum (Figure 4.9), there does not 
appear to be any meaningful difference in median Ricco’s area between visits for the 
healthy and stable glaucoma groups in any stratum. However, there does appear to be a 
slightly smaller median Ricco’s area at the second visit for the trabeculectomy group in 
stratum 1, but a larger median Ricco’s area on the second visit in strata 2 and 3.  
 
To gain an overall impression of changes in Ricco’s area between visits, Ricco’s area 
values, pooled from all locations per participant group, were plotted for each visit 
(Figure 4.10). A paired t-test was carried out on these data (with a Holm-Bonferroni 
correction). This showed a statistically significant difference between visits in stratum 3 
for the trabeculectomy group (p=0.04), but not in any of the other strata in any other 
participant group.
Chapter 4 	
 
 161 
                      
Lo
g 
R
ic
co
's
 a
re
a 
(d
eg
2 )
HV1 HV2 HV1 HV2 HV1 HV2
-1.5
-1
-0.5
0
0.5
n= 33 33 33 33 29 29 29
Stratum 1 Stratum 2 Stratum 3
TD= +6 to +2 TD= +2 to 0 TD= 0 to -7 
n= 46 n= 48 n= 50 n= 52 n= 55 n= 50
Healthy
 
Lo
g 
R
ic
co
's
 a
re
a 
(d
eg
2 )
SV1 SV2 SV1 SV2 SV1 SV2
-1.5
-1
-0.5
0
0.5
Stratum 1 Stratum 2 Stratum 3
TD= +4 to 0 TD= 0 to -2 TD= -2 to -14 
n= 54 n= 56 n= 51 n= 53 n= 49 n= 52
Stable Glaucoma
 
Lo
g 
R
ic
co
's
 a
re
a 
(d
eg
2 )
TV1 TV2 TV1 TV2 TV1 TV2
-1.5
-1
-0.5
0
0.5
n= 24 n= 25 n= 21 n= 24 n= 23 n= 23
Stratum 1 Stratum 2 Stratum 3
TD= +5 to -1 TD= -1 to -4 TD= -4 to -14 
Trabeculectomy
 
Figure 4.9. Comparison of Ricco’s area data pooled for all locations between visits 
across different strata in each participant group (Top: healthy group. HV1= visit 1, 
HV2= visit 2; middle: stable glaucoma group SV1= visit 1, SV2= visit 2; bottom: 
trabeculectomy group. TV1=visit 1, TV2= visit 2.) 
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Figure 4.10. Ricco’s area at each location on visits 1 and 2 in healthy (top left), stable 
(top right) and trabeculectomy groups (bottom). 
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When data are separated and shown paired by location in this way (rather than pooling 
all locations), it can be seen that while in some locations, Ricco’s area is larger in the 
second visit than in the first, the opposite can be seen in other locations. There are also 
locations in which no notable change in Ricco’s area can be seen. The spread of the data 
is approximately equal for the first and second visit in the healthy group, and also in the 
stable glaucoma group, with the exception of one location that shows a large reduction 
between visits. The spread of data is larger in the stable group compared to healthy. The 
spread of the data in the trabeculectomy group is larger in the first visit compared to that 
of data at the second visit. Even though not all locations showed an enlargement of 
Ricco’s area, there was a greater number of positive than negative slopes (i.e. more 
instances in which Ricco’s area was larger on the second visit) in this group. Overall, 
positive slopes were also steeper than negative slopes. The finding from the binomial 
test suggests that the greater occurrence of positive slopes was not due to chance 
(p=0.005). 
 
Linear mixed model analysis revealed that the effect of participant type on the between-
visit difference in Ricco’s area was not statistically significant. However, when we view 
the effect sizes, it can be observed that the between-visit difference in Ricco’s area for 
the stable glaucoma group was just 0.01 (SE = ±0.05) log deg2 greater than that found in 
the healthy control group. In contrast, the between-visit difference in Ricco’s area in the 
trabeculectomy group was 0.15 (SE = ±0.07) log deg2 greater than that found in the 
healthy control group (and 0.14 deg2 greater than that found in the stable glaucoma 
group). The median enlargement of Ricco’s area in healthy controls was 0.06 log deg2, 
therefore, the model reports between-visit differences in Ricco’s area of 0.07 log deg2 in 
the stable glaucoma group, and 0.21 log deg2 in the trabeculectomy group. Inspections 
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of the residuals confirmed normality and no heteroscedasticity. When the analysis was 
repeated with data for the healthy group removed from the dataset, the effect of 
participant type on between-visit Ricco’s area was borderline statistically significant 
(p=0.05).  
 
Table 4.7. Median [IQR] sensitivity (dB) in all participant groups at both visits 
  Median [IQR] sensitivity (dB) 
Participant group Visit GI GII GIII GIV GV 
Healthy 
1 
17.67 
[16.83 to 
19.34] 
23.71 
[23.22 to 
25.90] 
28.98  
[28.12 to 
29.76] 
31.77  
[31.51 to 
32.04] 
33.66 
[32.84 to 
34.58] 
2 
17.73 
[16.12 to 
18.63] 
23.78 
[22.69 to 
25.95] 
29.14  
[28.67 to 
29.79] 
31.96 
[30.86 to 
32.44] 
33.62 
[32.87 to 
34.65] 
Stable 
1 
15.62 
[14.66 to 
15.98] 
22.63 
[21.85 to 
23.66] 
28.24  
[26.99 to 
28.93] 
29.87 
[28.67 to 
31.63] 
31.75 
[31.18 to 
32.86] 
2 
15.97 
[13.93 to 
16.95] 
21.95 
[20.18 to 
24.50] 
27.84  
[26.78 to 
28.77] 
30.42 
[29.11 to 
31.39] 
32.16 
[31.68 to 
33.31] 
Trabeculectomy 
1 
17.62 
[17.02 to 
17.94] 
24.62 
[21.68 to 
24.95] 
28.23  
[27.99 to 
28.66] 
30.74 
[26.60 to 
30.57] 
32.99 
[32.69 to 
34.27] 
2 
14.66 
[13.24 to 
16.62] 
21.97 
[20.21 to 
23.67] 
27.92  
[24.97 to 
28.62] 
30.26 
[30.15 to 
31.26] 
32.68 
[29.87 to 
32.78] 
 
Sensitivity values were pooled across all locations in all participants, in each participant 
group. Sensitivity was greater to larger stimuli in all participant groups, in line with 
spatial summation (Table 4.7). Median sensitivity to a Goldmann I stimulus was lower 
in both visits for stable glaucoma group, compared to that in the healthy group. The 
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difference in median sensitivity to a Goldmann II stimulus (and larger stimuli) was less 
between these participant groups. Median sensitivity to a Goldmann I stimulus in the 
trabeculectomy group was more similar to that in the healthy group at the first visit. 
However, median sensitivity to the Goldmann I stimulus in the trabeculectomy group 
was reduced in visit 2 and closer to that in the stable group. For each Goldmann 
stimulus, a one-tailed paired t-test was performed on pooled data to investigate changes 
in sensitivity between visits. Between-visit changes in sensitivity to all stimuli were not 
statistically significant (all p > 0.12), except for the reduction in sensitivity between 
visits for a Goldmann I (p = 0.03). 
 
Figure 4.11 shows that there is no relationship between changes in IOP between visits 
with changes of RA between visits, it appears that changes in Ricco’s area is not 
dependent on the reduction of IOP. This absent of relationship persisted through all 
stratum/ no different pattern detected with worsening of TD values. There is wide 
variation of Ricco’s area sizes at different level of IOP changes.  
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Figure 4.11. Difference in IOP between visits as a function of difference in Ricco’s area 
on trabeculectomy group.
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Figure 4.12. Slope of second line as a function of total deviation in all participant 
groups on both visits. 
 
Figure 4.12 shows that there is a wide variation of slope of the second line of the two-
phase regression in all participant groups. For reference, a slope of 0 in the second line 
of the spatial summation function means that the line is flat and there is no summation 
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with increasing stimulus area. A slope close to -1 indicates that the relationship between 
intensity and area at threshold is close to that described by Ricco’s law. The two phase-
regression analysis determines the breakpoint as the point at which Ricco’s law no 
longer holds. Therefore, in this analysis, the slope of all second lines will be between -1 
and 0. Second line slopes were averaged per participant, giving 20 values for the healthy 
group, 20 for the stable glaucoma group, and 9 for the trabeculectomy group, for each 
visit. An independent samples t-test showed that there was no statistically significant 
difference in second line slope between glaucoma patients (combined stable glaucoma 
and trabeculectomy group data) and healthy controls (p(visit1) = 0.47, p(visit2) = 0.62). 
When comparing the second slope between the stable glaucoma group and healthy 
controls, there was still no statistically significant difference (p(visit 1) = 0.98, p(visit 2) 
= 0.69). Finally, there was no statistically significant difference in the slope of the 
second line between the stable glaucoma group and the trabeculectomy group (p(visit 1) 
= 0.18, p(visit 2) = 0.93). 
 
To add context to the changes between visits reported here, the average change in linear 
RGC number from the first to the second visit was +1.19 in the healthy group, +0.45 in 
the stable glaucoma group, and -7.8 in the trabeculectomy group.  
 
There is no statistically significant relationship between log Ricco’s area and age in the 
healthy participant group for both visits (p(visit1) = 0.39, p(visit2) = 0.1, slope(visit1) = 
-0.68, slope(visit 2) = -0.53) (Figure 4.13). 
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Figure 4.13. Ricco’s area size obtained per location from healthy participants’ against 
age for different visits. 
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4.6.2. Experiment 2 
Figures 4.14, 4.15 and 4.16 show the between-visit difference in front (ΔAf) and back 
(ΔAb) corneal surface Zernike coefficients for the 28 Zernike polynomials within the 
first 6th radial orders in all participant groups.  
 
ΔAf is smaller than ΔAb in the healthy group. However ΔAf appears to be highest for 
Zernike polynomial 9, but his is not observed for ΔAb. Likewise, low ΔAb is observed 
for the lowest order polynomials, which is not apparent to the same extent with  ΔAf.  
 
Although there is some variance in ΔAf and ΔAb across all 28 polynomials in the stable 
glaucoma group, qualitatively there are no obvious deviations from 0 (Figure 4.15). In 
the trabeculectomy group, however, the variance in ΔAf and ΔAb across polynomials 
appears qualitatively larger than that in the stable glaucoma and healthy groups, and 
with greater magnitude, particularly for the lower order polynomials (Figure 4.16). 
However, there is little consistency between groups in the polynomials for which ΔAf 
and ΔAb are greatest. 
 
When compared with the Zernike coefficient data obtained from healthy subjects in 
Chapter 2, the polynomial with the greatest ΔAf  and ΔAb  do not match. In the 
exploratory study explained in Chapter 2, the greatest ΔAf  is Zernike polynomial 2. In 
the current study, although the healthy group also has the greatest Ab in Zernike 
polynomial 0, the extent of difference is larger and the stable glaucoma group has the 
greatest ΔAf  and ΔAb in different Zernike polynomials. 
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Figure 4.14. Difference in Zernike coefficients for 28 Zernike polynomials contained in 
the first 6 radial orders for the front (top) and back (bottom) surface of the cornea in 
the healthy group. 
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Figure 4.15. Difference in Zernike coefficients for 28 Zernike polynomials contained in 
the first 6 radial orders for the front (top) and back (bottom) surface of the cornea in 
the stable glaucoma group. 
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Figure 4.16. Difference in Zernike coefficients for 28 Zernike polynomials contained in 
the first 6 radial orders for the front (top) and back (bottom) surface of the cornea in 
the trabeculectomy group. 
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Table 4.8. Zernike coefficients (mm) for polynomials of the first 6 radial orders from the 
front surface of the cornea of all participant groups in both visits.  
Types 0 1 2 3 
Median healthy 1st visit 0.135128667 0.000125333 0.000705 -0.00000233 
Median stable 1st visit 0.136450167 0.000509167 -0.0006 3.69835E-05 
Median trabeculectomy 1st visit 0.135 0.000281 -0.001446667 -0.000377333 
Median healthy 2nd visit 0.134320333 0.000180333 0.000955 0.000322333 
Median stable 2nd visit 0.136277833 0.000516334 -0.000256834 0.000005 
Median trabeculectomy 2nd 
visit 0.133415333 0.000456333 -0.000507 0.000364 
4 5 6 7 8 9 
0.080192 0.000586333 0.0000363 0.000101333 0.0000907 0.0000277 
0.080805334 0.000542 0.0000275 0.000105 -0.000278833 0.0000065 
0.079533333 0.000815333 -0.0000443 0.000204 -0.000162667 0.0000747 
0.079496 0.000506333 -0.000021 0.0000967 0.0000537 0.0000727 
0.080722167 0.000363 -0.00008 9.33165E-05 -0.00013515 0.00007415 
0.078664667 0.001265 -0.000113 0.000271 0.000263 0.000199333 
10 11 12 13 14 15 
0.000042 0.0000227 0.001460333 -0.0000367 -0.000123 -0.000029 
0.0000045 0.000019185 0.00143 -0.00000165 -0.000048 -0.000009485 
0.000238667 0.0000297 0.001491667 -0.00000133 -0.000158 -0.000075 
0.0000743 0.0000253 0.001412667 -0.0000837 -0.000057 0.0000157 
0.00003185 -0.00003215 0.001470167 0.000010165 -0.000028835 -0.00007515 
0.000160667 0.00000367 0.001393 -0.000201 -0.000317 -0.0000727 
16 17 18 19 20 21 
-0.0000273 0.000074 -0.000126 -0.0000337 -0.00000133 -0.000062 
-0.0000355 -0.000002 -0.000032 -0.00003185 -0.00007635 -0.0000545 
-0.000119667 0.000034 0.0000653 0.000103667 0.0000527 -0.0000977 
0.000000333 0.0000333 -0.000109667 0.00000767 -0.0000927 -0.0000437 
-0.000068 0.000004 0.00001915 -0.00002835 -0.000078 -0.000036 
-0.000101 0.000015 -0.00000167 0.000204 -0.0000607 -0.000208333 
22 23 24 25 26 27 
0.0000653 0.000011 -0.0000873 -0.0000183 0.000006 0.000008 
0.0000412 0.000025 -0.00003665 -0.000003 -0.000019685 0.000011185 
0.0000293 0.000000333 -0.0000427 -0.0000143 0.000007 0.000068 
0.000077 0.00000667 -0.0000593 -0.0000163 -0.000007 -0.0000187 
0.0000605 0.000024 -0.0000538 -0.0000105 -0.000004835 0.00000167 
0.000122 0.0000117 -0.000105 -0.0000453 -0.000069 -0.000065 
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Table 4.9. Zernike coefficients for polynomials of the first 6 radial orders from the back 
surface of the cornea of all participant groups in both visits.  
Types 0 1 2 3 
Median healthy 1st visit 0.163817 -0.000383 0.001034 0.001744333 
Median stable 1st visit 0.1588005 0.000167667 0.000564333 0.001119833 
Median trabeculectomy 1st visit 0.163272167 0.0003745 0.0000425 0.000715334 
Median healthy 2nd visit 0.163556333 -0.000283333 0.001228667 0.001456 
Median stable 2nd visit 0.158681 0.000202667 0.000652833 0.0013725 
Median trabeculectomy 2nd visit 0.160702667 0.00053 0.001107 0.0012 
4 5 6 7 8 9 
0.096768667 0.001353333 -0.000112 0.000695333 -0.000499333 0.000319333 
0.093582 0.000964667 -0.000118167 0.000371 -1.16665E-05 0.000504 
0.0958585 0.001216167 -0.000113684 0.000536184 -0.000534 0.000223334 
0.096425 0.000668 -0.000235333 0.000573333 -0.000297333 0.000399 
0.093474667 0.001551667 -0.000283667 0.000297 0.000272834 0.000306667 
0.094996 0.001544 -0.000152667 0.000575 -0.0003 0.000188 
10 11 12 13 14 15 
0.000666667 0.0000717 0.001593333 -0.000247333 0.000423667 0.000113333 
0.000684167 0.000134834 0.001365333 -0.000314167 0.000544 0.0001325 
0.000370667 0.0001685 0.001394334 -0.000262834 0.0004395 0.00007315 
0.000593 0.0000583 0.001598333 -0.000178667 0.000499333 0.0000467 
0.000408 0.00007065 0.001489334 -0.0003075 0.000633 -0.0000688 
0.000569667 -0.00003 0.001196667 -0.000117333 0.000308333 0.000071 
16 17 18 19 20 21 
0.0000883 0.000063 -0.000127333 -0.0000627 0.000037 0.000149333 
0.00004465 0.000036 0.0000305 0.00004865 -0.0000705 0.00005785 
0.000134833 -0.000019985 -4.99835E-05 0.00006765 -0.0000812 -0.00005715 
0.0000713 0.000031 -0.0000623 -0.0000127 0.000237333 0.00000567 
0.000107684 0.000024015 0.000054 0.00007885 5E-07 -0.000018685 
0.0000583 -0.000178667 0.0000157 -0.00000267 -0.0000537 0.000042 
22 23 24 25 26 27 
-0.000202667 -0.000042 0.0000207 0.0000317 -0.000209667 0.00027 
-0.000182834 -0.000003685 -0.00004065 0.0000225 -0.000226334 0.0000585 
-0.000144484 -0.0000542 -0.000001665 0.0000595 -0.000357 0.0001885 
-0.000148333 -0.0000353 0.0000157 0.000048 -0.000248333 0.000241 
-0.000163167 -0.0000555 -0.0000267 0.000001665 -0.000327167 9.43335E-05 
-0.000225333 -0.0000663 0.0000313 0.000057 -0.00014 0.000257 
 
The linear mixed model analysis showed that the effect of ΔA on ΔRA is not 
statistically significant (p = 0.98). Incorporating ΔA, polynomial number, and corneal 
surface into the model (but only on superior visual field data), reveals that ΔRA in the 
stable glaucoma group is 0.053 [SE: ±0.07] smaller than that in the healthy group, and 
that ΔR in the trabeculectomy group is 0.16 [SE: ±0.09] larger in the trabeculectomy 
group than in the healthy group. However, the effect of participant type still did not 
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reach statistical significance (p = 0.09). Inspection of the residuals in both models 
confirmed normality and no heteroskedasticity.  
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4.7. Discussion 
The aim of this study was to investigate changes in Ricco’s area in glaucoma patients, 
before and after IOP-lowering treatment, in order to test the hypothesis that an enlarged 
Ricco’s area in glaucoma returns to normal (or near normal) levels following IOP-
lowering treatment. Secondary aims were to investigate whether or not Ricco’s area is 
enlarged in patients requiring trabeculectomy surgery, relative to that in stable glaucoma 
participants for whom surgery is not required; and also, to investigate any changes in 
Ricco’s area that may have occurred during this timescale in stable glaucoma 
participants, relative to that in normals, in the absence of significant change in 
sensitivity to a conventional perimetric stimulus. Patients requiring trabeculectomy as 
part of their clinical care underwent measurements of spatial summation, from which 
Ricco’s area was determined, within a matter of days prior to surgery, and again, 
approximately 6 months later. The same experiments were performed at the same 
intervals in two control groups, one of which consisted of stable glaucoma patients and 
the other, healthy individuals without glaucoma.  
 
In agreement with the findings of Redmond et al. (2010a), This study has also found 
that Ricco’s area is, overall, larger in trabeculectomy and stable glaucoma groups 
compared to that in healthy participants in our study. The enlargement of Ricco’s area 
between the first and second visit in the trabeculectomy group reached statistical 
significance only for the most severe TD group (stratum 3, moderate-to-advanced visual 
field damage). When analysing the effect of participant group on between-visit 
differences in Ricco’s area, linear mixed effects model analysis reported a greater 
difference between visits for the trabeculectomy group than for the stable glaucoma and 
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healthy control groups, though the effect of participant type, overall, was not 
statistically significant (p = 0.09). When the data from the healthy group were 
eliminated from the data set, the model reported that the effect of participant type on 
between-visit differences in Ricco’s area was borderline significant (p = 0.05). This 
suggests that there are indeed genuine differences between first and second visits for 
trabeculectomy participants, particularly given the short timescale over which 
measurements were repeated (approximately 6 months), and the fact that the median 
between-visit differences in normals was much smaller (0.06 log deg2). It is worth 
noting, that in the study of Redmond et al. (2010a), the average difference in Ricco’s 
area between glaucoma patients and controls was 0.65 log deg2, so the change in 
Ricco’s area observed over approximately 6 months in this study is approximately 33% 
of what was found between groups by Redmond et al. (2010a). 
 
The magnitude of IOP reduction is related to the risk of glaucoma progression, with 
each mmHg reduction of IOP causing a lowering of the risk of glaucoma progression by 
10% (Leske et al. 2003). Therefore, the pattern of Ricco’s area changes could be 
different with topical treatment of IOP, as the lowering of IOP would not be as drastic 
when compared to that encountered following the trabeculectomy procedure. Hence, the 
risk of progression may be greater with topical treatment. This perhaps could result in 
larger Ricco’s area post-treatment compared to what was found following the 
trabeculectomy procedure. 
As previously discussed, trabeculectomy can affect the curvature of the corneal surface, 
and therefore the retinal image size of the stimulus which, in turn, can have an effect on 
the measured Ricco’s area. Therefore, an investigation of the effect of between-visit 
differences in corneal aberrations on between-visit differences in Ricco’s area was also 
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warranted. A comparison of Zernike coefficients between visits showed high within-
subject variability even in healthy participants. This is further supported by the fact that 
there is no consistency in the polynomial coefficient that changes most between visits in 
stable glaucoma patients and healthy controls. As there is no expected change in corneal 
curvature in both stable glaucoma and healthy participants, they would be expected to 
have similar changes (if any) in the Zernike coefficients between visits. In fact, in some 
of the Zernike polynomials, the between-visit difference in coefficients is actually larger 
in the healthy group than that in the trabeculectomy group. When the linear mixed 
effects model analysis was repeated, this time only including psychophysical data from 
the superior hemifield and including the effects of between-visit differences in 
aberrations (back and front surface), it is evident that the effect of participant type on 
between-visit differences in Ricco’s area was largely unchanged.  This suggests that any 
observed changes in Ricco’s area between visits in the current study are unlikely to be 
related to surgically-induced corneal changes, and more likely owing to true 
neurological changes. 
 
Sensitivity to Goldmann I-V is similar between visits in healthy and stable glaucoma 
groups. However, this is not the case for the trabeculectomy group. There are 
differences in sensitivity, between visits, to all Goldmann sizes in this group, however 
the difference becomes less obvious with increasing stimulus area. This supports the 
notion of a rightward shift of the spatial summation curve between visits, along the area 
axis (Figure 4.1 from into aim). This difference between visits does not reach statistical 
significance however, nor does the overall between-visit difference in Goldmann III 
sensitivity (average: 0.31dB). Sensitivity to Goldmann I and Goldmann II stimuli are 
reduced in the stable glaucoma group, compared to that in healthy controls. Again, this 
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difference is less obvious with increasing stimulus size, supporting the notion of an 
enlarged Ricco’s area in glaucoma, relative to that in healthy controls. The reason for 
such an obviously lower sensitivity to smaller Goldmann sizes could be due to the fact 
that the stimulus falls within Ricco’s area in that region of the visual field. According to 
the hockey-stick model of Swanson et al. (2004), the relationship between log RGC 
number and visual field sensitivity (in dB) is 1:1 when the stimulus is smaller than 
Ricco’s area. Therefore, for a given RGC dropout, a reduction in sensitivity to smaller 
stimuli will be more obvious.  
The data showed a wide range of second line slope values (ranging from 0 to close to -
1) in all participant groups that are not influenced by changes in total deviation values 
measured with SITA-Standard 24-2 test. Although probability summation is frequently 
described by Piper’s law (Piper, 1903), among others, this finding suggests caution 
should be exercised in making assumptions regarding the slope of the second line in 
future experiments aimed at mapping to the spatial summation function with perimetric 
stimuli or modelling of perimetric sensitivity based on measures of Ricco’s area. As 
Brindley (1970) points out, Piper’s law is only demonstrable under precise experimental 
conditions. The findings here are also in agreement with the previous study of 
(Redmond et al. 2010b), that there is no statistically significant association between 
Ricco’s area and age. However, there are large variations in the size of Ricco’s area size 
at different ages.  
 
There are several possible explanations for the enlargement of Ricco’s area between the 
first and second visit that is observed in the second and third stratum of the 
trabeculectomy group. What is unknown is how Ricco’s area might have changed had 
the trabeculectomy procedure not been undertaken, and the patient had continued with 
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their previous treatment regime. It is possible that even though Ricco’s area enlarged 
between visits in the trabeculectomy group, it might have enlarged by a greater degree, 
had the patients not have received this surgery. This is illustrated in Figure 4.17. It 
might be assumed that, had the trabeculectomy procedure not been carried out just after 
visit 1 (V1 in the Figure), Ricco’s area would have reached a value of A, instead of B. 
However this cannot be ascertained, as we do not have a measurement from a period of 
time before the surgery. We only have one measurement taken up to 2 weeks before the 
surgery, so it is not possible to know the rate at which Ricco’s area enlarged before the 
first visit, and what trajectory the trend would have taken had the trabeculectomy not 
been performed.  
 
 
Figure 4.17. Graphical explanation of one of the hypothesis. B is where current Ricco’s 
area size is after trabeculectomy surgery. A is the possible Ricco’s area size if 
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trabeculectomy surgery had not been performed. However this cannot be ascertain as 
measurement was not taken some time before surgery. V1= visit 1, V2= visit 2. 
 
Even though trabeculectomy surgery eliminates issues of compliance with topical 
medication, it may be that the surgery is not as effective as one might hope, given that 
changes in Ricco’s area are measurable approximately 5.5 – 6 months following 
surgery. An alternative hypothesis is that the trabeculectomy did, in fact, slow down, or 
halt (in the case of the lower stratum), what might have been a greater change in Ricco’s 
area had the eye not undergone the trabeculectomy procedure. Again, it is difficult to 
confirm or refute these ideas, given that the pre-surgery rate of change of Ricco’s area is 
unknown. Such a study would require > 5 years of follow-up to establish baseline 
levels. Lowering IOP has previously been observed to improve visual function in some 
cases however this treatment method is mostly chosen because IOP is the only 
modifiable risk factor in glaucoma. In the absence of an alternative treatment that does 
not rely on patient compliance, and a longitudinal study observing the effects of 
intervention with trabeculectomy on a range of visual functions, one cannot make firm 
recommendations on the optimum treatment regime.  
 
It is possible that the slight reduction in overall Ricco’s area in stratum 1 is the result of 
recovery from what was originally RGC dysfunction and that the enlargement of 
Ricco’s area observed 6 months after surgery in strata 2 and 3 of the trabeculectomy 
group is due to a delayed neural compensation mechanism to RGC dropout i.e. that the 
trabeculectomy did, in fact, prevent further retinal damage, but that the visual cortex 
continued to recover thereafter. In support of the former point, it was hypothesised that 
dysfunction would occur in very early glaucoma, and the locations represented in 
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stratum 1 meet this criterion. In support of the latter notion, the findings in amblyopia 
(Chapter 3), together with evidence in previously published literature suggest that 
Ricco’s area represents spatial pooling at multiple hierarchies in the visual pathway, 
including cortical loci (Pan & Swanson 2006; Redmond et al. 2010a) (see Chapter 3 for 
a full review). Pan & Swanson (2006) demonstrate that spatial summation of perimetric 
stimuli cannot be accounted for by probability summation across RGCs, but rather 
multiple cortical pooling mechanisms. Therefore it is possible that changes in Ricco’s 
area observed in glaucoma participants, as measured with perimetric stimuli, have a 
cortical basis. Studies have shown that even when Ricco’s area enlarges with retinal 
eccentricity, the threshold at Ricco’s area is constant overall (Fischer 1973; Ransom-
Hogg & Spillmann 1980; Volbrecht et al. 2000; Wilson 1970). 
 
Swanson et al. (2004) reported that Ricco’s area covers, on average, 31 RGCs across 
the normal visual field. Based on this report, Redmond et al. (2010a) put forward a 
hypothesis to explain the larger Ricco’s area in glaucoma patients, relative to that in 
healthy controls. The hypothesis states that in the visual cortex, there are receptive 
fields of different area that receive input from different numbers of RGCs, and it is 
those receptive fields that receive input from 31 RGCs that determine the size of 
Ricco’s area. Therefore, if (for example) 8 RGCs are lost, the cortical receptive field 
previously determining the size of Ricco’s area would now receive input from only 23 
RGCs and no longer meet the criterion for determining the size of Ricco’s area. 
However, if a cortical receptive field that previously received input from 39 RGCs now 
receives input from only 31 cells, then its size determines the size of Ricco’s area. A 
similar hypothesis could be used to explain the findings of the current study (Figure 
4.18). It has previously been shown that the visual cortex has remodelling capabilities 
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under certain conditions. As discussed in Chapter 3, geniculocortical axon arbour 
complexity can change within a very short timescale, in response to interocular 
differences in visual input (Antonini & Stryker 1993). Laboratory work in monkeys 
(Gilbert & Wiesel, 1992) and rats (Linden & Perry 1982) has shown that when a 
cortical insult is inflicted, those adjacent cells involved in visual processing can extend 
their dendritic arbors to cover damaged areas. Therefore, it is not implausible that 
cortical, and thus visual adaptation can occur in response to RGC dropout. 
 
Healthy Stable glaucoma Progressive glaucoma 
First
Visit
Second
Visit
Input: 31 RGCs (healthy)
Sensitivity: 31dB
Input: 31 healthy RGCs
Sensitivity: 31dB
Lost 5 RGCs (red)
Enlarged: Recruited 5 RGCs 
(green)
Sensitivity: 31dB
Lost 5 RGCs (red)
Enlarged: Recruited 5 RGCs 
(green)
Sensitivity: 31dB
No further loss of RGCs
Sensitivity: 31dB
Lost further 12 RGCs (red)
Enlarged: Recruited 12 
RGCs (blue)
Sensitivity: 31dB
Figure 4.18. Hypothesis on possible cause of enlargement of Ricco’s area in the 
trabeculectomy group second visit. 
 
In conclusion although Ricco’s area does not change by a sizeable amount in stable 
glaucoma patients and healthy controls over an approximately 6 month period, there are 
observable changes in a group of patients who have undergone a trabeculectomy 
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procedure for lowering IOP. When surgically-induced changes in corneal aberrations 
were accounted for, these observable changes in Ricco’s area between visits remain, 
suggesting that they are, in fact, true neural changes, rather than optical in nature. 
Although, given the findings in amblyopia outlined in Chapter 3, as well as those 
reported in published literature, this is suggestive of a cortical adaptation mechanism, it 
cannot be ascertained, in the current study, how the rate of change in Ricco’s area was 
affected by IOP-lowering treatment. Changes in Ricco’s area between visits were 
modest and fell just short of statistically significant, but in the context of previously 
published literature on how Ricco’s area differs in glaucoma patients and healthy 
controls, this effect size is noteworthy. Importantly, these changes were observed in the 
absence of statistically significant changes in sensitivity to a conventional Goldmann III 
stimulus. Further analysis of the comparative utility of Ricco’s area measurements and 
sensitivity to a Goldmann III stimulus is described in Chapter 5, with a view to 
ascertaining whether novel perimetric methods, designed to map to the changing spatial 
summation function in glaucoma may have superior utility to conventional stimuli in 
identifying visual field damage and/or change over time. 
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Chapter 5: Signal/Noise Analysis for Comparison 
of Methods of Mapping to the Changing Spatial 
Summation Curve in Glaucoma 
 
5.1. Introduction 
RGCs have been observed to undergo subtle premorbid changes, including pruning of 
dendritic tree size and changes in axonal diameter, in experimental glaucoma (Morgan 
et al. 2006; Shou et al. 2003; Weber et al. 2000). This suggests that there may be a 
period of cell dysfunction before death in glaucoma. This raises the possibility that if 
the period of dysfunction can be identified and treated early then improvement in visual 
function may be possible. The goal of treatment for glaucoma is preservation of vision. 
Although several methods have been proposed to measure changes in glaucoma over 
time, including ocular imaging with technology such as OCT and scanning laser 
ophthalmoscopy, perimetry are the only way to quantify functional deficits or 
improvements. Perimetry is commonly used for the identification and monitoring of 
glaucoma in conjunction with imaging of the retinal nerve fiber layer and optic disc 
with techniques such as OCT and confocal scanning laser tomography. Structural 
measures can provide information about structural integrity of RGC, however just 
because RGCs are present, it does not mean that they are functionally healthy. 
Therefore, structural measurements cannot provide information on whether a RGC is 
sick, healthy, or recently dead. The conceptual model of Porciatti and Ventura (2012) 
illustrates this point. The model points out that, rather than a functionally sound cell 
undergoing spontaneous apoptosis, it likely undergoes a period of treatable dysfunction 
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before it dies and also there is time lag between loss of function and loss of structure. 
Figure 5.1 stage 1 illustrates an RGC in its normal state. With an increase in IOP, the 
cell undergoing stress becomes dysfunctional (stage 2). At this stage, it may be possible 
to recover the health of the cell if appropriate and adequate treatment were to be 
administered. If IOP were to increase further, the RGC would then undergoes apoptosis 
(stage 3). From this stage onwards, no residual function would be left in the RGC. 
However the presence of the death RGC would still be measurable with imaging 
techniques, as its cell body would not have disappeared. According to the model, in 
order to prevent cell loss, treatment would have to be administered at stage 1 or 2. 
 
Figure 5.1. Conceptual model for RGC dysfunction and death by Porciatti and Ventura. 
Picture taken from Porciatti and Ventura (2012) 
Although several studies of optimum methods for glaucoma detection claim that 
structural loss occurs prior to functional loss (Kamal et al. 1999; Kamal et al. 2000; 
Kerrigan-Baumrind et al. 2000), it is difficult to understand how cells can retain 
function but lack structure or be absent altogether. Thus, it is more likely that high 
variability in current clinical functional techniques (Artes et al. 2002; Henson et al. 
2000; Wall et al. 2009) mean that they lack the required sensitivity to identify pre-
morbid changes in RGCs. 
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SAP remains the clinical standard for identifying and following functional visual loss 
over time in glaucoma. Despite its clinical standard status, as discussed extensively in 
Chapter 1, it has three cardinal limitations. Firstly, it has low sensitivity for subtle 
changes in early disease (Tafreshi et al. 2009). Although test-retest variability is lowest 
in early disease (Artes et al. 2002), it is unacceptably high if one wishes to identify 
differences from normality. Secondly, variability increases with depth of defect (Artes 
et al. 2002; Henson et al. 2000), meaning that it is more difficult to identify changes 
over time in glaucoma that is already established. Thirdly, it has a limited dynamic 
range and very high test-retest variability in advanced disease, in that remaining vision 
cannot be accurately quantified (if at all), and the limits of variability span almost the 
entire measurement range (Artes et al. 2002), thus making it difficult to distinguish true 
progression from variability of test results. Chauhan et al. (2008) performed a 
simulation of perimetric variability on different rates of change in sensitivity over time 
and found that, for example, if two visual field examinations are performed per year 
with SAP, it would take 8.5 years to identify mild progression (-0.25dB/year) in the 
presence of moderate variability (with statistical power of 80%). Considering that, in 
many clinics, only one visual field is typically undertaken every year (or sometimes 
even over a longer period), the time taken to identify subtle visual field damage will be 
much greater. Many attempts had been made to improve the ability to identify 
functional loss, such as the creation of new types of perimetry tests e.g. FDT and SWAP 
(Bayer & Erb 2002; Johnson et al. 1993; Sample et al. 1993). Caution should be 
exercised when interpreting research comparing SWAP and FDT to SAP, as some are 
limited by participant selection bias, in that they recruited participants with normal SAP 
but normal SWAP or FDT, or vice versa. The utility of these more recently developed 
tests has been inconclusive, predominantly owing to difficulty in directly comparing the 
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tests with the clinical standard (a more extensive discussion can be found in Chapter 1), 
because of the use of different stimuli, measurement scales, and measurement ranges to 
those used in SAP. Furthermore, the tests have different normative databases that have 
their own ranges, each determined with the previously mentioned different stimuli and 
measurement scales. 
 
Other methods for improving the ability to identify glaucoma and changes in sensitivity 
over time are the development of statistical paradigms, aimed at disentangling the signs 
of true damage (signal) from variability (noise). Artes & Chauhan (2009) developed a 
statistical technique to estimate the signal/noise ratio (SNR) for hemifield differences in 
sensitivity, which they then compared between SAP and FDT in the same cohort of 
glaucoma patients. To calculate signal, they took the mean of 6 visual field sector mean 
deviations (sMD) inferior visual field from the mean of 6 sMDs in the superior field and 
constructed a null distribution of differences in sMD for all patients, for 36 different 
combinations of test order. The signal was the mean of the distribution and the noise 
was the standard deviation. In this way, they were able to compare the utility of SAP 
and FDT, two techniques independently of stimulus configuration and measurement 
scale, and without the need for normative databases. They found that, on average, SNR 
was greater for FDT than for SAP when identifying hemifield differences. Although this 
analysis was useful in determining the utility of the two tests in identifying such 
differences, it could not be assumed that FDT had superior utility for identifying 
progression. On the basis of the findings of Artes & Chauhan (2009), Redmond et al. 
(2013a) used permutation of pointwise linear regression (PoPLR) (O’Leary et al. 2012), 
a technique based on SNR analysis, to compare the utility of FDT and SAP in 
identifying overall change over time in patients enrolled in a longitudinal visual field 
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study. This technique was designed to report whether or not there was statistically 
significant overall visual field deterioration. This analysis also allows techniques to be 
compared independently of stimulus configuration, measurement scale, and normative 
databases. They found that, despite the greater cross-sectional SNR for FDT (Artes & 
Chauhan 2009), SAP identified more instances of change over time than FDT.  
 
Accurate identification of change over time in glaucoma is important for the initiation 
of timely, and thus more successful, treatment, and a larger amount of attention has 
been given to this over the past few decades (for an extensive review please refer to 
Vianna & Chauhan,  2015). However the findings of this research have been poorly 
translated to clinical practice. One of the contributing factors is that some research was 
undertaken on laboratory equipment that limits its ability to be readily translated into 
the techniques available with clinical equipment. Patients are familiar with SAP, and 
many clinics have many years’ worth of data on which to base clinical decisions. The 
introduction of a new test strategy with a very different appearance or task for the 
patient can potentially cause problems such as new learning effects that could last over 
several visits, affecting continuity and thus the ability to identify pathological change 
over time. These new strategies also might not allow for direct comparison with patients 
previous SAP clinical data. Although the current parameters of SAP were imported 
directly from kinetic perimetry without any scientific basis, and at a time when the 
pathophysiological basis for glaucoma was not well understood, the risks to continuity 
associated with a major change in the task for the patient are too great. What is needed, 
therefore, is an optimization of the parameters used in SAP to enable greater sensitivity 
to glaucoma in the first instance as well as to changes over time. As shown in Chapter 4, 
Ricco’s area was enlarged in the second research visit, relative to that in the first visit, in 
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patients who had undergone trabeculectomy surgery, with no notable difference in 
Goldmann III sensitivity in the same test locations. Redmond et al. (2010a) also 
previously showed an enlarged Ricco’s area in clinically normal visual field locations of 
glaucoma patients, glaucoma patients, relative to that in age similar healthy participants. 
They indicated that, on average, sensitivity loss to a Goldman III stimulus in glaucoma 
could be mapped to the horizontally-displaced spatial summation curve. Therefore, it is 
probable that clinical measures of Goldmann III sensitivity loss are simply measures of 
displacement of the spatial summation curve. Considering the schematic spatial 
summation curves in Figure 5.2, this measurement could be considered inefficient, in 
that the effect of a horizontal displacement of the curve is smallest where the slope is 
shallow (i.e. when the stimulus is larger than Ricco’s area) and the stimulus is varying 
in contrast (along the y-axis). The largest ‘signal’ associated with a horizontally 
displaced spatial summation curve should be encountered when measuring the 
difference between the curves along the area axis (x-axis) within Ricco’s area (vector A 
in Figure 1; vector B shows the ‘signal’ for a conventional Goldmann III varying in 
contrast). Changes in Ricco’s area are a direct measure of this ‘signal’. As there is a 
larger theoretical signal at vector A: (changes in Ricco’s area) than at vector B (changes 
in Goldmann III sensitivity) it could be that progression is better determined by 
measuring the horizontal displacement of the spatial summation curve with a stimulus 
scaled to Ricco’s area, varying in area, than with a Goldmann III stimulus varying in 
contrast. In other words, the disease signal might be boosted if one measures the 
horizontal difference between spatial summation curves, within Ricco’s area than the 
vertical distance between curves outside Ricco’s area (as is the case with a Goldmann 
III). Indeed, in a recent study comparing different stimulus paradigms optimised for 
measuring altered spatial summation in glaucoma, stimuli smaller than Ricco’s area, 
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varying in area showed a significantly greater SNR than conventional Goldmann III 
stimuli (Rountree et al. 2018) for identification of glaucomatous damage. Area-
modulated stimuli demonstrated more uniform response variability with increasing 
damage, and therefore hold promise for identification of deterioration over time also. 
Area-modulated stimuli were not employed in the current study, but it is possible to 
understand the likely utility of such measurements in the current study by calculating 
the longitudinal SNR for measurements of Ricco’s area relative to measurements of 
Goldmann III sensitivity. 
The purpose of this study was to investigate whether, in a short timescale, 
measurements of changes in Ricco’s area over time (herein referred to as the Ricco’s 
area method or RA method) offer a higher SNR than measurements of changes in GIII 
sensitivity (herein known as the Goldmann III method or GIII method). If the RA 
method reveals a higher SNR than the GIII method, the finding could be used in support 
of the employment of area-modulated stimuli (within Ricco’s area) for identification of 
glaucomatous damage over time in the clinical setting. 
 
Figure 5.2. Schematic spatial summation curve for two points in time, assuming 
progression between the two visits (blue symbols: visit 1; pink symbols: visit 2). A 
larger signal to damage might be encountered when measuring the displacement of the 
spatial summation curve along the area axis within Ricco’s area (A) than when 
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measuring vertical displacement in the curves (difference along the intensity axis) for a 
Goldmann III stimulus outside Ricco’s area (B). The length of arrows A and B denotes 
the disease signal. 
 
In this chapter comparison of SNR for the RA and GIII methods are compared with data 
collected over a 6 months interval was performed. One difficulty in comparing the 
utility of different instruments and tests in identifying change over time is that they are 
often on different measurement scales and have different units. This is also the case in 
the current study. Ricco’s area measurements are in deg2 while Goldmann III sensitivity 
measurements are in decibels (dB). The problem of having different measurement scales 
can be addressed by comparing signal-to-noise ratio (SNR) for between-visit 
differences in RA and Goldmann III sensitivity. The method of Artes & Chauhan 
(2009) is unsuitable for our aim as they were investigating cross-sectional hemifield 
data. In addition, their method of comparing mirror sectors may have masked diffuse 
loss of sensitivity in glaucoma. Similarly, PoPLR is inappropriate for use in the current 
study as this is a trend-based analysis, rather than an event-based analysis, as is required 
in the current study. Gardiner et al. (2013) compared the longitudinal SNR of SAP and 
OCT by applying linear regression of mean deviation (MD) of SAP and retinal nerve 
fiber layer thickness of OCT over time. They then used the rate of change over time 
(slope) as signal and standard deviation (SD) of the residuals as the noise measure. 
However the decibel scale is a logarithmic scale, while the retinal nerve fiber layer 
thickness scale is linear. Using linear trend lines on a decibel scale over time might not 
be the best methodology as it could give larger estimates of noise in MD residuals with 
increasing depth of defect (heteroscedasticity). Here, an alternative approach for event-
based analysis of SNR is described. 
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5.2. Methods 
Data for this study were the same as those described in Chapter 4. Participant 
characteristics, psychophysical methods (including apparatus and stimuli), and analysis 
used to determine Ricco’s area and Goldmann III thresholds are described in detail in 
Chapter 4, but are briefly outlined below for clarity. 
 
5.2.1. Participants 
A comprehensive overview of participant characteristics can be found in Chapter 4. The 
difference in this chapter is that only data from participants that completed 2 visits are 
included. Nine glaucoma patients who were listed for trabeculectomy surgery 
(‘trabeculectomy group’; median age [IQR]: 67 [58, 77.50] years) and 20 stable 
glaucoma participants (‘stable glaucoma group’; median age [IQR]: 69 [62.50, 76.50] 
years) were recruited from the glaucoma clinic in the University Hospital of Wales. 
Twenty healthy participants (‘healthy group’; median age [IQR]: 67 [63.25, 71.75] 
years) were recruited from the database of Cardiff University eye clinic. Severity of 
glaucoma is classified based on Hodapp-Parrish-Anderson criteria. The trabeculectomy 
group had a range of visual field loss from early to advanced with median MD [IQR] 
visit 1: -5.27 [-8.70 to -3.50] dB; median MD (IQR) visit 2: -5.06 [-11.56 to -1.36] dB. 
The stable glaucoma group had minimal to early visual field damage in both visits 
(median MD [IQR] visit 1: -1.88, [+1.10 to -8.13] dB; median MD [IQR] visit 2: -1.15 
[+3.83 to -8.21] dB. 
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5.2.2. Apparatus and stimulus 
Stimuli were achromatic circular stimuli, presented on a white background (10 cd/m2) 
for 200 ms. Five different stimulus sizes were used, Goldmann sizes I-V (0.11°, 0.22°, 
0.43°, 0.87° and 1.7° diameter). An Octopus 900 perimeter (Haag Streit, Koeniz, 
Switzerland), controlled with the Open Perimetry Interface, was used to present the 
stimuli at 8 visual field locations at eccentricities of 12.7° and 21.2° (Figure 4.3 in 
Chapter 4).  
 
5.2.3. Thresholding procedure 
Achromatic contrast detection thresholds were measured for each of the Goldmann sizes 
I-V in a randomized order. A 4:1 staircase procedure was used, which was adapted from 
that produced by Andrew Turpin and Luke Chong (University of Melbourne, 
http://people.eng.unimelb.edu.au/aturpin/opi/interface.html, accessed on 15th March 
2014; adapted code can be found in Appendix 2). The initial step size was 4 dB until the 
first reversal was encountered, after which point it reduced to 1dB. A yes/no response 
criterion was used. At each location, the procedure stopped after 8 reversals and the 
final threshold returned was taken as an average of sensitivity at the final 4 reversals. 
The entire procedure was repeated twice more, such that for each participant, 3 sets of 
threshold measurements were obtained for each Goldmann size (a total of 15 sets of 
threshold measurements per participant). All procedures were carried out with natural 
pupil sizes and central refractive error corrected fully with full aperture trial lenses. 
Fixation was monitored visually and eye position was adjusted when the pupil moved 
from the optimum position in the eye monitor. Breaks were given approximately after 
every 10 minutes, with additional breaks granted when requested by the patient.  
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5.2.4. SNR procedure 
Whereas many previous studies have compared clinical tests based on disease signal or 
variability separately, Rountree et al. (2018) point out the importance of considering 
both simultaneously, as a signal/noise ratio. In the current study, signal, noise, and SNR 
were calculated for a) the difference in Ricco’s area between visits (RA method) at each 
location in each individual, and b) the difference in predicted Goldmann III threshold 
(GIII method) between visits at each location in each individual. The procedure for 
calculating SNR is described as follows, with reference to Figure 5.3.  
 
Signal 
Ricco’s area values used to calculate the signal are the same as the Ricco’s area data in 
Chapter 4. In summary, the three threshold values for each of the Goldmann I-V were 
averaged to give one threshold value for each of the Goldmann sizes. For example, in 
Figure 5.3, the threshold for a Goldmann I stimulus in visit 1 was calculated as mean(A, 
B, C), threshold for a Goldmann III in visit 2 was calculated as mean(V, W, X), etc. 
Two-phase regression analysis was applied to averaged threshold data to obtain a spatial 
summation curve, and thus a Ricco’s area estimate, per location per visit. The difference 
in Ricco’s area (ΔRA) and difference in predicted GIII thresholds from the fitted curves 
(ΔGIII) between first and second visits was calculated, and taken as the signal for the RA 
and GIII methods respectively. This procedure was repeated for each of the 8 test 
locations in each participant. Data were then averaged to give 1 final signal value per 
method per participant. 
Noise 
Given that the threshold for Goldmann I-V was measured 3 times for each location per 
visit, 3 values were available for each of the Goldmann I-V stimuli per visit. This is 
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illustrated in the Tables in Figure 5.3. For example, at each location, threshold 
measurements for the Goldmann I stimulus on the first visit were named A, B, and C, 
and each of the three threshold measurements for the GIII stimulus on the second visit 
were named P, Q and R etc. Instead of averaging by stimulus area, as in the calculation 
of the signal, a program was created to randomly select one of the three values for each 
stimulus area per location for each visit. An example is shown in Figure 5.3, where the 
pink shaded areas in each of the tables indicate randomly chosen thresholds per stimulus 
area per location. With these data, two spatial summation functions were determined, 
one for each visit. Two-phase regression analysis was then applied to the randomly 
selected Goldmann I-V threshold values to obtain a Ricco’s area estimate for each visit. 
The difference in Ricco’s area estimates between visits (ΔRA = Ricco’s area, visit 2 – 
Ricco’s area, visit 1) was calculated. The difference between the fitted two-phase 
regression lines for an area of -0.84 log deg2 (GIII) was also calculated (ΔGIII). The 
entire procedure was repeated, with both ΔRA and ΔGIII calculated each time. As there 
are 3 available values for each of the Goldmann sizes, 243 (3x3x3x3x3) sets of 
threshold data were permuted and thus 243 ΔRA and ΔGIII values were estimated per 
location. Therefore for each participant at each visit, a total of 1944 ΔRA and ΔGIII 
estimates were obtained across 8 different test locations. Spatial summation curves were 
excluded if R2 <0.9. Null distributions of ΔRA and ΔGIII values were constructed. The SD 
of each of these distributions was taken to represent the noise for each method. The 
aforementioned process was repeated for all participants.  
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Figure 5.3. SNR protocol for Ricco's area calculation on each participant. 
 
Signal/noise ratio 
Signal values were calculated for individual participants per location and then averaged 
to give one signal value per participant. Therefore, 9 signal values were obtained for the 
trabeculectomy participants, 20 for stable participants and 20 for the healthy participants 
for each method. Noise values were also averaged per location and then per participant. 
Therefore, for each method, one value per participant was obtained. To calculate SNR 
signal was divided by noise for each method and for each participant. Signal was then 
averaged across all participants per participant groups, per method and the same was 
done for the noise.  
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5.2.5. Data analysis  
The average signal and average noise values were then compared between RA and 
Goldmann III data across the same participant group to explore differences between 
signal and noise separately between the two methods. A comparison was also made 
between different participant groups to investigate whether signal and/or noise differ 
substantially between participant groups for each method. Mean SNR was calculated for 
the RA and GIII methods for each of the participant groups, to investigate whether the 
RA method demonstrates a greater signal/noise ratio longitudinally than the GIII 
method. The standard deviation of SNR values was calculated to investigate whether 
there was greater variance in the SNR for one method over the other and between 
participant groups.  
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5.3. Results 
Table 5.1. Mean and SD of signal, noise and SNR of the RA and GIII methods in all 
participant groups. T=trabeculectomy group; S=stable glaucoma group; H=healthy 
group. 
Participant 
groups 
Data  
types 
RA method GIII method 
Mean SD Mean SD 
T signal 0.32 0.23 0.25 0.32 
noise 0.34 0.18 0.93 0.47 
SNR 2.04 1.25 0.41 0.6 
S signal 0.2 0.12 0.02 0.58 
noise 0.33 0.15 0.73 0.36 
SNR 1.11 0.68 0.21 0.84 
H signal 0.16 0.2 1.11 0.73 
noise 0.23 0.08 1 0.52 
SNR 1.34 0.96 0.94 0.95 
 
The signal is higher in stable glaucoma and trabeculectomy groups with the RA method 
when compared to the Goldmann III method (Table 5.1). The noise is smaller with the 
RA method for all participant groups. The SNR is larger across all participant groups 
for the RA method than for the Goldmann III method. It is worth noting that the SNR in 
the trabeculectomy group is substantially larger with the RA method than for the GIII 
method. The SD of SNR values in the trabeculectomy group is larger for the RA 
method than for the GIII method. The SD of SNR values in the stable glaucoma group 
is smaller for the RA method than for the GIII method, while in the healthy group the 
SD of SNR values is comparable between methods.  
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Figure 5.3, Scatterplots with lines of equality for all participant groups. The deeply 
shaded area emphasizes SNR values below zero and the lightly shaded area marks SNR 
values from 0-1. 
 
Based on Figure 5.3, a greater number of data points fall above the line of equality, 
indicating that there are more participants for whom SNR with the RA method is greater 
than that with the GIII method. This observation is consistent in all participant groups, 
when data are partitioned into two strata: a) 0 < SNR < 1, and b) SNR > 1. In addition, 
almost all of the SNR values are > 0 for both methods, indicating that, for the most part, 
Ricco’s area enlarges and Goldmann III sensitivity is reduced in visit 2, compared with 
visit 1. 
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5.4. Discussion 
The purpose of this study was to investigate whether, in a short timescale, 
measurements of changes in Ricco’s area over time offer a higher SNR than for 
measurements of change in GIII sensitivity.  
 
With SAP, tests need to be repeated multiple times per year before progression of visual 
field damage can be ascertained with a high degree of confidence (Chauhan et al. 2008). 
A test with a high cross-sectional SNR is needed clinically for identification of 
glaucoma in the first instance. Similarly, a high longitudinal SNR is needed for a 
confident and timely identification of deterioration over time. If variability (noise) is 
high and masks true change (signal), then much time will have passed, and a great deal 
of damage will have occurred, before a confident identification of change is made. In 
the current study it can be observed that the SNR is higher for the RA method than that 
for the GIII method in all participant groups. This suggests that the RA method (or 
similar method for measuring the horizontal separation of spatial summation curves 
between visits) has greater utility for the identification of deterioration in the visual field 
over time than the conventional method of measuring changes in sensitivity to a 
Goldmann III stimulus. The estimated global rate of visual field deterioration per year is 
-0.22 dB (range: -4.9 to +1.9), -0.46 dB (range: -8.7 to 0.2) and -1.13dB (range: -11.3 to 
-0.1) for untreated NTG, Primary OAG, and pseudoexfoliative glaucoma respectively 
(Heijl et al. 2003), while for treated Primary OAG and pseudoexfoliative glaucoma, the 
rate of deterioration is −0.80 dB/year (range: −5.58 to +1.24) (Heijl et al. 2013). 
Pseudoexfoliative glaucoma has a more advanced rate of deterioration compared to 
other glaucoma types. Considering that the glaucoma groups included in the current 
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study protocol were Primary OAG and NTG, and that measurements were only taken at 
2 visits spaced 6 months apart, it is unsurprising that no meaningful differences were 
observed in our Goldmann III threshold measurements between visits for 
trabeculectomy and stable groups. This is evidenced in Table 4.5 in Chapter 4, that 
compared the values for sensitivity to a Goldmann III obtained between 2 visits. In the 
current chapter, SNR is substantially lower with the GIII method than with the RA 
method for both trabeculectomy groups. Although no meaningful inter-visit difference 
in Ricco’s area estimates was observed in the stable group (Chapter 4), the RA method 
nonetheless demonstrated a greater SNR compared to the GIII method in this chapter. 
The SNR was observed to be positive with both methods in most participants in the 
healthy and stable glaucoma groups, indicating an enlargement of Ricco’s area or 
reduction in sensitivity to a Goldmann III stimulus between visits. This could suggest 
that the analysis is sensitive to subtle changes over time, or it could just indicate normal 
fluctuations of measurement technique. The fact that the majority of SNR values were 
greater than 0, particularly for the glaucoma groups, indicates that this is a real effect 
that is being observed within a very short timescale, rather than simply measurement 
noise. The mean SNR is closer to 0 for the healthy control group (in which one would 
expect no meaningful change over time), which lends further support to this argument.  
 
A six-month timescale was chosen for the study because Ricco’s area was previously 
observed to change in clinically normal regions of the visual field in glaucoma and 
considering that, in a clinical setting, 2-3 visual field examinations are recommended 
per year (i.e. a 3-6 month interval), it is reasonable to investigate whether or not changes 
are observable over such a short timescale. Secondly it was considered essential to 
ensure that our participants with stable glaucoma were in fact stable, particularly for the 
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experiments outlined in Chapter 4. If the timescale of investigation were too long, then 
progression may have occurred in the stable participant group, and it would have been 
difficult to identify effects specific to the trabeculectomy group. It was therefore  
considered prudent to ensure that any effects observed within the trabeculectomy group 
could be solely attributed to particulars for that group (e.g. treatment). Thirdly, the main 
research objective was to look for very subtle changes in response to pressure-lowering 
treatment. Measurements of Ricco’s area immediately after lowering of pressure 
(Chapter 4) could provide insight into how the visual system adapts after treatment.  
 
In conclusion, the SNR was higher in all-participant groups for the RA method 
compared to the GIII method. This suggests that a clinical test, optimised to map 
changes in spatial summation in glaucoma (e.g. a stimulus smaller than, but scaled to 
Ricco’s area, modulating in area) could have greater utility in identifying visual field 
deterioration (or improvement) over a short timescale than a test employing 
conventional Goldmann III stimuli. It should be noted that measurements of Ricco’s 
area or spatial summation curves are not advocated here for use in clinical practice. 
Such a procedure would be much too time consuming. Rather, the findings provide 
some evidence that a change in sensitivity to a Goldman III stimulus is an inefficient 
measure of subtle visual field deterioration in glaucoma, and that a better method might 
be to undertake a test employing a stimulus that is optimised to follow the changing 
spatial summation curve (Rountree et al. 2018). Additionally, data were gathered with a 
clinically available instrument suggesting that it is possible to measure such subtle 
changes with existing clinical instrumentation, albeit with an optimised approach. 
Therefore, if the task of the patient is unchanged with the optimised approach, it might 
be expected that any required adaptation to the new test strategy by patients and 
perimetrists could easily be overcome.
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Chapter 6 Conclusion and Future works 
 
The main objective of this PhD was to investigate, with measurements of Ricco’s area 
before and after the commencement of rigorous IOP-lowering treatment on subjects 
with glaucoma, whether or not visual consequences of RGC dysfunction (as separate to 
death) are observable. Based on the finding of Redmond et al. (2010a) that Ricco’s area 
is larger in early glaucoma than in healthy controls, the hypothesis was that an 
observation of any shrinkage of Ricco’s area after IOP-lowering treatment would be 
suggestive of recovery from pre-morbid dysfunction, whereas the absence of shrinkage, 
or indeed a continued enlargement of Ricco’s area would be suggestive of RGC death 
or cortical adaptation to RGC death. As such, Ricco’s area estimates were compared 
with those in participants with stable glaucoma as well as healthy individuals (both 
control groups).  
In order to investigate this, a series of experiments was conducted in Chapter 2 to find 
the optimum test parameters for the measurement of spatial summation (specifically, 
Ricco’s area) to be used in the main experiments, described in subsequent chapters. The 
most suitable experimental apparatus, number of stimuli, thresholding algorithm, and 
test locations were carefully considered through a review of published literature and by 
conducting preliminary experimental tests. It was decided that the Octopus 900 
perimeter was the most appropriate apparatus for measuring spatial summation in 
glaucoma patients. Goldmann I – V stimuli were found to sufficiently sample the spatial 
summation curve across much of the visual field regions of interest, thus experiments 
entailed measurements of sensitivity (converted to threshold) to these stimuli. It was 
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decided that, on balance, a test paradigm incorporating a 4:1 staircase algorithm, 
terminating after 8 reversals (and threshold taken as an average of the last 4 reversals), 
to measure threshold at 8 visual field test locations enabled the measurement of good 
quality spatial summation curves (with R2 >0.9 and minimal failure of spatial 
summation curve fitting) within a reasonable time period. Given that the spatial extent 
of perimetric stimuli on the retina could be changed due to uncorrected (or ill-corrected) 
refractive error, the effect of dioptric blur on measurements of Ricco’s area was 
quantified. Such effects were minimal, for up to 3.00D of induced blur, and were not 
statistically significant. It was considered that a change in corneal wavefront aberrations 
post-trabeculectomy surgery could potentially affect the retinal image size formed 
between visits, and thus give rise to an apparent change in the neural contribution to 
Ricco’s area. Therefore, between-subject and between-visit variance in corneal 
wavefront measurements (specifically, Zernike polynomial coefficients up to the 6th 
radial order) were also investigated over 5 visits in a small number of healthy 
individuals in order to contextualise any surgically-induced changes found as part of the 
main experiments. Finally, an exploratory study of any potential learning effect on 
measurements of Ricco’s area was conducted, in order to investigate how many times 
Ricco’s area was required to be measured before and after surgery so that accurate 
surgery-related effects on sizes could be established. Although it is widely documented 
in published literature that initial measurements of visual field sensitivity with SAP are 
usually discarded due to a learning effect, such a learning effect was not anticipated for 
measurements of Ricco’s area (it was considered almost impossible for subjects to learn 
or bias the position of the breakpoint on the spatial summation curve, because of the 
randomization of tests of sensitivity to different stimulus sizes). No learning effect was 
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observed, and therefore it was decided that initial measurements would not need to be 
discarded in the main experiments. 
Redmond et al. (2010a) showed that when the difference in Ricco’s area between 
glaucoma patients and healthy controls was taken into account, sensitivity to a range of 
perimetric stimulus areas overlapped between the two groups. This finding supported 
previous publications describing the importance of spatial summation in the 
determination and interpretation of perimetric sensitivity. Pan & Swanson (2006) 
demonstrated that probability summation across RGCs could not account for spatial 
summation of perimetric stimuli, but rather cortical pooling by multiple spatial 
mechanisms. An overview of findings from the literature suggests that losses of 
sensitivity to fixed-area perimetric stimuli may be an indirect measurement of a 
displaced spatial summation curve, arising from changes in spatial pooling at a cortical 
level.  
In order to better understand the physiological basis for Ricco’s area (the second 
objective of this PhD) and the mechanisms involved in determining sensitivity to a 
perimetric stimulus, an investigation of spatial summation in amblyopia was conducted. 
Amblyopia is a condition in which retinal receptive fields have previously been shown 
to be normal, and one in which functional deficits are largely attributed to regions of the 
visual cortex. Therefore, an investigation into changes in Ricco’s area in amblyopia was 
undertaken, in order to provide an improved understanding the physiological basis for 
Ricco’s area, and by extension, possible explanations for the change in Ricco’s area in 
glaucoma. It was observed that Ricco’s area is larger, compared to that in healthy 
controls, when measured through amblyopic eyes, and smaller than that in healthy 
controls when measured through non-amblyopic eyes. In healthy observers, it was 
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observed that Ricco’s area is smaller, when measured binocularly, than when measured 
monocularly. In amblyopic participants, binocularly-measured Ricco’s area is smaller 
than monocularly-measured Ricco’s area through the amblyopic eye, and larger than 
that measured through the non-amblyopic eye. A likely basis for these findings is in 
layer 4 of V1, where dendritic arbors of geniculocortical cells from the non-amblyopic 
eye have previously been shown to be more complex, and those from the amblyopic eye 
have been shown to be less complex. These arbors have the potential for greater and less 
spatial pooling, respectively. This finding has important implications for glaucoma, as it 
adds to the growing literature suggesting that spatial summation of perimetric stimuli 
has a cortical origin. 
Redmond et al. (2010a) hypothesized that the larger Ricco’s area in glaucoma patients 
is due to a switch in the spatial frequency channel that determines Ricco’s area, based 
on the report that approximately 31 RGCs underlie Ricco’s area across the visual field 
(Swanson et al. 2004). In many perimetry studies in glaucoma, it is generally assumed 
that a loss of visual function is due to RGC death, but as previously mentioned, it is 
possible that early deficits may be a result of RGC dysfunction. If RGCs become 
dysfunctional before death, one might reasonably assume that the visual cortex receives 
fewer signals from these cells. Assuming the hypothesis of Redmond et al. (2010a) is 
correct, a switch in the spatial frequency channel determining Ricco’s area should take 
place in response to dysfunction, given that signals to that channel ordinarily 
determining Ricco’s area are reduced in number or weighting. A spatial frequency 
channel that previously pooled signals from a greater number of RGCs (> 31 RGCs), 
but because of RGC dysfunction, now pools signals from exactly 31 RGCs, would 
determine Ricco’s area in these patients. However, should dysfunctional cells recover in 
response to rigorous IOP-lowering treatment, the spatial frequency channel determining 
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the larger Ricco’s area should regain lost signals, in which case it would pool signals 
from > 31 RGCs once more. If all dysfunctional RGCs were to recover, the spatial 
frequency channel originally determining Ricco’s area would re-recruit signals, 
enabling it to meet the critical number of inputting RGCs (31 RGCs) once again. This 
would manifest as a shrinkage of Ricco’s area from a previously enlarged state. On the 
other hand, if RGCs had died, rather than become dysfunctional, they would not recover 
in response to IOP-lowering treatment, and Ricco’s area would not be expected to 
shrink to normal (or near-normal) levels. In fact, depending on the timescale for cortical 
adaptation to RGC loss, Ricco’s area might continue to enlarge for a period following 
damage, despite any cessation in further RGC death. It is difficult to ascertain whether 
the enlargement of Ricco’s area in glaucoma is a response to cell sickness or cell death 
by undertaking a cross-sectional study. Therefore, a longitudinal study in which Ricco’s 
area is compared before and after commencement of a more rigorous treatment such as 
trabeculectomy surgery, would provide an opportunity to test this hypothesis. In the 
study outlined in Chapter 4, Ricco’s area was measured over 2 visits in participants 
listed for trabeculectomy surgery during the course of their clinical care. Experiments 
were undertaken once within 2 weeks before the surgery and once approximately 6 
months after the surgery. Identical experiments were undertaken on two control groups: 
a cohort of participants determined to have stable glaucoma by the hospital eye service, 
and a cohort of healthy participants. When Ricco’s area estimates were compared 
between visits over this short timescale, it was observed that Ricco’s area of participants 
that had undergone trabeculectomy surgery showed a slight overall reduction from the 
first to the second visit in those location with very early damage, but an enlargement 
from first to the second visits in those locations with early-moderate-advanced damage, 
although these differences were not statistically significant overall. In the control 
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cohorts, minimal or no overall change in Ricco’s area was found between visits. 
Although the effect of participant type on between-visit changes in Ricco’s area was not 
found to be statistically significant (though it was borderline significant), the effect size 
in trabeculectomy patients was greater than that of the stable glaucoma group by a 
meaningful amount. Furthermore, a reduction in Ricco’s area in one disease stratum and 
an enlargement in the other two strata may account for the lack of statistical significance 
of an overall effect of participant type. The potential effect of between-visit differences 
in aberrations on measurements of Ricco’s area, particularly in the trabeculectomy 
group, was investigated in a linear mixed effects model of effects on between-visit 
differences in Ricco’s area that included participant type, subject, and test location. No 
statistically significant effect of between-visit difference in aberrations was found on the 
between-visit difference in Ricco’s area. The size of the effect of participant type on 
between-visit differences in Ricco’s area was largely unchanged when between-visit 
differences in aberrations were included in the model. This finding, along with the lack 
of an effect of dioptric blur on Ricco’s area measurements in healthy individuals 
(Chapter 2), suggests that optical factors are not sizeable contributors to between-visit 
differences in Ricco’s area in the study described in Chapter 4. Taking into account the 
findings of the study of Ricco’s area in amblyopia (Chapter 3), it is entirely possible 
that the changes observed in the trabeculectomy group are the result of cortical changes 
in response to RGC dysfunction (stratum 1), and death (strata 2 and 3). Indeed, animal 
studies of induced damage in the visual cortex have shown changes in dendritic arbors 
of remaining healthy cells over a period of time after the initial insult (Gilbert & Wiesel, 
1992). Changes in Ricco’s area were observable even over a very short timescale, in the 
absence of statistically significant changes in Goldmann III sensitivity measured over 
the same time period.  
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Lastly, the third objective of this PhD was to investigate whether, in a short timescale, 
measurements of changes in Ricco’s area over time offer a higher SNR than for 
measurements of change in GIII sensitivity. Given the findings in Chapter 4, a statistical 
comparison of the signal/noise ratio (SNR) for changes in Ricco’s area and Goldmann 
III sensitivity measurements in glaucoma was conducted, to assess whether novel 
perimetric methods using a stimulus scaled to Ricco’s area, that measure the horizontal 
displacement of the spatial summation function in glaucoma, are likely to be superior in 
identifying change over time in glaucoma. Measurements of inter-visit differences in 
Ricco’s area were observed to offer a higher longitudinal signal/noise ratio when 
compared to measurements of differences in Goldmann III sensitivity. This thesis does 
not advocate the measurement of Ricco’s area or spatial summation curves in glaucoma 
clinics, but the findings do provide support for the hypothesis that stimuli optimised to 
map changes in spatial summation in glaucoma (Rountree et al. 2018) may have a 
higher longitudinal SNR than conventional Goldmann III stimuli. 
Study limitations 
Although changes in Ricco’s area were observed between visits in the trabeculectomy 
group, true dysfunction or death of RGCs (i.e. the ground truth) cannot easily be 
ascertained in specific locations in the human retina in vivo. As the term suggests, 
dysfunction can only be measured with a functional test. In this study, it is possible that 
there is indeed a recovery of RGCs from a dysfunctional state, and that trabeculectomy 
actually succeeded in halting progression by reducing what would otherwise have been 
a greater enlargement. However, a change in trajectory cannot be ascertained as 
measurements of Ricco’s area were obtained on two visits only. One measurement was 
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taken up to 2 weeks before the surgery and the other was taken approximately six 
months after the surgery. 
The finding of a smaller Ricco’s area in the non-amblyopic eye of amblyopic 
participants in Chapter 3 is suggestive of greater visual acuity in the non-amblyopic eye. 
However, this finding was unexpected, and therefore spatial acuity at the test locations 
was not measured prospectively. Although beyond the scope of this thesis, ongoing 
separate work within our group is aimed at better understanding the functional 
capabilities of the non-amblyopic eye of amblyopic individuals. 
Future study 
In order to build a more comprehensive picture of the effect of trabeculectomy surgery 
(or other IOP-lowering treatment) on visual function (including the ability to ascertain 
whether or not recovery from dysfunction has indeed occurred), a longer longitudinal 
study should be conducted, following subjects with glaucoma for a period of time 
before the surgery, and then a period of time afterwards. The availability of several 
measurements of Ricco’s area during a stable period would allow for a calculation of 
projected changes (or otherwise) in Ricco’s area over time, so that any departure from 
the normal rate of change can be easily identified. This would also enable a more 
accurate determination to be made regarding the success, or otherwise, of IOP-lowering 
treatment that might not otherwise be determinable with a conventional Goldmann III 
stimulus. The availability of several measurements of Ricco’s area post-treatment would 
provide a more accurate picture of the success (or otherwise) of the treatment, how the 
visual system adapts to the treatment, and whether or not there is a limit to the 
enlargement of Ricco’s area. Such a large venture is beyond the scope of a PhD 
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however, as this would require several years of repeated experiments. However, the 
findings presented in this thesis provide some preliminary data to inform the design of 
more definitive experiments, in addition to providing initial data on the likelihood of 
measurable dysfunction and neuro-recovery. 
Another interesting investigation to pursue is that of changes in cortical adaptation in 
glaucoma patients, with functional imaging techniques, to better understand how 
cortical function is altered in response to changes in RGC function and/or population.  
A study of grating resolution acuity in amblyopic and non-amblyopic eyes will be 
beneficial to investigate whether or not a smaller Ricco’s area in non-amblyopic eyes is 
accompanied by ‘super-normal’ acuity, and to gain a better understanding of the 
functional capabilities and limitations of eyes that have traditionally been considered 
‘normal’. 
A higher SNR for the RA method compared to the GIII method suggests that stimuli 
optimised to map changes in Ricco’s area in glaucoma (i.e. stimuli smaller than Ricco’s 
area, varying in area) may have greater utility for the identification of visual field 
change over time than the Goldmann III stimulus. A formal comparison of the utility of 
area-modulated stimuli and conventional contrast-modulated Goldmann III stimuli for 
identifying change over time in glaucoma is warranted. 
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Je S, Ennis FA, Morgan JE, Redmond T. Spatial summation of perimetric stimuli across the visual 
field in anisometropic and strabismic amblyopia. (in review) 
 
Je S, Ennis FA, Morgan JE, Redmond T. Spatial summation of perimetric stimuli across the visual 
field in anisometropic and strabismic amblyopia. Invest Ophthalmol Vis Sci 2015:56;2212 E-Abstract 
(ARVO Abstract) 
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Appendix 4: Ethical approval 
Part of the research infrastructure for Wales funded by the National Institute for Social Care and Health Research, Welsh Government. 
Yn rhan o seilwaith ymchwil Cymru a ariannir gan y Sefydliad Cenedlaethol ar gyfer Ymchwil Gofal Cymdeithasol ac Iechyd, Llywodraeth Cymru 
 
Cynhelir Cydweithrediad Gwyddor Iechyd Academaidd y Sefydliad Cenedlaethol ar  
gyfer Ymchwil Gofal Cymdeithasol ac Iechyd gan Fwrdd Addysgu Iechyd Powys 
 
The National Institute for Social Care and Health Research Academic Health Science  
Collaboration is hosted by Powys Teaching Health Board 
 
 
 
 
Wales Research Ethics Committee 1 
Sixth Floor, Churchill House 
17 Churchill Way 
Cardiff   CF10 2TW 
 
Telephone: 029 2037 6823 
     
E-mail: jagit.sidhu@wales.nhs.uk 
 
Website: www.hra.nhs.uk      
 
  
20 May 2014 
 
Dr Tony Redmond 
Lecturer 
Cardiff University 
School of Optometry and Vision Sciences 
Maindy Road 
Cardiff 
CF24 4HQ 
 
 
Dear Dr Redmond 
 
Study title: Measuring changes over time in the retina in eye 
disease 
REC reference: 14/WA/0105 
Protocol number: SPON 1272-2013 
IRAS project ID: 141319 
 
Thank you for your letter of 13 May 2014, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair, Dr K. 
Craig.  
 
We plan to publish your research summary wording for the above study on the HRA 
website, together with your contact details. Publication will be no earlier than three months 
from the date of this opinion letter.  Should you wish to provide a substitute contact point, 
require further information, or wish to make a request to postpone publication, please 
contact the REC Manager, Mrs Jagjit Sidhu, jagit.sidhu@wales.nhs.uk. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the start of the 
study. 
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Management permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned. 
 
Management permission ("R&D approval") should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk.   
 
Where a NHS organisation’s role in the study is limited to identifying and referring potential 
participants to research sites ("participant identification centre"), guidance should be sought 
from the R&D office on the information it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in accordance with the 
procedures of the relevant host organisation.  
 
Sponsors are not required to notify the Committee of approvals from host organisations 
 
Registration of Clinical Trials 
 
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database within 6 weeks of recruitment of the first 
participant (for medical device studies, within the timeline determined by the current 
registration and publication trees).   
 
There is no requirement to separately notify the REC but you should do so at the earliest 
opportunity e.g when submitting an amendment.  We will audit the registration details as part 
of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is registered 
but for non clinical trials this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. 
Guidance on where to register is provided within IRAS.  
 
It is the responsibility of the sponsor to ensure that all the conditions are complied 
with before the start of the study or its initiation at a particular site (as applicable). 
 
Ethical review of research sites 
 
NHS sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see "Conditions of the favourable opinion" below). 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
 
Document   Version   Date   
Copies of advertisement materials for research 
participants  
1.0  25 February 2014  
Covering letter on headed paper    04 March 2014  
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Evidence of Sponsor insurance or indemnity (non NHS 
Sponsors only)  
  18 September 
2013  
GP/consultant information sheets or letters  1.0  25 February 2014  
Letter from sponsor    04 February 2014  
Letters of invitation to participant  1.0  06 March 2014  
Other [CV]  Shindy Je  25 February 2014  
Other [CV]  Prof Morgan  06 March 2014  
Other [Letter from funder]    14 August 2013  
Other [Website Advertisement]  1.0  25 February 2014  
Other [CV]  Lindsay Rountree  25 February 2014  
Participant consent form [Healthy Participants]  1.0  25 February 2014  
Participant consent form  1.0  25 February 2014  
Participant information sheet (PIS)  2.0  16 April 2014  
Participant information sheet (PIS) [Healthy 
Participants]  
2.0  16 April 2014  
REC Application Form  1,0  11 March 2014  
Research protocol or project proposal  1.0  25 February 2014  
Summary CV for Chief Investigator (CI)  Dr T Redmond  04 March 2014  
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating Procedures for 
Research Ethics Committees in the UK. 
 
After ethical review 
 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Notification of serious breaches of the protocol 
 Progress and safety reports 
 Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the light of 
changes in reporting requirements or procedures. 
 
Feedback 
 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.  If you wish to make your views 
known please use the feedback form available on the HRA website: 
http://www.hra.nhs.uk/about-the-hra/governance/quality-assurance/   
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We are pleased to welcome researchers and R & D staff at our NRES committee members’ 
training days – see details at http://www.hra.nhs.uk/hra-training/  
 
14/WA/0105                          Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project. 
 
Yours sincerely 
 
p.p. 
Dr K Craig 
Chair 
 
Email:jagit.sidhu@wales.nhs.uk 
 
Enclosures:  “After ethical review – guidance for researchers” [SL-AR2] 
 
Copy to:  R& D Office, Cardiff & Vale University Health Board 
   R&D Office, Cardiff University 
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